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ABSTRACT OF DISSERTATION 
 
 
BIOMIMETIC ORAL MUCIN FROM POLYMER MICELLE NETWORKS 
Mucin networks are formed by the complexation of bottlebrush-like mucin glycoprotein 
with other small molecule glycoproteins. These glycoproteins create nanoscale strands that 
then arrange into a nanoporous mesh. These networks play an important role in ensuring 
surface hydration, lubricity and barrier protection. In order to understand the functional 
behavior in mucin networks, it is important to decouple their chemical and physical effects 
responsible for generating the fundamental property-function relationship. To achieve this 
goal, we propose to develop a synthetic biomimetic mucin using a layer-by-layer (LBL) 
deposition approach. In this work, a hierarchical 3-dimensional structures resembling 
natural mucin networks was generated using affinity-based interactions on synthetic and 
biological surfaces. Unlike conventional polyelectrolyte-based LBL methods, pre-
assembled biotin-functionalized filamentous (worm-like) micelles was utilized as the 
network building block, which from complementary additions of streptavidin generated 
synthetic networks of desired thickness. The biomimetic nature in those synthetic networks 
are studied by evaluating its structural and bio-functional properties. Structurally, synthetic 
networks formed a nanoporous mesh. The networks demonstrated excellent surface 
hydration property and were able capable of microbial capture. Those functional properties 
are akin to that of natural mucin networks. Further, the role of synthetic mucin as a drug 
delivery vehicle, capable of providing localized and tunable release was demonstrated. By 
incorporating antibacterial curcumin drug loading within synthetic networks, bacterial 
growth inhibition was also demonstrated. Thus, such bioactive interfaces can serve as a 
model for independently characterizing mucin network properties and through its role as a 
drug carrier vehicle it presents exciting future opportunities for localized drug delivery, in 
regenerative applications and as bio-functional implant coats.  
KEYWORDS: Biomimic, Bioapplication, Drug delivery, Filomicelle, Mucin, Polymer 
networks 
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CHAPTER 1. INTRODUCTION 
 
The development of complex nanostructures through molecular self-assembly has received 
much attention, owing to its potential in a wide range of applications (e.g., biomedical, 
energy/energy storage, membranes).1, 2 For instance, the use of amphiphilic di- and tri-
block copolymers based molecular self-assemblies (e.g., filamentous micelles, spherical 
micelles, vesicles, and lamellae) has been extensively explored in the field of biomedical 
science (e.g. as a drug nanocarrier in drug delivery applications).3-6 More recently, these 
polymeric nanoscale systems have been shown to serve as building blocks in layer-by-layer 
(LBL) self-assembling systems, yielding even more complex hierarchical superstructures.7, 
8 The ability of these complex superstructures to function as drug cargo and form bioactive 
surfaces has generated interest in drug delivery9 and biomimetic applications.10-12 
In the human body, mucin networks are formed by the complexation of bottlebrush-
like mucin glycoproteins with other small molecule glycoproteins. Structurally, these 
glycoproteins create nanoscale strands that then arrange into a nanoporous mesh. These 
networks serves a multitude of functions, including surface lubrication and bacterial 
regulation, providing surface hydration and barrier protection. The function of these 
networks is greatly tied to their structural (e.g. morphology, thickness, and mesh size), 
chemical (e.g. charge, hydrophobic interactions) and mechanical properties (e.g. rheology). 
Yet, as these properties are highly interrelated, it is difficult to tease out their relative 
importance. By taking cues from oral biology, in this work, we suggest it may be possible 
to use directed self-assembly of micellar systems to synthetically recreate the 
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micro/nanoscale features of mucin networks. These synthetic networks are expected to 
serve as an artificial model. By developing a modular structural mimic, which is capable 
of easily tuning its network property (e.g. morphology, mesh size, thickness, chemistry), 
the bulk behavior in natural mucin networks can be easily decoupled, allowing one to 
identify its relative significance.  
In this work, we demonstrate the ability to synthetically recreate mucin-like 
structures from layer-by-layer networks of filamentous micelle nanostructures. Using a 
layer-by-layer approach, the micelles are self-assembled at the solid-liquid interface in a 
controlled fashion, generating hierarchical 3-dimensional networks of desired thickness. 
During LBL development, alternating additions of biotinylated-polymeric micelles and 
streptavidin were performed. Unlike conventional polyelectrolyte-based LBL methods, the 
self-assembling was driven through highly bio-specific biotin-streptavidin interactions. To 
critically evaluate the biomimetic nature of these synthetic mucin networks, an in-depth 
study on their structural and biofunctional property was carried out.  
The synthetic mucin networks demonstrated the formation of nanoporous structures 
during multilayer growth through micelle fusion. These porous structures, with their 
enhanced surface area, allowed for bacterial capture, and through their hydrophilic 
domains, exhibited good surface hydration. Further, the networks demonstrated substantial 
robustness under destabilizing chemical environments. Since, the micelle structures can 
encapsulate small molecules within its hydrophobic core, we have demonstrated these 
synthetic networks can serve as drug releasing networks. This functional property finds 
application in providing a localized delivery or in developing bioactive interface (e.g. as 
functional thin-film coats).  
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From these encouraging results, we suggest the synthetic networks can be extended 
to serve as a model framework in exploring functional properties in natural mucin 
networks. By careful selection of LBL building blocks, the network properties (e.g. charge, 
porosity or barrier thickness) can be tailored to decouple their critical functionality (e.g. 
bacterial capture, drug permeation).13, 14 Analogously, these network properties (structural 
and functional) can be extended to provide a more fundamental understanding of mucin-
bacterial interactions (e.g., charge vs. structural properties of the mucin network resulting 
in bacterial capture). Additionally, these functional structures can potentially serve as a 
drug delivery system for topical applications. By integrating with non-invasive delivery 
systems (e.g. thin films, patches), they can potentially be used for a localized sustainable 
payload delivery with possible epithelial protection.  
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CHAPTER 2. BACKGROUND 
Based on the research article: 
S.P. Authimoolam and T.D. Dziubla, “Biopolymeric Mucin and Synthetic 
Polymer Analogs: Its Structure, Function and Role in Biomedical 
Applications”, Review article, Polymers (Submitted). 
2-1. Mucin Network Molecular Properties 
Mucins are glycosylated glycoproteins secreted by epithelial goblet cells, and mucus cells 
present in submucosal glands.15 The term “glycosylation” refer to covalent association of 
carbohydrate (oligosaccharide) chains with glycoprotein (polypeptide) backbone. In the 
oral mucosal surface, the acinar epithelial cells, and in gastric region, the foveolar cells are 
primarily responsible for mucin production. These glycoproteins are key constituents in 
forming slimy lubricous coatings, and in the oral cavity, they primarily determine the 
rheological properties of saliva.3, 16, 17 The mucin glycoproteins can be broadly categorized 
on the basis of their molecular weight (MW) and its interconnected function. In the oral 
cavity, the low MW glycoprotein chains of 200-300 kDa, composed of a single 
glycosylated peptide chain, form an important fraction of the free flowing saliva and they 
help regulate bacterial clearance. While, the high MW glycoproteins of >1000 kDa 
constitute a significant part of oral salivary films, or mucin network coats (bound saliva), 
which helps from a protective epithelial shield.4, 18, 19 In the buccal region, these functional 
coats are more commonly referred as oral mucus, mucin coats or salivary pellicle.3, 16, 17 
In general, the mucin molecule contains a polypeptide backbone which is 
predominantly composed of serine, alanine, proline, glycine and threonine, and constitutes 
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nearly 75% of the total amino acid. The hydrophilic oligosaccharide side chain decorates 
the peptide backbone, which gives mucin its bulk hydration properties (Figure 2.1).20, 21 In 
mucin, nearly 50-80% of its dry weight is composed of these oligosaccharide chains.22, 23 
These oligosaccharide chains are highly polydisperse and vary substantially between 
species and mucosal surfaces.23 In addition, mucins also contain non-glycosylated sites, 
which enable interchain disulfide bridging through complexation with the glycosylated 
subunits. These unprotected non-glycosylated regions are vulnerable to proteolytic 
cleavage. Thereby, under proteolytic conditions, the mucins can break-down into smaller 
subunits and become part of the free-flowing saliva.  
Mucin possess a bottlebrush-like structure. The high molecular weight 
glycoproteins are structurally analogous to filament possessing high structural aspect ratio 
(L/D).24 These glycoproteins crosslinks via disulfide bonds, forming longer branched 
structures (mucin multimers). The multimers can randomly undergo higher order 
associations with glycoprotein chains and with small molecule proteins (Figure 2.1). These 
associations are driven by a wide variety of molecular interactions such as disulfide 
bridging, hydrophobic interactions, electrostatic forces and hydrogen bonding, forming a 
more intact, 3-dimensional viscoelastic biopolymeric network.20, 25 For instance, in the oral 
cavity, the salivary proteins adsorb onto the mucosal epithelial surface. The process is 
accompanied by continuous depositions (self-association) from glycoproteins chains and 
complexation with oral proteins,17 forming oral mucus coats.   
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Figure 2.1. Progression of higher order complexation in mucin glycoproteins  
Scheme showing progression of the high-order complexation process, which results in the formation of ordered mucin aggregates. Mucin 
aggregates contain two-distinct zones: the more intact adherent mucin layers, and loosely-held (expanded) mucin layers of high free-
volume. Adapted from Cone R.A., Barrier properties of mucus, Advanced Drug Delivery Reviews, 2009, 61, 75-85, “Johansson ME, 
Larsson JM, Hansson GC. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of 
host-microbial interactions. Proc Natl Acad Sci U S A 2011;108 Suppl 1:4659-65” 26 and “Khanvilkar K, Donovan MD, Flanagan DR. 
Drug transfer through mucus. Adv Drug Deliver Rev 2001;48:173-93”.27  
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2-2. Natural Mucin Network Function 
Mucin is almost ubiquitously presently in all biological systems. They line mucosal 
epithelial surfaces in the ocular, nasal, buccal, respiratory, gastrointestinal tract, vaginal 
and rectal regions. In general, mucin networks regulate bacterial adherence (aggregation 
and/or clearance), provide surface lubricity, retain moisture (through surface hydration), 
acts as a protective shield for the underlying mucosal surface, and allow for a selective 
permeability (e.g. oxygen transport, nutrients).4, 17-19 
In eyes, the protective barrier is referred as the tear film (thickness ~6-10 µm),22 
which is constituted by 1) an innermost ocular mucin coat that immediately surrounds the 
epithelial surface in protecting them, 2) an intermediate aqueous layer that is formed from 
soluble mucin components, and 3) an outermost oily layer. The function of the mucin layer 
in tear film is to help 1) regulate the stability of aqueous-oily layers,28 2) act as a barrier in 
protecting the underlying epithelial surface, and 3) aid in retaining epithelial moisture.28, 29 
In the buccal cavity, the mucin networks offer selective permeability (e.g. 
unhindered transport of solubilized molecules to taste receptors) and coupled with its 
barrier properties (e.g. lubrication, surface hydration and protection) helps in regulating 
oral health. Clinically, with lack of those functional properties, it results in oral dryness 
(e.g. xerostomia) accompanied by painful inflammation. With the loss of the mucin barrier,  
there is a high risk for increased bacterial colonization and mucosal ulcerations.17 These 
mucin networks, when extended over enamel surfaces, are referred to as acquired enamel 
pellicle. When the tooth surface is exposed to acidic conditions, the pellicles aid in reducing 
enamel-demineralization.30 Mechanistically, the mucin networks are formed through 
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higher ordered complexation-aggregation deposition process as that of acquired pellicles, 
independent of the substrate-interfacial site (enamel or buccal surface) or tissue hardness 
(soft or hard oral tissue).  
In the respiratory tract, the mucin network regulates bacterial and particulate 
removal through mucociliary clearance. During inhalation, the respiratory mucin coats 
provide air humidification and helps maintain epithelial hydration.31 In regions of the 
stomach and duodenum, the adherent mucin layer acts as a shield, protecting the epithelium 
from direct gastric juice exposure (e.g. hydrochloric acid, pepsin), commonly referred as 
gastric mucosal barrier (GMB).32 The barrier property in GMB is due to the formation of 
a mucin-bicarbonate barrier, where the bicarbonate secretions occur from the mucosal 
surface. This barrier creates a pH gradient across luminal (low pH) to epithelial side (high 
pH), protecting the epithelial surface.33, 34 Also, the mucin networks are selectively 
permeable, allowing for cell migration and repair of damaged tissue. The mucin network 
creates a micro-environment for cellular components (e.g. cells, plasma proteins), forming 
a mucoid cap via its scaffold-like structures, thus promotes revascularization.35, 36 
In the gastrointestinal tract, mucin’s slippery lubricative effect facilitates an easier 
bolus (food) passage through the intestine. In addition, mucin serves as a matrix that 
promotes adherence of probiotic strains (e.g. lactobacilli, bifidobacterium).37-39 The 
synergistic probiotic-mucin association helps form significant mucosal protective barriers, 
protecting against harmful microbial infections (e.g. bacterial, viral).40-44 Any compromise 
in the barrier integrity could alter food digestion, render epithelium vulnerable to enteric 
pathogens and can cause intestinal inflammation.38, 45  
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In the cervix, the mucin network functions like a selective permeable layer, 
commonly the cervical mucus plug. The mucus plug hinders transport of bacteria and 
viruses (e.g. Lactobacillus spp., herpes simplex virus)46, 47 in the reproductive tract, while 
preferentially aiding in the mobility of spermatozoal migration. Any irregularities in 
function of the cervical mucin networks can even cause infertility.48, 49 Recent studies 
(Shukair et al. (2013), Boukari et al. (2009)) have demonstrated the protective barrier effect 
of human cervicovaginal mucus in impeding HIV type1 transport to underlying epithelium. 
50, 51 
2-3. Mucin Network Structural Characteristics 
Morphologically, during the initial network formation stage over a surface, the 
glycoprotein depositions resembles as granular inhomogeneous structure. However, at 
greater time scales of aggregation, due to prolonged fibrillar depositions and complexation 
process, those granular structures form a continuous interwoven morphology (reticulated 
structures).52, 53 For instance, Lie et al. (1976) used hydroxyapatite/epoxy resin splints as a 
model enamel substrate in studying the mechanism of mucin pellicle formation. In their 
study, the splints were bound to the buccal surface. At relatively short time scales (~2 h), 
the pellicles formed heterogeneous granular structures with a barrier thickness ranging 
from 25 to 125 nm. While at greater time scales (~24 h), they formed a continuous thick 
film of ~550 to 900 nm.30, 52-54 In more recent work, Baek et al. (2009) used optical 
approaches in studying the time-dependent salivary pellicle formation over tooth surfaces, 
in congruence with the earlier results, this study suggested a similar structural surface 
growth tendency.55  
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In a more simplistic representation, mucin networks can be visualized as 
multilayers of mucin glycoproteins. In the respiratory or gastrointestinal tract, the networks 
contain two distinctive zones. Such delineation was also found in the oral cavity, in both 
the buccal soft surface and tooth pellicle. The two zones were 1) loosely adherent outer 
layers with an expanded free volume that were prone to easy removal, and 2) a more intact, 
mucosal adherent inner layer.56-58 The loosely held outer layers are formed via disulfide 
intermolecular bonding. While, the inner layers of mucin networks are self-organized from 
relatively longer mucin chains, whose hydrophobic domains firmly anchors it to the 
epithelial surface. Further, aided by complexation, they form a more robust, tight 
network.27 This work is designed in recreating the intact inner layers via a synthetic 
approach.  
Hong et al. (2005) examined the mucin aggregation tendency as a function of pH 
and suggested its morphology resembled that of micellar aggregates.54 Interestingly, the 
structural and rheological properties of the mucin network is highly interrelated and is 
greatly influenced by pH and ionic concentration. For instance, using gastric mucin, studies 
by Cao et al. (1999),59 which was later supported by Hong et al. (2005),54 have 
demonstrated that mucus undergoes sol-gel transition under different pH, where at 
simulative gastric environment (pH <4), the glycoprotein chains possess an extended 
conformation as opposed to the random coil state. This chain reorientation favors 
hydrophobic complexation between glycoprotein chains, causing gelation of viscous 
solution into a tight protective intestinal barrier. Apart from the pH, such conformational 
shifts can occur due to changes in ionic environment effecting from electrostatic charge 
interactions.59 Hence, influenced by regional environmental conditions, the structural 
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organization of natural mucin networks can differ along different regions within the body. 
This structural property variation (e.g. pore size, viscosity) plays a critical role in its 
biofunctional behavior. As an example, human cervical mucus shows dissimilar network 
structural organization at different phases of menstrual cycle, impacting the spermatozoal 
transit.60, 61  
The radius of gyration of high MW natural mucin (~19000-32000 kDa) ranges from 
~ 190 to 270 nm. In a more detailed look, the mucin diameter can range from 3-10 nm, and  
its length can span out from 100 nm to several microns.62 For instance, studies by Round 
et.al (2002) have shown that in ocular regions, the glycoproteins contour length distribution 
can extend upto 1500 nm.63, 64 These glycoprotein chains self-organize forming networks, 
whose structural properties, such as thickness and porosity, can vary significantly both 
within and across different regions (Figure 2.2). For instance, in human gastrointestinal 
track, the mucin network thickness is found highly variable ranging between 50 to 450 µm 
(see Figure 2.3 for thickness distribution in different mucosal surface).36 Likewise, the 
thickness variations can also be seen in different species, for instance Atuma et al (2001)56 
measured the rat gastro-intestinal mucin network thickness. In their studies, the network 
thickness was quantified for both intact and loosely-bound mucin layers (Figure 2.4).  
The thickness variations in mucin networks is highly dependent on their nearness 
to secretory glands and other physical factors. For instance in the oral cavity, the mucin 
network thickness can be independent of age factors, however other factors such as relative 
position of salivary glands or surfaces that are adjacent to breathing, mastication, and 
swallowing can significantly affect.65 Studies by Collins et al. (1987) 65 and Tinanoff et al.  
(1976) 66  have compared mucin thickness of different age groups. Their results suggests, 
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in oral cavity, the mucin thickness is independent of the differences in total surface area 
availability between adult and children. And, relative to buccal soft tissue, the mucin 
thickness along enamel surfaces is significantly lower (Table 2.1). 
Study by Olmsted et al. (2001)67 on human cervical mucins have shown that network 
porosity is highly variable, ranging from 20 to 200 nm. Lai et al. (2011) reported that in 
cervicovaginal regions, the mucus mesh size ranges from 50 to 1800 nm40, while Matsui et 
al. (2006)68 reported the  tracheobronchial mucus to range from 200 to 1000 nm. 
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Table 2.1. Comparison of oral mucin thickness in adult and children 
 
Surface Total Surface Area (cm2) 
Mucin Thickness 
(µm) Reference 
Oral Cavity 
(5-year Children) 
~117.6 ± 7.6 ~50-90 
Tinanoff et al. 
(1976)66 
Oral Cavity 
(Adult) 
~214.7 ± 12.7 ~70-100 
Collins et al. 
(1987)65 
Tooth Enamel -  ~0.03-0.1 
Tinanoff et al. 
(1976)66 
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Figure 2.2.  Cryo-SEM imaging of pulmonary mucin, demonstrating heterogeneous 
mesh size  
(Illustrated figure was taken from article “J. Kirch, A. Schneider, B. Abou, A. Hopf, U.F. 
Schaefer, M. Schneider, C. Schall, C. Wagner, C.M. Lehr, Optical tweezers reveal 
relationship between microstructure and nanoparticle penetration of pulmonary mucus, P 
Natl Acad Sci USA, 109 (2012) 18355-18360.”)69   
Reproduced with permission, Copyright © 2009, National Academy of Sciences.  
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Figure 2.3. Thickness distribution of mucin networks across different mucosal surfaces in healthy humans  
Adapted from Collins et al. (1987),65 Olmsted et al. (2001),67 and Allen et al. (1993).35 
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Figure 2.4. Thickness distribution of mucin networks in rat gastro-intestinal tract  
Adapted from Atuma et al. (2001).56 
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2-4. Bacterial Interactions with the Mucin Network 
Mucins, via their adhesion tendency, play a critical role in microbial capture across 
different regions, which helps regulate microbial growth and maintain health.  Human body 
is rich in diverse variety of bacterial flora. For instance, it is estimated in humans that nearly 
500 species of bacteria populate the oral cavity (e.g. Streptococcus, Gemella, 
Granulicatella, Veillonella).70-72 In the mucosal epithelium, the loosely adherent mucin 
outer layers function as a sacrificial trap in aggregating bacteria, which aided by oral 
salivary flow helps in regulating bacterial clearance.20 While, the innermost, tightly bound 
mucin layers act as a barrier and prevents bacteria accessing the epithelial surface. In the 
gastrointestinal tract, the mucin barriers shield the epithelial surface from polymicrobial 
infection. This barrier function, if compromised, can lead to chronic inflammation, causing 
ulcerative colitis.38 The mucin bacteria adherence mechanism can be more readily 
understood by knowing the bacterial growth process over tooth surfaces. The mucin 
pellicles promote bacterial adherence, yet also helps protect the tooth from acid 
demineralization effects.73 Interestingly, if the adherence process is left unregulated, this 
can result in a serious complications, including the dental caries and periodontal disease in 
oral cavity, or cystic fibrosis, chronic obstructive pulmonary disease (COPD) and bronchial 
asthma in pulmonary tracts.74, 75 
Extensive studies were performed to understand the bacterial distribution among 
different mucosal regions, and how their diversity changes with pathologic conditions. For 
instance, Aas et al. (2005)72  studied the bacterial flora diversity in different regions 
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(hard/soft tissues) of the oral cavity and found that there is significant difference in bacteria 
flora distribution between diseased and healthy patients (see Table 2.2). 
The mucin-microbial capture mechanism can be attributed to the specific surface 
receptors available in the microbes (e.g. adhesins such as lectins and enzymes). Driven 
through non-covalent molecular forces such as charge and hydrophobicity (mucoadhesive 
effect),76, 77 the microbial receptors specifically bind to the oligosaccharide chains available 
in mucin glycoproteins (e.g. oral pellicle).72, 76, 78-80 During the mucoadherence process, the 
favorable molecular conformation of glycoprotein chains facilitates improved microbial 
capture. For instance, mucins with high proline content, due to its hydrophobic nature, 
easily anchors to the epithelial surface, which allows oligosaccharide side chains to orient 
toward exterior apical side, aiding adherence.20 Apart from adhesive forces, the screening 
effect emanating from the size differences between network mesh and microbes can also 
play an important role, thwarting microbial accessibility to the underlying surface.   
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Table 2.2. Predominant bacterial species and its distribution in oral cavity.  
Lists of predominant bacterial species distribution in different regions within the oral cavity 
of healthy human. Adapted from findings from Aas et al.72 
 
 
 
 
 
 
 
 
 
 
 
Region within Oral Cavity Predominant bacterial species 
Bacterial epithelium Streptococcus mitis, Streptococcus mitis bv.2, Abiotrophia defective, Gemella hemolysans 
Maxillary anterior vestibule Streptococcus mitis, Granulicatella spp., Gemella spp. 
Tongue Streptococcus spp., Granulicatella adiacens, Veillonella spp. 
Hard palate Streptococcus spp., Granulicatella elegans, Granulicetella hemolysans, Neisseria subflava 
Soft palate Streptococcus mitis, Granulicatella adiacens, Gemella hemolysans 
Tonsil Prevotella spp., Porphyromonas spp.,Firmicutes spp. 
Tooth surface 
Streptococcus sp. Clone EK048, Streptococcus 
sanguinis, Strepetococcus gordonii, Rothia 
dentocariosa, 
Gemella hemolysans, Gemella adiacens, 
Actinomyces sp. Clone BL008, Abiotrophia defectiva 
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2-5. Need for Rigorous Characterization  
In drug delivery applications, the mucin coats and its underlying epithelium were the major 
contributors in inducing reduced drug permeability across buccal mucosa. In an effort to 
improve the drug permeability across mucin networks, there is a growing interest among 
researchers to understand network properties (physical and chemical behavior). Much of 
their work has centered on studying the effect of nanoparticle physicochemical 
characteristics (e.g. nanoparticle size,81 surface chemistry,67, 82, 83 and PEGylation81) on the 
transport properties across mucin networks.  
Despite these efforts, the bulk network behavior remains unclear or sometimes 
contradictory. For instance, different studies conducted in understanding effect of 
nanoparticle (NP) surface chemistry (carboxy-, amine- or sulfate- functionalized NPs) 
lacked any conclusive trend.67, 82, 83 Lai et al. (2007)81 studied the transport of PEGylated 
nanoparticle across mucin networks, using NPs of different diameters. To obviate PEG 
interpenetration with mucin glycoprotein chains, the study utilized relatively lower MW 
PEG chains of ~2kDa and their results showed an improved transport across mucin network 
in comparison with uncoated particulates. 81, 84 Interestingly, among PEGylated 
nanoparticles the larger particulates demonstrated a more rapid transport than the smaller 
particles. In particles with larger diameter ~200, ~500 nm, diffusion was only 6 and 4-fold 
lower in cervical mucus than that of pure water, respectively. However, for smaller 
particles (diameter ~100 nm), the diffusional rate was nearly 200-fold lower. This was 
particularly surprising as the mesh size in the mucin networks was previously reported to 
be in the range of 10-200 nm.67, 81, 85 
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The formation of mucin networks is a dynamic process is constantly subjected to 
removal and reformation effects. Thus, a thorough understanding of mucin network 
properties, its physical and chemical understanding can play a critical role in predicting 
bulk interaction with drug (or drug nanocarrier) formulations. Such approaches help 
formulation scientists in designing drugs that allows for a rapid mucin clearance and 
improved epithelial availability.  
2-6. Synthetic Mucin Networks 
2-6.1. Why Develop Synthetic Mucin Networks? 
Mucin network function (e.g. bacterial capture, permeable barrier) arise from complex 
interplay of molecular interactions and structural properties. By developing versatile 
synthetic systems, the key characteristic network property can be easily tailored. By 
understanding physicochemical changes in synthetic network and its effects on bulk 
properties, the combinatorial trend can potentially be deduced aiding in the development 
of a predictive mucin network model. The predictive model can be used to decouple 
fundamental cause-effect relationships in natural mucin networks. For instance, in studying 
the barrier tendency in mucin network and its effect on particle mobility (nanoparticle 
permeation rate) for transmucosal drug delivery or in understanding fundamental bacterial-
mucin network interactions or studying independently the role of chemical and structural 
properties of mucin network on biofunction such as mucin bacteria interactions. 
Additionally, these modular biomimetic structures can serve as an in vitro model which 
can be used in studies involving trans-mucosal drug delivery.  
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2-6.2. Key Factors in Synthetic Mucin Networks 
Few key considerations in developing a synthetic structures 1) requires a facile approach 
in forming networks, 2) the approach should be highly modular and versatile that is capable 
of developing networks with tunable structural (e.g. barrier thickness, network mesh size) 
and chemical property (e.g. charge, hydrophobicity), 3) ability to easily elicit 
physicochemical modifications in component building blocks, 4) synthetic networks 
should be capable of structurally and functionally mimicking bulk properties of natural 
networks, and 5) the approach should be capable of recreating the formation mechanism of 
natural mucin networks. 
2-6.3. Proposed Approach for Developing Synthetic Mucin Networks 
A simple biomimetic system that can recreate the mucin network is proposed (Figure 2.5). 
In the synthetic approach, polymer based nanostructures were used as the principal building 
block. These polymeric nanostructures5, 86, 87 can be deposited onto a surface in a controlled 
fashion by providing a series of alternating rinses from complementary crosslinking 
chemistries. Our hypothesis is that through control of the shape/structure conformations of 
polymeric nanostructures, it is possible to generate a 3-dimensional network structure 
similar to that of natural mucin. In evaluating this proof of concept, biotinylated polymeric 
micelles of different size/structures (filomicelles or spherical micelles) will be formulated 
and deposited as layer-by-layer (LBL) via biotin-streptavidin affinity interactions. This 
approach is expected to serve as a model framework in fabricating modular structures of 
specific physicochemical properties. By using polymeric micelles as a building block, 
micelle can be incorporated with growth factor, small molecule drugs and/or enzymes to 
render therapeutic/biofunctional property to the self-assemblies. The approach can also be 
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extended to function as a drug releasing network (e.g. localized buccal drug delivery) or as 
a drug protective cargo (e.g. protein encapsulation) or in developing a functional bioactive 
interface (e.g. implant coatings). By administering biotinylated micelles and streptavidin 
as a series of non-viscous oral mouth rinses, these self-organized superstructures can also 
be potentially in situ grown over entire buccal cavity for bio-applications or used as a 
biofunctional implant coat in LBL systems requiring higher number of deposition cycles. 
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Figure 2.5. Illustrative scheme showing biomimetic synthetic mucin network  
Scheme illustrative of proposed application as a synthetic oral mucin mimic and its 
comparison with naturally formable oral mucus. 
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2-6.4. Filamentous Micelles as an Building Block in Synthetic Network Formation 
As described earlier, during hierarchical self-assembly (aggregation) and formation of 
mucin networks, the mucin glycoproteins constitute the major component building blocks. 
The high molecular weight mucin glycoprotein is structurally similar to filamentous 
micelles (FM), possessing high aspect ratio (L/D). Studies by Round et.al (2002) have 
shown that in ocular regions, the glycoproteins contour length distribution can extend upto 
1500 nm.63, 64 The radius of gyration in high MW natural mucin (19000-32000 kDa) 
glycoprotein ranges from 190-270 nm. Mucin diameter ranges from 3-10 nm, while its 
lengths can span out from 100 to several microns.62 The synthetic alternate, polymeric 
filomicelle possess diameter of 180-324 nm with its contour length distribution ranges from 
5-25 µm.88 Conceptually, FM can be visualized as bundles of mucin glycoproteins. In FM, 
the PEG chains form the outer corona which can be projected as a structural replacement 
of oligosaccharide branched structures in natural mucin. While, drug loaded micellar core 
in FM is visualized for the polypeptide backbone present in natural mucin (see analogical 
structural comparison between building blocks in Figure 2.6).  
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Figure 2.6. Structural comparison between natural mucin glycoprotein and synthetic 
filomicelle  
Scheme shows naturally formable mucin (adapted from “Engineering design and molecular 
dynamics of mucoadhesive drug delivery systems as targeting agents” by Serra, Peppas et 
al., 2009)89 and analogical synthetic mucin precursor, filomicelle.  
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2-6.5. Role as a Drug Releasing Network in Oral Mucosal Delivery 
In oral mucosal drug delivery system, the commonly adopted approaches were 
mucoadhesive gels and thin films. These treatment methods are an improvement over non-
carrier delivery routes (e.g. sprays, tablets), yet suffer from poor oral retention and/or 
patient compliance.90, 91 For instance, spreading mucoadhesive gels over entire buccal 
cavity in oral complication such as xerostomia creates poor patient compliance due to their 
bulkiness. Xerostomia is a painful inflammatory condition that invariably occurs in 
subjects lacking oral mucin network. With loss of salivary flow, the patients develop 
painful inflammation due to lack of oral hydration. Patients develop a perceptive feeling of 
dryness, with difficulty in swallowing and becomes increasingly susceptible to mucosal 
ulceration, bacterial and fungal infections (e.g. dental caries, oral candidiasis).92 In the 
United States, one to four million people suffers from Sjőgren’s syndrome (dry mouth & 
dry eyes) and nearly 20-30% of the people were affected by xerostomia, with increasing 
prevalence among seniors and women.93-95 This illustrates the critical role of mucin 
networks in the oral cavity. Therefore, developing a synthetic network with additional 
capable drug delivering potential could serve as a replacement for lost mucin barrier and 
could potentially be applied in oral mucosal specific drug delivery applications.  
Our current approach uses polymeric micelles as a network building block, well 
known for its drug-delivery potential. Therefore, by utilizing its ability to encapsulate small 
molecule drug or protein, they could develop into a functional drug eluting system. Such 
approaches could obviate inadequacies in the existing treatment methods by potentially 
offering 1) enhanced therapeutic bioavailability by improving oral drug residence time, 2) 
provide localized oral drug delivery for mucosal complications (e.g. oral mucositis, 
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candidiasis), 3) protect injured oral surfaces through its robust polymeric barriers, and 4) 
ability to develop into a porous network that can function as permeable structure which 
selectively allows soluble molecule (e.g. nutrients) to access the oral taste buds.  
2-7. Molecular Self-assembly in Fabricating Complex Structures 
2-7.1. Molecular Self-assembly  
Whitesides et al. (2002)96 stated self-assembly as, “a spontaneous process in which 
components, either separate or linked, form ordered aggregates, this is not limited to 
molecules extends from molecules to galaxies”, which concisely suggests its broad 
perspective. Due to its prevalence or common occurrence, self-assembly is not a single 
field of study, and it lacks a structured definition.97 
Self-assembly is a facile, cost-effective bottom-up approach in generating 
nanostructure systems. In recent years, nanoscience and nanotechnology as a field has 
received attention, exploring its potential in extensive variety of applications (e.g. 
Theranostics, biomimetics, and drug delivery). This resulted in the generation of newer 
fields (e.g. nanomedicine, nanobiotechnology) with specific interests under the umbrella 
of “nano”.97 The understanding of different critical factors that independently or in 
combination play a critical role in self-assembling had enabled researchers to utilize the 
approach in developing functional nanostructures (Figure 2.7).  
2-7.2. Generating Polymeric Nanostructures at Liquid-Liquid Interface 
Synthetic molecular self-assembly has received much attention for their potential in 
biological applications (e.g. nanostructures such as micelles, liposomes, polymersomes).1-
3 Among polymer based self-assembly, the use of amphiphilic di- and triblock copolymers 
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and their role in developing polymeric nanostructure as a carrier vehicle has received much 
interest in the areas of liquid-liquid interfacial self-assembling. This is due to the ability of 
those polymers to generate a wide variety of complex supra-molecular architectures such 
as filamentous micelles, spherical micelles, vesicles, and lamellae structures.3, 4, 98-101 
The ability of amphiphilic polymers to create different morphologies is due to the 
balance of three forces that contribute to free energy during molecular self-assembly. These 
forces comprises of 1) interfacial energy between core and corona chains, 2) the repulsive 
forces (e.g. steric/ionic forces) between coronary chains, and 3) the stretching of core 
chains.99 By altering the force balance, desired morphological changes can be induced. For 
instance, in diblock copolymers possessing dissimilar blocks, by tuning amphiphilicity 
and/or relative hydrophobic block length, the hydrophobic core packing properties was 
altered yielding different micellar morphologies.5, 86, 102  
During self-assembling of amphiphilic diblock copolymers at the bulk liquid-liquid 
interface, the hydrophobic chains pack into a compact core while the hydrophilic chains,  
due to their preferential affinity towards bulk aqueous phase orient outward forming a 
hydrophilic outer coronary shell. This process forms nanostructures with micellar core that 
can serve as a depot for small molecule drug or protein loading. The morphology of the 
nanostructures is highly dependent on its packing properties. Conventionally, the packing 
properties in diblocks (or lipids) are expressed in terms of molecular packing parameter 
(P),  
P= ν/a0*lC,  
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where ν=volume encompassed by hydrophobic block, a0=effective cross-sectional area of 
hydrophilic block, and lC=critical length of hydrophobic block.103-105  P<1/3 forms spheres, 
1/3 <P< 1/2 for cylindrical structures and 1/2 <P<1 forms vesicle bilayers. In lipid or 
polymer based drug carrier formulation, this dimensionless parameter (p) helps predict and 
control formable structures.105-107 
These polymer based nanostructures have been widely studied for drug delivery 
applications. While utilizing these micelle as a building block to hierarchically form more 
complex structures is relatively less studied.96, 108 Our current work suggests such 
approaches can be extended in forming a structural synthetic biomimic with potential to 
serve as an artificial model and possess regenerative medicine applications, by utilizing its 
structural complexity.  
2-7.3. Hierarchical Self-assembly as an Approach in Generating Biomimetic 
Structures 
2-7.3.1. Hierarchical Self-assembly 
While, the formation of polymeric micelles from amphiphilic copolymers or liposomes 
from lipids are few example of single-leveled molecular self-assemblies, however in 
natural processes, much of the structures are derived out of more complex multileveled 
self-organization or hierarchical self-assembly. Hierarchical self-assembly is a process 
where primary precursors (or building block) self-associate into secondary complex 
structures, which in turn can result to form more complex structures. During multi-level 
self-assembly, structures at different length scales can span out (Figure 2.7). For instance, 
protein aggregates were hierarchical self-organization which precedes from amino acid, 
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peptide, and protein self-assembling and the self-organization seen in tendons precedes 
from tropocollagen, microfibrils, subfibriles, fibrils, and fascicles 96, 109, 110.  
2-7.3.2. Few Recent Works Utilizing Hierarchical Self-assembling Approach 
O’Leary et.al (2011)12 replicated the process of multileveled hierarchical assembling of 
collagen using a peptide sequence proline-hydroxyproline-glycine (derived from collagen). 
Peptide self-organizes via molecular interactions (electrostatic, hydrogen bonding) 
between lysine and aspartate groups. During the process, an off-set lag between 
neighboring peptide chains is generated which causes spatial reorganization, forming a 
triple helix. These helixes further propagated and resulted in fiber growth, which under 
similar bridging forces bundled and laterally stacked up themselves, forming nanofiber 
hydrogel. Interestingly, these synthetic collagen analogues degraded under collagenase, 
which was similar to the properties found in natural structures, thereby further 
demonstrating their biomimetic nature. 
In an another study, Knowles et.al (2010)111 demonstrated self-assembly in 
amyloidogenic protein. Using a 2-step process, hierarchical self-organization of proteins 
generated structures at multiple length scales. In the first step, monomeric protein is self-
assembled in bulk solution, forming amyloid protein fibrils. By using those preassembled 
fibrils in the second step, a thin film was self-organized through a casting (solvent 
evaporation) method at solid interfaces. This generated nanostructured protein films, 
possessing excellent mechanical rigidity, which can be potentially used as a protein specific 
biofunctional coat.111, 112 
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Similarly, Li et al. (2014)113 demonstrated an hierarchical 2-step self-organization 
in forming flower-like microspheres. These microspheres were organic-inorganic hybrids, 
which were formed from dopamine (DA) and phosphotungstic acid (PTA). During the 
initial stage, the nanoparticle building blocks were rapidly formed via nucleation growth. 
These nanoparticles, through a more gradual secondary process, resulted in loosely 
aggregated primary structures with short nanopetal like-growth, resembling ellipsoidal 
structures. Taken further, the ellipsoidal structures transitioned into highly ordered, flower-
like microspheres containing hundreds of nanopetals with smooth surface morphology, a 
result of classical ostwald ripening. The fundamental mechanism behind those hierarchical 
aggregation is not fully understood. Interestingly, those hybrid 3-D hierarchical structures 
were explored for their potential in oral drug delivery by physisorption of model anti-
cancer drug, doxorubicin (pKa=8.22). With pH shifts along the GI tract, these loaded drug 
carriers could be desorbed in intestine to result in a rapid drug release. 
In our current work, we adopted a layer-by-layer technique to form biomimetic 
structures in a more controlled way at liquid-solid interfaces. Utilizing the versatility of 
LBL, the self-organizing process can be driven through wide range of molecular 
interactions, and structures of desired thickness can be developed by controlling number 
of LBL deposition cycles. Further, during the LBL process appropriate structural 
components can be incorporated to fabricate into a desired functional biomimic.   
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Figure 2.7. Self-assembling at different length-scales and various critical factors 
affecting the self-organization process  
a) Scheme outline self-assembly, which can hierarchically span different length scales. b) 
Suggests different critical factors which independently or in combination can play a critical 
role during self-assembling or to develop desired complex structures.96  
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2-8. Layer-by-Layer Technique 
2-8.1. LBL Technique and Its Versatility 
Iler (1966),114 in his pioneering work, had introduced the layer-by-layer technique by self-
assembling multiple layers of colloidal particles from alternating positive and negatively 
charged colloids. Adopting a similar approach, Decher et al. in 1990’s 115-117 stimulated a 
wide interest by demonstrating polyelectrolyte based multilayer growth from oppositely 
charged polymers.118, 119 Layer-by-layer (LBL) assembly is a simple yet powerful 
technique to develop multilayers with controlled precision. Conceptually, the multilayers 
are developed by providing alternating additions of complementary building blocks that 
are driven by molecular interactions such as electrostatic, covalent, hydrophobic,120, 121 
hydrogen bonding,122 metal-ligand coordination,123 or a combination of multiple molecular 
interactions (molecular recognition) 120, 124, 125 (Table 2.4). With examples from various 
possible molecular interactions, the field grew more versatile, encompassing a wide variety 
of building blocks such as polyelectrolytes, redox-active polymers, and structures such as 
polymeric/organic dendrimers,126-128 micelles, metal nanoparticles,129 protein 
nanoparticles,130 nanotubes,131, 132 quantum dots,133 polypeptides,134 viruses,124, 135, 136 
nucleic acid, RNA,137 DNA,138, 139 inorganic sheets,140, 141 colloidal structures, and rods129 
(Table 2.3). Further, LBL approaches are not confined to planar smooth surface but can be 
extended over more complex rough surfaces independent of shape topography (e.g. hollow 
spheres, nanoparticles). Therefore, with careful selection of building blocks and molecular 
driving force, multilayers of desired structural (e.g. nanoporous/ thin films) or functional 
properties (e.g. optical,142 electrical, chemical or mechanical) can be fabricated for variety 
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of applications (e.g. coatings,143 biosensing, separations,120, 123, 144 biomimetics, drug 
delivery,145 and bioimaging146) (Table 2.5). 
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Table 2.3. Versatility of layer-by-layer self-assembling approach in incorporating diverse building blocks 
This summary table illustrates the versatility of the LBL approach in incorporating building blocks of different structural and functional 
properties.  
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Building 
Blocks 
 
Building block 
 
Driving force 
 
Findings 
 
Application 
 
Reference 
 
 
Using 
quantum dots  
 
 
Cadmium telluride 
quantum dots / poly-
L-lysine 
 
 
Electrostatic 
interaction 
• Functioned as an 
effective 
antibacterial 
coating. 
 
• As antibacterial,  
colored surface 
coat (from 
quantum dots)  
 
Li et al. (2013) 
 
133 
 
 
 
 
 
 
Using carbon 
nanotubes 
(CNT)  
 
CNT functionalized 
with 
sodiumdodecylsulfate 
(SDS, anionic 
detergent)  and cetyl 
trimethylammonium 
bromide (CTAB, 
cationic detergent) 
 
 
 
 
Electrostatic 
interaction 
• Formed stable dense 
mesoporous 
network. 
• Incorporating 
charge-based 
interaction over 
CNT avoided 
multilayer 
delamination. 
 
 
 
• As an 
electrochemical 
energy storage 
device 
 
 
 
Bohnenberger 
et al. (2014) 
 
131 
 
 
 
Using RNA  
 
Poly(anilineboronic 
acid) (PABA) / 
ribonucleic acid  
(RBC) 
 
Electrostatic 
interaction 
with covalent 
linkage 
• Boronate ester 
(covalent) linkage 
formation from 
PABA/RBC 
interaction. 
• Controlled RNA 
release 
 
• To provide 
controlled RNA 
release from 
multilayer films 
 
 
 
Recksiedler  
et al. (2006) 
 
137 
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Table 2.3, continued  
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Applications 
 
Building block 
 
Driving force 
 
Findings 
 
Application 
 
Reference 
 
 
Using 
dendrimers 
Poly(amidoamine) 
dendrimer / 
Poly(styrenesulfonate) 
(deposited on planar 
substrates and in latex 
colloids) 
 
 
Electrostatic 
interaction 
 
• Multilayers can trap 
charged molecules. 
• Can provide 
controlled release. 
 
• Functions as a 
nanoreservoir 
 
Khopade et al. 
(2002) 
 
126 
 
 
 
 
Using protein 
nanoparticles 
 
Bovine serum albumin 
nanoparticles (BSA-
NP) / 
poly(dimethyldiallyla
mmonium chloride) or 
BSA-NP/poly(acrylic 
acid) (PAA) 
 
• Electrostatic 
interaction  
 
• Electrostatic 
(with  
hydrogen 
bonding and 
hydrophobic 
interactions) 
• Additional 
molecular 
interactions 
(hydrogen bonding) 
was utilized with 
electrostatic 
interaction. 
• Formed significant 
improvement in 
multilayer thickness 
growth. 
• In constructing 
multilayer coats or 
novel structures 
via nanoparticle. 
 
• LBL in various 
applications such 
as biomedical or 
energy storage 
devices 
 
 
 
 
 
Mohanta et al. 
(2013) 
 
130 
 
 
 
 
Using DNA 
 
 
 
DNA/ 
poly(allylamine) 
 
 
 
Electrostatic 
interaction 
 
 
Ability to grow DNA 
based multilayer and 
its structural 
evaluation 
Complexation of 
DNA with different 
polyamines found in 
biological systems.  
Can generate 
functional 
biostructures. 
 
 
 
Lvov et al. 
(1993) 
 
138 
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Table 2.4. Layer-by-layer self-assembling approach driven by variety of different molecular interactions  
Few recent illustrations suggestive of LBL technique that are driven by wide variety of molecular interactions.  
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LB
L 
Molecular 
Interactions Building block Driving force Findings 
Potential 
Application Reference 
Electrostatic 
interactions 
(with 
post-modified 
covalent 
cross-links) 
Poly(allylamine 
hydrochloride) (PAH) , 
poly(sodium-p-styrene 
sulfonate) (PSS) and 
4,4’-diazido-2,2’-
stilbenedisulfonic acid 
disodium (DAS) for 
photo-cross-linking 
Electrostatic 
interactions 
with subsequent 
covalent 
crosslinking via 
photochemical 
reaction 
• Formed robust 
multilayers with 
covalent cross-links 
• In fabricating 
stable synthetic 
vesicles, and in 
drug delivery 
applications as 
diffusion 
barriers 
 
An et al. 
(2014) 
 
147 
Driven by 
metal-ligand 
co-ordination 
Co2+-Poly(styrene 
sulfonate) / poly(4-vinyl 
pyridine) 
Metal-ligand 
co-ordination 
(Co2+- 
Pyridine) 
• Multilayer formation 
on planar and hollow 
fiber substrate. 
• Enhanced higher 
selectivity and water 
tolerance level. 
• In membrane 
separation 
applications 
Zhang et 
al. (2010) 
 
123 
 
 
Driven by 
highly 
specific 
affinity 
interactions 
Unilamellar vesciles 
decorated with 
biotinylated cyclodetran 
(B-CDV) as guest 
molecule or 
concanavalin A 
conjugated cyclodextran 
(C-CDV) as guest 
molecule. 
B-CDV/Streptavidin or 
C-CDV/Mannose 
• Biotin-
streptavidin 
interactions 
(association 
constant, 
Ka~1014 M-1)   
• Concanavalin 
A Mannose 
(association 
constant, 
Ka~104 M-1) 
• Formed 3-d constructs 
of vesicle LBL. 
• Concanavalin-
mannose interaction 
destabilized 
(detached) the 
constructs during 
rinse steps. 
• Biotin-streptavidin 
interactions formed 
more intact structures 
• Can potentially 
be used in 
developing 
synthetic 
biological 
tissue models 
 
• Can function as 
a biomimic 
 
 
Roling et 
al. (2013) 
 
125 
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Table 2.4, continued 
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Molecular 
Interactions Building block Driving force Findings 
Potential 
Application References 
Driven by 
hydrogen 
bonds 
Tannic acid, poly(vinyl 
pyrrolidone) 
Hydrogen 
bonding 
 
• Temperature and pH 
was used as a trigger 
response to dissemble 
the hydrogen bonds in 
LBL. 
• A tunable and sustained 
release of tannic acid 
(polyphenolic drug). 
As a drug 
loaded films 
in medical 
devices 
Zhou et al. 
(2013) 
 
122 
Driven by 
hydrophobic 
interactions 
DurafloTM heparin 
(containing 
hydrophobic binding 
moiety, benzalkonium 
chloride), sirolimus, an 
immunosuppressive 
drug 
Hydrophobic 
interactions 
• LBL fabricated onto 
stent devices. 
• Dual drug release 
(heparin and sirolimus) 
As drug 
eluting stents, 
inhibiting 
restenosis and 
thrombosis 
Su et al. 
(2013) 
 
148 
 
Driven by 
combination 
of multiple 
interactions 
Gelatin/ tannic acid 
(on ultrafiltration 
membrane 
poly(acrylonitrile)) 
Hydrophobic 
interaction, 
hydrogen bonds 
• High free volume, 
better water perm-
selectivity than gelatin 
membranes.  
• Shows improved 
stability 
For long-run 
membrane 
separations 
Zhao et al. 
(2013) 
 
149 
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Table 2.5. Layer-by-layer self-assembling approach in fabricating multilayer structures for diverse applications  
Few recent works illustrating potential of LBL technique in developing multilayer structures for diverse applications 
LB
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Applications Building block Driving force Findings 
Potential 
Application Reference 
In  
membrane 
applications 
Graphene oxide/ 
aminated graphene oxide 
(on polyamide thin-film 
composite (PA-TFC) 
membrane) 
Electrostatic 
interaction 
• Enhanced water permeation 
and antifouling property. 
• Protective membrane barrier 
against chlorine degradation. 
• As a long-lasting 
permeable 
membranes in 
water treatment 
applications. 
 
Choi et al. 
(2013) 
 
150 
As a gas 
barrier 
Poly(diallyldimethylam
monium) chloride 
(PDDA)/ sulfonated 
polyvinylidene fluoride 
(SPVDF)-graphene 
oxide (GO) composite 
Electrostatic 
interaction 
• Improved mechanical 
property. 
• Reduced the gas permeation 
due to higher diffusional path 
length. 
• In hydrogen gas 
barrier 
applications. 
 
Rajasekar 
et al. 
(2013) 
 
151 
In  paper 
processing 
Polyethyleneimine (PEI) 
/ nanofibrillated 
cellulose 
(deposited onto pulp 
fibres) 
Electrostatic 
interaction 
• Stretchable paper by 
depositing multilayers onto 
pulp fibres prior to paper 
processing. 
 
• In paper-
processing and in 
packaging 
industry. 
• As cost-effective 
approach in tuning 
material properties 
 
Marais et 
al. (2014) 
 
152 
As an 
antifouling 
coats 
Polyanion or Polyanion-
g-perfluoroalkyl 
Polyethylene glycol/ 
Polyethyleneimine 
Electrostatic 
interaction 
• Amphiphilic coatings 
prevented marine bacterial 
adhesion. 
• As an marine anti-
fouling coat 
Zhu et al. 
(2014) 
 
153 
In 
regenerative 
application 
Silk fibroin/ 
Lysozyme 
(on cellulose electrospun 
template) 
Electrostatic 
interaction 
• Formed protein-coated mats. 
• Biocompatible, possess 
antibacterial effects, and 
promoted wound healing 
• In dermal 
regenerative 
application 
 
Xin et al. 
(2014) 
154 
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2-8.2. Layer-by-layers in Developing Bioinspired Materials and in Biomimetics 
Nature has fascinated researchers for ages, resulting in attempts to fabricate functional 
materials by mimicking structures or processes found in biological systems. Their 
contributions yielded novel synthetic and bio-inspired materials (Table 2.6). For instance, 
studies in the past (Burzio et al. (2000)155 and McDowell et al. (1999)156) have 
demonstrated that a bio-functional molecule, 3, 4-dihydroxyphenylalanine (DOPA), 
extracted from marine mussels (byssus foot secretion) possesses excellent adhesion 
properties. DOPA undergoes ionic coordination with Fe3+, a main contributor, which gives 
byssal threads in mussels the strong adhesion potential.155, 156 Inspired by its biofunctional 
property, a recent study Karabulut et al. (2012)157 used a DOPA-functionalized 
carboxymethylcellulose nanofibirils in combination with the polyelectrolyte, 
poly(ethyleneimine) in developing multilayer thin films as adhesive coatings. The 
fabricated multilayers undergo complexation with Fe3+ (DOPA-Fe3+), which improved 
their film stability and adhesiveness. Similarly, Reisch et al. 158 developed multilayers that 
mimic the anti-thrombogenic properties of blood cells. In their study, the antifouling 
moieties (ethylene oxide (EO), phosphorylcholine (PC)), which were commonly found in 
outer erythrocyte membrane, was chemically grafted onto the charged-based 
polyelectrolytes. These polyelectrolytes were then fabricated into a thin-film using a LBL 
technique.159, 160 Due to those functional moieties, the LBL possessed zwitterionic 
character, resulting in excellent surface hydration that resisted protein adsorption due to 
the more tightly bound water molecules.161 In another study, Costa et al. 162 used a 
phosphonate-modified levan (Ph-levan) with chitosan to develop superior adhesive 
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coatings driven by electrostatic interactions. Levan is a linear fructose polymer, a 
bioadhesive and an exopolysaccaride found in nature as microbial secretions. Those films 
can be used to form wound healing bandages and surgical sealants. 
Also, there is a growing interest in developing structures that synthetically mimic 
the extracellular matrix. For instance, in a recent study by Matsuzawa et al. (2013),10 a 
combination of extracellular matrix (ECM) components (fibrinogen, gelatin, type IV 
collagen, laminin) was used to construct a LBL over cell membranes, forming nano-
extracellular matrix. These synthetic structures protected cells against external physical 
stresses mimicking ECM function. In another study, by de Mesquita et al. (2011),163 
cellulose nanowhiskers (CNW), derived from eucalyptus wood pulp (plant source) and 
bovine collagen, was used to fabricate a hybrid, biodegradable multilayer thin film. This 
LBL was formed through hydrogen bonding and charge-based molecular interactions, 
leading to a nanoporous structure that mimics ECM. These porous thin-films are capable 
of immobilizing nano-crystals and through dense CNW packing can demonstrate improved 
mechanical property. Such functional properties are crucial in tissue engineering and bio-
implant applications.  
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Table 2.6. Layer-by-layer incorporating bioinspired materials  
Illustrations of few recent findings, which incorporates bio-inspired materials for development of advanced functional materials through 
layer-by-layers techniques.   
Bio-inspired source LBL building 
blocks 
Driving 
force Findings Application Reference Key 
component 
Functional 
property 
Levan 
Exo-
polysaccharide 
(from bacterial 
secretions) 
Bioadhesive 
 
Phosphonate-
derived levan, 
Chitosan 
Electro-
static 
interaction 
• Superior adhesive 
properties 
• As adhesive coatings 
• In wound healing 
bandages, surgical 
sealant.  
Costa et al. 
(2013) 
 
162 
Dopamine 
(found in 
mussel as 
byssus foot 
secretion) 
Bioadhesive 
Carbon 
nanotubes 
functionalized 
with poly-
(dopamine), 
Poly-
(ethylene-
imine) 
Electro-
static 
interaction 
• Formed stable, 
superhydrophobic 
multilayered film. 
 
• Resisted platelet and 
E.coli adherence. 
• In medical devices 
preventing 
thrombosis and 
bacterial infections. 
• In biomedical 
nanodevices and as 
separation 
membrane. 
Wang et al. 
(2014) 
 
132 
Phosvitin 
(phosphor-
glycoprotein 
derived from 
egg yolk, 
chelates with 
metal, calcium 
ions 
To biomimic 
calcium 
phosphate bio-
mineralization 
process 
resulting from 
phospho-
proteins 
 
Chondroitin 
sulfate (CS) / 
poly-(L-
lysine) (PLL) 
Electro-
static 
interaction 
• Introducing phosvitin 
(polyanionic building 
block) over 
preassembled CS/PLL 
LBL destabilizes the 
multilayers.   
• Stronger interactions 
of phosvitin/PLL over 
CS/PLL caused 
disassembling. 
• In fabricating 
protein-responsive 
films.  
• Useful in biosensing 
and in drug-delivery 
applications). 
Abdelkebir 
et al. 
(2011) 
 
164 
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2-8.3. Layer-by-layer in Drug delivery and Bio-applications 
In drug delivery applications, LBL thin films can be fabricated to provide a controlled and 
sustained drug release (Table 2.7).145 They can be broadly categorized as 1) stimuli 
induced release 2) controlled release by incorporating additional barriers, and 3) release 
due to the inherent property of building blocks. 
In ensuring an on-demand or a tailorable drug release, multilayers can be fabricated 
based on component responsiveness to external stimuli. Various stimuli, such as 
temperature, pH, salt, enzyme and photo/electro-responsiveness, can trigger drug release 
from LBLs.145 For instance, in a study by Zhu et al. (2013),9 a micelle-LBL system was 
fabricated to provide an on-demand temperature triggered drug release. In their study, a 
neutral temperature-responsive diblock copolymer (poly(N-vinylpyrrolidone)-b-poly(N-
isopropylacrylamide)) was preassembled into micelles with an anti-cancer agent, 
doxorubicin, drug loading. The micelles were self-assembled with tannic acid driven 
through hydrogen bonding. Stimuli-responsive drug release was demonstrated by 
subjecting the LBLs to temperature triggered swelling/deswelling cycles.9, 165 
Alternatively, drug release can be tuned by incorporating diffusional barriers near 
drug loaded zones. These barriers are usually created through post-LBL modification 
methods such as UV-/photo- or chemical- or temperature-induced cross-linking. Apart 
from altering drug release properties, the crosslinking usually improves the overall LBL 
stability. For example, Kim et al. (2008)166 demonstrated pH sensitive drug release from 
biodegradable polymeric micelle layer-by-layers. In their study, block copolymeric 
micelles (poly(ethylene oxide)-b-poly(caprolactone)) was self-assembled with poly(acrylic 
acid) (PAA). Under acidic pH (~2.5) the PAA forms hydrogen bonds with the PEG 
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coronary micellar chains. Under physiological pH (~7.4), these multilayers are easily 
destabilized through deprotonation of the PAA carboxylic acid groups. Therefore, in tuning 
drug release kinetics, the multilayers were crosslinked by heat treatment. This post-LBL 
modification converted the carboxylic acid in PAA into a more robust anhydride linkage, 
altering LBL degradation and its drug release. The fabricated thin films also demonstrated 
its biofunctional ability, where the release of encapsulated drug (triclosan) inhibited the 
antibacterial growth (S. aureus).  
Also, the LBL drug release can be controlled through the intrinsic properties of the 
building blocks, including molecular weight, hydrolytic tendency (self-biodegradability) 
or its charge density167 in LBL components (e.g. polymers or structures such as micelles). 
For instance, Park et al. (2012)168 demonstrated the ability to capture drug loaded 
nanoparticles (NP) within hyaluronic acid (HA) based LBL films. The multilayers were 
fabricated via alternate depositions from positively charged polyethylene imines (PEI) and 
negatively charged HA, using its electrostatic charge interactions. Since, hyaluronic acid 
undergoes chain entanglements with inter- and intramolecular hydrogen bonding, it 
resembles hydrogel rheology.  This complexation allows for a facile nanoparticle capture 
and immobilization within LBL films. In their studies, poly(ethylene glycol)-b-poly(D,L-
lactic-co-glycolic acid) (PEG-b-PLGA) based NPs were incorporated at different locations 
within LBL, and the release of single and multi-component drugs with LBL deconstruction 
(pH ~7.0, PBS) was demonstrated. Further, by carefully placing additional diffusional 
barriers between NP loaded zones, a tunable and sustained drug release platform can be 
achieved in those systems. Such thin films possess applications such as a drug-eluting stent 
in preventing restenosis. 
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It is pre-requisite for the researchers to possess a fundamental grasp on 
physiochemical properties of the building blocks, and its likely effect on drug release 
property.145 For instance, hydrolytic polymers are susceptible to pH changes which can 
rapidly destabilize LBL multilayers to result in a burst release. Therefore, in effectively 
tailoring the LBL for desired release characteristics, a combination of different strategies 
(as detailed in sections 1-3) may have to be employed.  
In our current work, we used the inherent diffusional release properties from the 
micellar structures for drug release. While, in eliciting a modified drug release kinetics, 
additional polymeric multilayers was incorporated as capping layers over the preassembled 
networks as a post-modification approach.  
 
  
47 
Table 2.7. Layer-by-layer fabrication for bioapplications 
Few recent works using layer-by-layer technique for drug delivery and in bio-applications. 
Key 
component LBL building blocks 
Driving 
force 
Drug loading/ LBL 
post-modification Findings Application Reference 
LBL as 
nano-
capsules 
Modified chitosan (with N-
acetyl-L-cysteine), 
glycopolymer poly(D-
gluconamidoethyl 
methacrylate-r-3-
acrylamidophenyl-boronic 
acid) (containing glucose-
sensitive moiety, 
phenylboronic acid) 
Electro-
static 
interaction 
• Insulin drug loading 
and disulfide cross-
linking of LBL. 
• Forms nano-
capsules by 
dissolution of 
template structures 
• Glucose-
responsive drug 
release 
(nanocapsule 
swelling) 
• As self-regulated 
drug delivery 
systems. 
Guo et al. 
(2014) 
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Hydrolytic 
self-
degradable 
LBL 
multilayers 
Degradable polycation 
poly(β-amino ester)/ 
polyanions (poly(styrene 
sulfonate) or poly(acrylic 
acid)) or calf thymus DNA 
Electro-
static 
interaction 
-NA- 
• Using pH or use 
of different 
polyanions 
induces change in 
rate of multilayer 
erosion resulting 
in tunable release 
profile 
• As hydrolytically 
self-degradable 
thin films  
• For controlled 
drug release at 
physiological 
conditions. 
Vazquez et 
al. (2002) 
 
170 
LBL as thin 
films 
Polelectrolytes poly(styrene-
4-sulfonic acid) sodium salt 
(PSS), poly(diallyldimethyl-
ammonium chloride  
Electro-
static 
interaction 
• Antileishmanial 
chalcones drug 
loading 
• Diffusion based 
drug (chalcone) 
release from LBL 
thin films 
• For controlled 
and sustained 
release of 
antileishmanial 
chalcones 
Bhalerao 
et al. 
(2014) 
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LBL 
fabricated 
onto stent 
surfaces 
DurafloTM heparin 
(containing hydrophobic 
binding moiety, 
benzalkonium chloride), 
sirolimus 
Hydro-
phobic 
interaction 
• Sirolimus drug, an 
immune-
suppressive agent 
• Dual drug release 
(heparin and 
sirolimus) 
• As drug eluting 
stents, inhibiting 
restenosis and 
thrombosis 
Su et al. 
(2013) 
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CHAPTER 3. RESEARCH GOALS 
 
3-1. Introduction 
Here, we developed hierarchical 3-dimensional networks resembling natural oral mucin 
networks. Unlike conventional polyelectrolyte-based LBL methods, we utilized biotin-
functionalized filamentous (worm-like) micelles as the network building blocks, 
complemented by addition of streptavidin to generate mucin-like layers of desired 
thickness. Using layer-by-layer self-assembly as an approach, we performed controlled 
molecular assembly. With careful selection of building blocks (e.g. micelle morphology), 
networks with tunable structural and biofunctional properties can be achieved. The 
biomimetic nature of the network was studied and its role as a drug delivery vehicle capable 
of providing tunable release is explored. 
3-2.  Objective and Significance 
The overall objective of this work is to: 
Synthetically create mucin-like biomimetic networks using a layer-by-layer (LBL) self-
assembling approach and evaluate its structural and biofunctional property for potential 
biological application, and to serve as a decoupling tool in understanding bulk functional 
behavior in natural mucin networks.  
To achieve the overall objective, the research was structured into three interdependent 
stages, each were described below as separate specific aims. 
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3-2.1. Specific Aim #1: Developing Hierarchical Layer-by-Layer Networks of 
Polymeric Micelles as a Synthetic Mucin Mimic 
1. Synthesize amphiphilic diblock (poly(ethylene glycol)-b-poly(lactic acid)) based 
copolymers of different polymer amphiphilicities, and characterize them using 
fourier transformed infrared spectroscopy (FTIR), proton nuclear magnetic 
resonance spectroscopy (1H-NMR), and gel permeation chromatography (GPC) 
techniques.   
2. Synthesize supramolecular morphologies of spherical and filamentous micelle from 
amphiphilic diblock copolymers. 
3. Develop layer-by-layers networks of micelle (micelle-LBL) on synthetic and 
biological surfaces using highly biospecific biotin-streptavidin affinity interaction. 
3-2.1.1. Hypothesis #1 
Micelle nanostructures of different structural morphologies can be synthesized from 
amphiphilic diblock copolymers, and those preassembled structures can be hierarchically 
self-organized as layer-by-layer networks using affinity based biotin-streptavidin cross-
linking chemistry.  
3-2.1.2. Significance and Outcome 
To evaluate the above hypothesis, studies were performed which were detailed in Chapter 
4. Supramolecular micellar structures were synthesized from amphiphilic diblock 
copolymers (poly(ethylene glycol- block- lactic acid)  (PEG-b-PLA)) based copolymers. 
Methoxy-poly(ethylene glycol- block- lactic acid) based copolymers were synthesized 
using ring opening polymerization (ROP) of different polymer amphiphilicities. Using 
steglich esterification chemistry, biotin-functionalized poly(ethylene glycol- block- lactic 
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acid) copolymer (Biotin-PEG-PLA) was synthesized. FTIR and 1H-NMR techniques 
verified the formation of diblock copolymer in all the synthesized polymers and their 
molecular weight were determined through GPC. Spherical and filamentous micelles were 
synthesized from amphiphilic diblock copolymers by altering the hydrophobic core 
packing parameter. Layer-by-layer networks were deposited from complementary 
additions of biotinylated micelles and streptavidin using biotin-streptavidin affinity 
linkage. Among micelles, filamentous structures with high structural aspect ratio 
demonstrated an enhanced capacity to form LBL networks than spherical micelles. This 
suggests micellar shape affects the network formation ability. Irrespective of the shape 
effects, micelles without biotin were unable to form any LBL structures illustrating that 
self-assembling is driven by those non-covalent molecular interactions.  
3-2.2. Specific Aim #2: Structure, Stability and Bio-functional Evaluation of 
Synthetic Mucin  
1. Evaluate structural characteristics of layer-by-layers networks of spherical (SM-
LBL) and filamentous micelles (FM-LBL) and visualize formation of hierarchical 
networks using micro- and nano-characterization techniques such as 
epifluorescence microscopy, confocal laser scanning microscopy (CLSM), atomic-
force microscopy (AFM) and scanning electron microscopy (SEM). 
2. Evaluate stability of synthetic mucin developed from layer-by-layer networks of 
filamentous micelle under simulated saliva and protease environment.   
3. Investigate microbial capture and surface hydration property of synthetic mucin as 
a function of its network characteristics.   
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3-2.2.1. Hypothesis #2 
LBLs of filomicelles can structurally develop into networks that mimic natural 
mucin networks and further exhibit structural stability under simulated oral 
chemical environment for potential oral regenerative application.  
3-2.2.2. Significance and Outcome 
LBL structure was studied, evaluating the effect of biotin, micelle morphology (filomicelle 
(FM) vs spherical micelle (SM)) and number of layers on micelle-LBL network formation. 
Networks were visualized under scanning electron microscopy and through 
epifluorescence microscopy. FM-LBL networks formed a nanoporous network with 
complete surface coverage, whereas SM-LBL networks showed relatively weak network 
forming ability with lower surface coverage. The results reinforced the earlier findings that 
there is a shape-dependent effect on LBL formation. Thickness measurement of FM-LBL 
networks under CLSM demonstrated a linear increase in thickness with number of layer. 
FM-LBL networks resisted disassembling by remaining predominantly intact under 
simulated chemical environment and demonstrated good accessibility to the innermost 
structures suggesting its porosity akin to that of natural mucin. The sessile drop-contact 
angle measurement showed a substantial improvement in surface hydration properties with 
FM-LBL network deposition. Also, FM-LBL promoted bacterial adhesion, likely due to 
its higher surface area availability from its nanoporous networks. These critical surface 
properties in synthetic networks were illustrative of their biomimetic nature analogous to 
natural mucin networks.  
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3-2.3. Specific Aim #3: Evaluating Ability of Synthetic Mucins to Function as a Drug 
Release Network 
1. Develop networks from polymeric micelles and investigate their structural and 
bacterial inhibition characteristics.   
2. Develop polymeric capping barriers atop pre-assembled synthetic mucin networks 
and evaluate the effect of these barriers on the overall bulk network stability.  
3. Investigate the role of synthetic mucin as a drug releasing network and study effect 
of polymeric capping barriers in altering drug release kinetics.  
3-2.3.1. Hypothesis #3 
Synthetic mucin networks can function as a drug release network, which upon fabrication 
with polymeric layer-by-layer capping barriers can create an additional diffusional 
resistance to yield tunable drug release.   
3-2.3.2. Significance and Outcome 
The ability to form micelle-LBL networks from different compositions of polymeric 
micelles was demonstrated. Additionally, network structure and bacterial inhibition 
characteristics was illustrated. Filamentous network topography and surface properties 
were studied indepth under tapping- and contact-mode atomic force microscopy. In 
forming tunable drug release, polymeric capping layers were self-assembled over the FM-
LBL networks through complementary crosslinking additions from biotinylated polymer 
and streptavidin. The polymer poly(acrylic acid) was biotinylated using carbodiimide 
coupling chemistry, and was characterized for its extent of purity and amount of biotin 
grafting. The biotin-grafted polymer formed protective capping layers over 7-layered FM-
LBL networks, while the non-biotinylated polymers with lack of affinity interactions were 
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unable to form capping layers. Those polymeric capping layers demonstrated good 
chemical intactness against destabilizing proteolytic environment, and functioned as a 
protective barriers shielding the underlying protein crosslinks in synthetic mucin network. 
This critical barrier tendency was used in tuning release from FM-LBL networks. Drug 
release studies from synthetic mucin networks (FM-LBL) with- and without capping layers 
was performed. With increasing polymeric capping layers an additional diffusional 
resistance was created to alter the drug release from synthetic mucin networks. This 
demonstrates the potential of synthetic mucin networks as a drug-delivery vehicle, which 
can yield a tunable release based on its polymeric network properties.  
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CHAPTER 4. HIERARCHIAL LAYER-BY-LAYER NETWORKS OF 
POLYMERIC MICELLES  
Based on the research article: 
S.P. Authimoolam, A.L. Vasilakes, N.M. Shah, D.A. Puleo and T.D. 
Dziubla, “Synthetic Oral Mucin Mimic from Polymer Micelle Networks”, 
Biomacromolecules, 2014, 15, (8), 3099-111. 
4-1.  Introduction 
Supramolecular assembly represents a self-organization process in which components are 
driven via non-covalent forces in forming a more ordered structural aggregate. The driving 
forces can include molecular interactions such as ionic, hydrophobic/hydrophilic, van der 
Waals, hydrogen bonding, physical factors (e.g. shape) or micro-phase separation.172, 173 In 
polymer systems with covalently coupled incompatible blocks (e.g. diblock/triblock 
copolymers), its relative chain rigidity (e.g. rod-like or coil-like flexibility) affects the 
aggregate packing, ensuring micro-phase separation. For instance, Heald et al. (2002),174 
used NMR tool in studying conformation state of hydrophobic and hydrophilic regions in 
poly(ethylene glycol)-b-poly(lactic acid) (PEG-b-PLA) based nanoparticles (NPs). The 
NPs were formulated from diblocks of different relative block lengths. Their results 
suggested, for fixed PEG chain length by increasing PLA MW, in NP its micellar core 
exhibited a change from liquid-like to solid-like state. With increasing PLA chain length, 
the blocks exhibited a relatively less flexible conformation. This transitioned the diblocks 
PEG-PLA into a more solid-like core packing.  
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Like surfactant based systems, different structural aggregates (e.g. spheres, 
cylindrical, lamellae, and vesicles) can be obtained via use of diblock copolymers. During 
the micro-phase separation of diblock copolymers, microdomains rich in each blocks are 
segregated, whose spatial arrangements are highly dependent on relative volume fractions 
in polymeric blocks. By modifying such conformational arrangements in the 
microdomains, different supramolecular morphologies can be yielded.172 These aggregates 
formed via diblock copolymers are relatively more stable than the surfactant systems, 
thereby extensively applied as drug payload carrier.175  
For instance, Simone et al. (2007),176 formulated micelles of different 
morphologies by tuning the relative hydrophobic to hydrophilic chain length in diblock 
copolymers. In their study, the hydrophobic chains in the diblocks were tailored for a fixed 
hydrophilic block length, this altered the core packing properties and yielded tunable 
structural geometries. This concept was also extended to generate nanostructures via 
peptide self-assembling, Lim et al. (2007)177 used Tat cell penetrating peptide (Tat CPP) 
conjugated with hydrophobic lipid based dendrimer structures. By increasing the number 
of dendrimeric grafts the core packing was altered, yielding peptide nanostructures of 
spherical, short cylindrical and cylindrical morphologies.173, 177 
In transitioning the morphologies of pre-assembled structures, Geng et al. (2005)178 
used a hydrolytically degradable diblock copolymer (poly(ethylene oxide)-b-poly(ε-
caprolactone)). The formulated worm-like micelles were spontaneously degraded in 
forming shorter fragments, and subsequently transitioned into spherical micelles. 
Alternatively, the filomicelle length can be reduced mechanically using a more elementary 
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sonication method179 or more controllably reduced through nanoporous extrusion 
methods.180  
Simone et al. (2009),102 in another study, demonstrated micellar aggregates systems 
that are capable of tunable flexibility and structural properties. In their approach, for a fixed 
hydrophobicity (hydrophobic to hydrophilic ratio) in diblocks and by increasing the overall 
chain length in diblock copolymers, the filomicelle properties such as stiffness, persistence 
length and diameter were increased.  
The filamentous micelles possess relatively higher structural aspect ratio than the 
spherical micellar systems. As a drug carrier, they have exhibited a higher circulation time 
than the conventional drug delivery systems (DDS).181 Studies by various researchers 
(Dalhaimer et al. (2004),182, 183 Discher et al. (2005),184 Geng et al. (2007),180 Ilies et al. 
(2007)185, and Shuvaev et al. (2011)186) have extensively demonstrated that these 
filomicelles can be decorated with bio-specific functional moiety (e.g. biotin, antibody) 
and applied for improving targeting and payload delivery. In a recent work by Pal et al. 
(2012),187 self-assembled block copolymers of polystyrene-b-poly(4-vinylpyridine) (PS-b-
P4VP) into a hairy nanofibers. The fibrous aggregates were used a structural template for 
loading gold nanoparticle, forming a hybrid metal-polymer construct.187  
In bioapplications, the self-assembled nanostructures possess potential ability to 
biomimic. For instance, inspired by amphiphilic phospholipid bilayers in cell membrane, 
a considerable interest has been generated in lipid self-assembling, forming liposomes.188 
While, in polymeric diblock systems, spherical vesicles (e.g. polymersomes) are 
emphasized as virus mimic188 and filomicelles are suggested for its structural relevance to 
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filamentous phage.189 These structural mimics are usually formed from single-leveled self-
organization at bulk liquid interfaces.  
The property of these synthetic mimics are not just confined to bulk structural 
behavior and can exhibit interesting physicochemical property at the solid-interfaces. For 
instance, self-organization of diblock copolymers at solid-interface via a deposition 
process can significantly change the interfacial surface characteristics.190 Andrade et al. 
(1985),191 extensively detailed capable role of polymers in impacting interfacial surface 
characteristics. Few key functional properties related to the current work include surface 
lubrication, friction, hydration tendency, biocompatibility and permeability.190, 191 By 
taking cue from such potential possibilities, the approach can be extended to form more 
complex molecular architectures by involving self-organization of preassembled structures 
at solid surfaces. The pre-assemblies (e.g. micelles, vesicles) apart from yielding higher 
ordered hierarchical aggregates was expected to possess unique surface properties. Thus, 
in our current work, in developing surface-aggregates in a controlled fashion, a layer-by-
layer deposition approach was adopted.  
4-2. Experimental Section 
4-2.1. Materials 
3,6-Dimethyl-1,4-dioxane-2,5-dione (Lactide), poly(ethylene glycol) methyl ether 
(molecular weight (MW) ~5000 Da), stannous 2-ethylhexanoate, curcumin (from curcuma 
longa), 2-(4-hydroxyphenylazo) benzoic acid (HABA), nile red and anhydrous diethyl 
ether were purchased from Sigma Aldrich (St. Louis, MO). Biotin-poly(ethylene 
glycol)amine was purchased from Laysan Bio, Inc. (Arab, AL). Poly(DL-lactide) (acid 
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terminated; inherent viscosity 0.15-0.25 dL/g) was purchased from Durect (Cupertino, 
CA). Recombinant streptavidin (produced in E. coli) was purchased from Prospec-Tany 
(East Brunswick, NJ). Avidin (from egg whites) was purchased from Life Technologies 
(Grand Island, NY). Chloroform, N, N’-dicyclohexylcarbodiimide (DCC) and 
dichloromethane (DCM) were purchased from Acros Organics (Waltham, MA). 
Rat dermal tissue was prepared by excising the dorsal skin flap (thoracic to 
abdominal area) of a freshly euthanized rat. The harvested tissue was placed in a saline 
soaked towel, and stored in an airtight polyethylene ziplock bag at -80°C. The tissue was 
thawed to room temperature prior to use. 
4-2.2. Synthesis and Characterization of Amphiphilic Diblock Copolymers 
Methoxy-poly(ethylene glycol-block-lactic acid) (mPEG-PLA) was synthesized by ring 
opening polymerization (ROP) of D-lactide with mPEG (molecular weight (MW) ~5,000 
Da) using stannous octoate (1% w/w) as a catalyst; adopting the procedure from Simone et 
al.5 (Figure 4.1). The reactant mixture (mPEG and D-lactide) was preheated (140°C, for 2 
h, under N2 atmosphere) to remove any traces of water. The catalyst was added upon 
reduction of reactant temperature to 120°C and ROP was allowed to proceed for 6 h.  
The synthesized diblock copolymers were purified by dissolving in 
dichloromethane (DCM) and re-precipitated twice in cold diethyl ether.86 Upon 
purification, the diblock formation was verified through FTIR and H-NMR techniques and 
polymer molecular weights were determined using gel permeation chromatography (GPC).  
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4-2.3. Synthesis and Characterization of Biotinylated Diblock Copolymer  
Biotinylated poly(ethylene glycol-block-lactic acid) (biotin-PEG-PLA) was synthesized by 
covalently coupling biotinylated poly(ethylene glycol)-amine (biotin-PEG-NH2, MW 
~5,000 Da) with acid-terminated poly(lactic acid) (PLA-COOH, MW ~18,000-24,000 Da) 
(Figure 4.5). The reactant polymers (biotin-PEG-NH2 and PLA-COOH) were dissolved 
in DCM (polymer concentration ~2% w/v) and kept sealed under a nitrogen atmosphere. 
N-N’-dicyclohexylcarbodiimide (DCC) was added dropwise (PLA:DCC molar ratio ~1:2) 
to the polymer solution and the reaction was allowed to proceed for 24 hours.  
The reaction mixture was filtered to remove byproducts (like dicyclohexylurea) 
formed during the course of reaction, followed by precipitation twice in cold diethyl ether. 
Any trace solvent residue in the precipitated product was removed by rotary evaporation. 
Further, to remove any unreacted biotin-PEG-NH2 chains from the desired biotin-PEG-
PLA product, the obtained polymer was dissolved in acetone and precipitated twice in cold 
deionized water.192 The precipitate was centrifuged to collect the product, followed by 
lyophilization to remove any residual water. The purified product (biotin-PEG-PLA) was 
characterized using GPC and 1H-NMR.   
The presence of biotin was quantified using the 2-(4-hydroxyphenylazo) benzoic 
acid (HABA)-avidin assay. The HABA-avidin working solution (red/orange colored) was 
prepared as outlined by Shuvaev et al.98 To the working solution, biotin-PEG-PLA 
copolymer was added. This addition of biotin (or biotinylated compound) onto the working 
solution results in color change, which was measured from decrease in absorbance (λ=500 
nm) using a spectrophotometer (Cary WinUV). This absorbance shift was correlated to 
calibration obtained from known biotin concentrations. 
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4-2.4. Biotin-Functionalized Polymeric Micelle Synthesis  
Biotin-functionalized polymeric micelle (Biotin-micelles) were synthesized using a 
previously described cosolvent/evaporation method.179 Blends of custom-synthesized 
poly(ethylene glycol)-b-poly(lactic acid) (PEG-b-PLA) based diblock copolymers, 
methoxy-PEG-PLA (50 mg, ~91% w/w) and biotinylated-PEG-PLA (5 mg, ~9% w/w) (see 
Figure 4.1, 4.2, 4.3, 4.4, 4.5, 4.6, 4.7, and 4.8 for diblock copolymer synthesis and 
characterization) were dissolved in a water-immiscible organic solvent (chloroform), 
which was then dispersed in a continuous aqueous phase (deionized (DI) water, 50 ml) 
using an ultrasonic homogenizer (Fisher Scientific, Sonic dismembrator Model 100). The 
oil/water dispersion was vigorously stirred overnight (~16 h) at room temperature until the 
organic solvent was completely evaporated off to form hardened biotin-micelles.193 
Micelles were visualized by adding nile red stain (0.05 mg, ~0.09% w/w) or curcumin (1.5 
mg, ~2.65% w/w) during synthesis.  
Upon hardening, the biotin-micelles were centrifuged (1000 rpm for 10 min) to 
separate larger sized macroparticles from the desired micelle fraction. The micelle fraction 
was again centrifuged (7500 rpm for 45 min) and re-suspended in DI water to remove 
excess curcumin or nile red stain. Micelles without biotin were synthesized using a similar 
procedure, but using mPEG-PLA without adding biotin-PEG-PLA polymer during 
formulation.  
4-2.5. Formation of Layer-by-Layer Networks of Micelles   
In vitro layer-by-layer networks of micelles (micelle-LBL) were deposited on biotin coated 
plates (Thermo Scientific Pierce, Rockford, IL, pre-blocked 96-well strip plates) at room 
temperature. The base biotin layer was alternatively rinsed with streptavidin (1 mg/ml in 
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phosphate buffered saline (PBS, pH 7.4), 100 µl/well, and 1 min incubation) and micelles 
(~5 mg/ml in DI water, 100 µl/well, and 1 min incubation). To develop and verify the 
ability to deposit LBL networks via biotin-streptavidin interactions, networks were 
developed using biotinylated-micelles (SM and FM) and micelles-without biotin 
separately. Excess micelles and streptavidin during LBL deposition were removed with 
PBS rinses between each layer. To demonstrate the micelle-LBL (FM-LBL or SM-LBL 
networks) growth, networks with an increasing number of layers (NoL = 1, 3, 5, and 7) 
were developed. In order to quantify and visualize the developed LBL networks, the 
fluorophore curcumin was loaded into the micellar cores. The homogeneity of micelle-
LBL network deposition on the entire base surface was mapped using fluorescence (from 
curcumin) area scans using a microplate spectrophotometer (Ex/Em: 420/500 nm, 
top/bottom read, BioTek Synergy Mx, Gen5 2.0, Winooski, VT). Micelle-LBL networks 
were also imaged using epifluorescence microscopy (Nikon Eclipse LV100, FITC filter, 
under 10x/20x objectives, NIS Elements). 
4-2.6. Ex vivo FM-LBL Network Formation 
Rat dermal tissues (circular patches of diameter ~15 mm) excised from freshly euthanized 
rats were used as an ex vivo model for the human mucosal surface. With the epidermal side 
placed face-down, the FM-LBL network was deposited on the exposed dermal surface. 
First, a base streptavidin layer was deposited (1 mg/ml in PBS, 100 µl/well, 2 min 
incubation). This was followed by alternating rinses of FM (~10 mg/ml in DI water, 100 
µl/well, 1 min incubation) and streptavidin (1 mg/ml in PBS, 100 µl/well, 1 min incubation) 
till a desired NoL (1, 3, 5, 7) were deposited. FM (biotin-FM and FM-without biotin) was 
used separately during LBL deposition to verify the ex vivo formation of FM-LBL 
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networks. Excess FM and streptavidin were removed by rinses with PBS between each 
layer. Tissues coated with FM-LBL networks were placed inside cells of a 12-well plate 
and network growth was determined using fluorescence (from curcumin) using a 
microplate spectrophotometer (Ex/Em: 420/500 nm, top/bottom read, BioTek Synergy Mx, 
Gen5 2.0, Winooski, VT). Tissues coated with FM-LBL networks (NoL=7) containing 
either biotin-FM or equivalent control (FM without biotin) were also imaged using 
epifluorescence microscopy (Nikon Eclipse LV100, FITC filter, under 10x/20x objectives, 
NIS Elements). The networks were deposited on tissues at room temperature under similar 
conditions.     
4-3. Results and Discussion 
4-3.1. Synthesis and Characterization of Amphiphilic Diblock Copolymers  
Diblock copolymers of different polymer amphiphilicities were synthesized by altering the 
hydrophobic (PLA) block molecular weight (target PLA MW were ~10,000 Da, 20,000 
Da, 32,000 Da, 50,000 Da, 60,000 Da and 90,000 Da), while keeping the hydrophilic 
(mPEG) block (MW ~5000 Da) constant. This was achieved by altering the stochiometric 
molar ratio of mPEG:D-Lactide used in the ROP reaction (Figure 4.1). Diblock 
copolymers of different PLA block MWs, and therefore different amphiphilicities were 
used to synthesize filamentous or spherical micellar morphologies. In our current studies, 
a diblock polymer with low PLA MW of ~20,000 Da (mPEG5k-PLA20k) was used to 
synthesize spherical micelles. On the other hand, a diblock polymer of relatively high PLA 
MW of ~50,000 Da (mPEG5k-PLA50k) was used to synthesize filamentous micelles. 
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GPC showed an increase in polymer MW with increasing molar ratio of mPEG:D-
Lactide (Figure 4.2). The purified diblock copolymers were characterized using Fourier 
transform infrared (FTIR) spectroscopy. The presence of mPEG and PLA blocks was 
confirmed from their respective methylene and carbonyl peaks in FTIR spectra.194 The 
peaks near 2700-3100 cm-1 and 1450 cm-1 (-CH stretching from –CH2 groups) were 
contributions from methylene groups of the PEG. The peak at 1750 cm-1 were contributions 
by the carbonyl stretching in the ester groups of the PLA block (Figure 4.3). The polymers 
were further characterized using proton nuclear magnetic resonance (1H-NMR) 
spectroscopy, where the proton contributions from PLA block (-CH ~5.2 ppm and -CH3 
~1.5 ppm) and PEG block (-CH2 ~3.6 ppm) (Figure 4.4). Therefore, from GPC results in 
conjunction with FTIR and GPC characterization verified the formation of the diblock 
copolymer.  
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Figure 4.1. Reaction scheme for mPEG-PLA diblock copolymer synthesis  
Scheme shows ring-opening polymerization (ROP) of D-Lactide with  mPEG (MW~5,000 
Da) using catalyst stannous 2-ethylhexanoate to form  diblock amphiphile. 
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Figure 4.2. GPC MW characterization on synthesized mPEG-PLA polymers 
Plot shows increase in polymer molecular weight with increasing PLA block length 
modifiying the diblock amphiphilicity. 
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Figure 4.3. FTIR characterization on mPEG-PLA polymers 
Results illustrate the presence of both PEG and PLA blocks by detecting its respective 
carbonyl and methylene  groups in the diblock copolymers. 
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Figure 4.4. H-NMR characterization on mPEG-PLA diblock copolymers 
Results reinstate the formation of diblocks, verified through PEG peaks (-CH2 group) and PLA peaks (-CH3 and –CH peaks). 
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4-3.2. Synthesis and Characterization of Biotin Functionalized Diblock Copolymer  
Biotinylated poly(ethylene glycol-block-lactic acid) (biotin-PEG-PLA) was synthesized by 
covalently coupling biotinylated poly(ethylene glycol)-amine (biotin-PEG-NH2) with acid-
terminated poly(lactic acid) (PLA-COOH, MW ~18,000-24,000 Da), using a carbodiimide 
chemistry (Figure 4.5).  
GPC MW characterization of biotin-PEG-PLA showed a subtle change in weight-
average MW from PLA-COOH (Figure 4.6). 1H-NMR more readily verified the 
conjugation of biotin-PEG with PLA-COOH from the proton contributions from PEG (-
CH2 ~3.5 ppm) and PLA blocks (-CH ~5.2 ppm and -CH3 ~1.4 ppm) on purified biotin-
PEG-PLA copolymer (Figure 4.7). The PEG peak verifies the presence of biotin in the 
diblock, as the peak contributions from the small biotin molecules were not clearly 
resolvable through 1H-NMR.  
Biotin accessibility and activity in diblock copolymer was quantified through the 
colorimetric HABA-avidin assay (Figure 4.8). The biotinylated compound was added to 
the working solution constituting HABA-avidin complex (red/orange colored). This 
addition instantly replaces the weak HABA-avidin intermediate (kd= 10-6 M) into a more 
stable biotin-avidin complex (kd= 10-15 M).195, 196 During the complexation there is a 
concomitant release of free HABA which yields a color change (pale orange/yellow) that 
is readily measurable from decrease in absorbance. From a biotin calibration curve of 
known concentrations (Figure 4.8b), the extent of biotin conjugation onto diblock 
copolymers was calculated. This confirmed that nearly all the PLA chains were conjugated 
with biotin-PEG (~100% conjugation).  
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Figure 4.5. Reaction  scheme for Biotin-PEG-PLA diblock copolymer synthesis  
Scheme shows DCC coupling reaction from carboxylic acid of PLA-COOH (MW~ 17,500 Da, as per GPC) with amine from Biotin-
PEG-NH2 (MW~ 5,000) to form Biotin-PEG-PLA 
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Figure 4.6. GPC MW characterization on synthesized Biotin-PEG-PLA polymer 
Changes in PLA MW from PEG coupling can only be seen as a subtle change in weight-
average molecular weight. 
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Figure 4.7. H-NMR characterization on biotin functionalized diblock copolymer  
Results verifies the formation of diblocks through PEG peaks (-CH2 group) and PLA peaks 
(-CH3 and –CH peaks). Contributions from biotin in Biotin-PEG-PLA could be readily 
deduced, a result of overwhelming  PEG and PLA protons contribution present in the 
polymer. 
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Figure 4.8. Biotin detection in Biotin-PEG-PLA polymer 
a) Scheme showing mechanism of HABA-avidin assay used for biotin detection. The 
addition of biotin-PEG-PLA polymer replaces the relatively less stable HABA-avidin 
complex into a more stable biotin(PEG-PLA)-avidin complex. This new complexation is 
accompanied by free HABA release, which was readily deducable at wavelength (λ=500 
nm). (b, c) Correlating this absorbance shift with known biotin calibration suggested that 
near ~100% conjugation of Biotin-PEG to PLA chains, confirming that a minimal free or 
unreacted PLA chains (PLA without biotin) is present along Biotin-PEG-PLA diblocks.  
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4-3.3. Formulating Biotin Functionalized Polymeric Micelles  
Spherical micelles (SM) and filamentous micelles (FM) were synthesized using 
amphiphilic diblock copolymers of poly(ethylene glycol)-b-poly(lactic acid) (PEG-b-
PLA), via a cosolvent/evaporation method (Figure 4.9).179 During micelle synthesis, the 
progressive evaporation of the dispersed organic phase at the oil/water interface reduces 
the interfacial tension and increases polymer concentration within the evaporating droplet, 
resulting in a directed self-assembly of the diblock copolymers.87, 197 As shown in previous 
studies,5, 86, 102 by tuning the copolymer amphiphilicity via the relative hydrophobic block 
length within methoxy-PEG-PLA (mPEG-PLA), its hydrophobic core packing property is 
altered to yield different micellar morphologies (Figure 4.10, 4.11, and 4.12). 
Biotinylated-PEG-PLA was blended with mPEG-PLA to add affinity to the synthesized 
micelles. 
The synthesized micelles were characterized using scanning electron microscopy 
(SEM) and fluorescence microscopy using curcumin or nile red loaded into the 
hydrophobic micelles (Figure 4.10, 4.11, and 4.12). The mPEG-PLA diblocks with higher 
PLA content of ~68-80% w/w formed FM, whereas lower PLA content in the diblocks 
(PLA <68% w/w) formed SM, consistent with previously published data.5, 86, 198 For all 
subsequent studies, mPEG5k-PLA50k copolymer was used to form FM, and mPEG5k-
PLA20k was used to form SM. Under DLS, the spherical micelles possessed an average 
particle diameter of ~245 nm. Filomicelles (FM), possessed a length distribution of ~5-25 
µm, based on images collected from fluorescence micrographs (Figure 4.13). The 
structural aspect ratio (length to diameter ratio, L/D) in FM is ~20-100, however this was 
much lesser for SM, which is nearly one.  
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Figure 4.9. Scheme showing synthesis of polymeric micelles from diblock copolymers 
Supramolecular morphologies of spherical and filamentous micelles were synthesized 
using PEG-PLA based diblock copolymers via cosolvent/evaporation method.  
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Figure 4.10. Synthesis of biotinylated polymeric micelle from different amphiphilic 
diblock copolymers and visualizing filamentous micelle structures 
a) Summary of results obtained during synthesis of biotinylated spherical (biotin-SM) and 
filamentous (biotin-FM) micellar morphologies from different amphiphilic copolymers. b) 
Visualization of biotinylated filamentous micelles (biotin-FM) without any drug loadings 
under bright field microscopy c) Epifluorescence micrographs of curcumin encapsulated 
biotin-FM and its visualization under scanning electron microscopy (inset figure). d) 
Epifluorescence micrographs of nile red encapsulated biotin-FM.  
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Figure 4.11. Epifluorescence micrographs of nile-red encapsulated biotinylated 
filamentous micelles 
Nile-red encapsulated biotin-FM visualized under different levels of magnification (under 
epifluorescence microscopy, using TRITC filters) a) 10x magnification b) 20x 
magnification c) 50x magnification. 
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Figure 4.12.  Epifluorescence micrographs of curcumin encapsulated biotinylated 
spherical micelles 
Curcumin encapsulated biotin-FM visualized under different levels of magnification 
(under epi-fluorescence microscopy, using TRITC filters) a) 10x magnification b) 20x 
magnification c) 50x magnification. 
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Figure 4.13. Size distribution of  biotin functionalized filamentous and spherical 
micelles 
Length distribution of filomicelles (FM) are estimated from ImageJ post-processing on FM 
fluoroscence micrographs. Size distribution of spherical micelles (SM) measured using 
dynamic light scattering (DLS), which showed an average particle diameter of ~245 nm.  
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4-3.4. Layer-by-Layer Networks of Micelle (micelle-LBL)  
4-3.4.1. Micelle-LBL on Synthetic Interfaces 
The formulated SM and FM were assembled into 3D porous networks on substrates via a 
layer-by-layer process involving alternating deposition of streptavidin and either one of the 
biotinylated micelles driven by specific biotin-streptavidin interactions (scheme shown in 
Figure 4.14). In our current approach, to develop multilayers via oral rinses and to 
withstand harsh intra-oral dynamics (e.g., mechanical (abrasive) and chemical forces), 
post-molecular self-assembling may require use of multiple forces of molecular 
interactions. Thus, to improve structural integrity of synthetic mucin networks, strong 
affinity pairing (e.g., antigen-antibody or biotin-streptavidin) was preferred over 
conventional charge based interaction.199, 200  
During LBL deposition, the observed increase in fluorescence with number of 
layers (NoL = 1, 3, 5 and 7) demonstrates the ability to grow micelle-LBL networks on 
surfaces in a regular and predictable fashion. Micelles without biotin were unable to form 
these multilayered systems because of a lack of specific affinity interactions. Similarly, 
without streptavidin additions, the biotinylated-micelles cannot effectively crosslink, 
preventing network growth (Figure 4.15 and 4.16).  
By monitoring biotin-micelle depositions without streptavidin would help 
determine whether biotin moieties by themselves would cause inter-micelle complexation 
and grow into networks. To examine such a possibility and to see if non-specific 
interactions significantly affect network formation, LBL networks were grown using 
biotinylated spherical micelles (biotin-SM) without streptavidin. These networks were 
formed by adopting a similar procedure as described under micelle-LBL network 
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formation, but without providing intermittent streptavidin additions. Biotin-SM (without 
streptavidin additions) showed poor ability to form networks without the affinity-based 
crosslinker streptavidin (Figure 4.15). This observation was visually confirmed via 
fluorescence imaging (Figure 4.16), suggesting an insignificant impact of non-specific 
interactions on network formation.   
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Figure 4.14. Layer-by-layer network formation procedure from filamentous and spherical micelles using affinity driven cross-
linkers 
a) Scheme showing formation of layer-by-layer networks of filomicelle (FM-LBL) using biotin-streptavidin affinity linkages by 
alternating additions of biotinylated-filomicelle (Biotin-FM) and the protein streptavidin. b) Similarly, layer-by-layer networks of 
spherical micelle (SM-LBL) are formed from biotinylated-spherical micelle (Biotin-SM) and the protein streptavidin.  
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Figure 4.15. Micelle-LBL network growth using spherical micelle (SM-LBL) 
Deposition of biotinylated-spherical micelle (Biotin-SM) and the protein streptavidin 
resulted in layer-by-layer network formation. On the contrary, layer-by-layer deposition of 
Biotin-SM without its affinity-based crosslinker streptavidin could not form networks. 
Similarly, layer-by-layer deposition of streptavidin and spherical micelles without biotin 
moieties showed inability to form networks. These control systems illustrate the significant 
role played by the affinity-based biotin-streptavidin crosslinker required for the network 
growth.  
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Figure 4.16. Effect of affinity based cross-linkers and number of layer additions in formation of in vitro SM-LBL networks 
Fluorescence micrographs showing the effect of affinity-based moieties (biotin, streptavidin) and number of layer additions (NoL) 
performed during micelle-LBL network formation process on polystyrene substrates. Control layer-by-layer (LBL) depositions of 
Biotin-SM without streptavidin, and micelles without biotin moieties with streptavidin additions were performed separately. These 
controls lacked either biotin or streptavidin affinity moieties, hence insignificant network formation trends were observed even with 
increasing NoL. This is unlike the LBL depositions of biotin-SM and streptavidin that showed significant LBL growth because of their 
ability to effectively crosslink via the biotin-streptavidin affinity linkages.    
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Interestingly, among biotin functionalized micelles the FMs demonstrated an 
enhanced capacity to self-assemble and form 3D networks compared to the SM, an 
indication of shape-dependency on network formation (Figure 4.17). FM possess an 
extremely high projected surface area owing to their high structural aspect ratio compared 
to SM. Aspect ratios (L/D)FM are typically >20 compared to (L/D)SM of ~1, where L = 
longer aspect (length) and D = shorter aspect (diameter) (Figure 4.13). Thus, FM generates 
higher ligand-receptor surface interactions during the LBL deposition process, which 
increase their ability to form networks. Therefore, FM-LBL networks self-assembled with 
at least a 2-fold increase in fluorescence compared to SM-LBL networks at the same 
number of layers.  
4-3.4.2. Micelle-LBL on Biological Surface 
To demonstrate the ability to form FM-LBL networks on biological tissues, networks were 
deposited ex vivo on excised rat dermal tissue. Again, biotinylated-FM showed a 
significantly better ability to form LBL networks, whereas FM without biotin (control) 
showed only a weak increase in fluorescence from non-specific tissue adsorption. Thus, 7-
layered biotinylated-FM-LBL networks showed ~2.5-fold higher fluorescence than control 
FM, conforming the ability to develop FM-LBL networks on tissue surfaces (Figure 4.19 
and 4.20).   
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Figure 4.17. Cross-comparing in vitro layer-by-layer networks of spherical and filamentous micelles with curcumin drug loading 
Micelle-LBL network growth was studied by tracking the relative fluorescence intensity (RFU) from curcumin loaded micelles for 
increasing number of layer addition cycles (NoL). (Left) Micelle-LBL network growth using curcumin-loaded filomicelle (FM-LBL) 
and spherical micelle (SM-LBL). 
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Figure 4.18. In vitro layer-by-layer network formation from nile red encapsulated 
filamentous micelles  
Micelle-LBL network growth was studied by tracking the relative fluorescence intensity 
(RFU) from nile red loaded micelles for increasing number of layer addition cycles (NoL). 
Biotinylated FM demonstrated better multilayer growth in comparison to FM without 
biotin, due to its ability to effectively cross-link via affinity interactions.  
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Figure 4.19. Ex vivo layer-by-layer network formation from curcumin encapsulated 
filamentous micelles 
Ex vivo FM-LBL network were formed on rat dermal tissue using curcumin-loaded 
filomicelle (FM-LBL). FM-LBL network growth was studied by tracking the relative 
fluorescence intensity (RFU) from curcumin drug loadings for increasing number of layer 
addition cycles (NoL). Biotinylated FM demonstrated better multilayer growth in 
comparison to FM without biotin, due to its ability to effectively cross-link via affinity 
interactions.  
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Figure 4.20. Epi-fluorescence micrographs on ex vivo developed layer-by-layer 
networks of filamentous micelles 
Visualization of 7-layered FM-LBL networks through epi-fluorescence microscopy. FM 
without biotin did not result in network formation.                     
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4-4. Conclusion 
In conclusion, poly(ethylene glycol)-b-poly(lactic acid) based diblock copolymers of 
different polymer amphiphilicities were custom synthesized. By controlling critical 
packing parameter of the diblocks, supramolecular morphologies of spherical and 
filamentous micelle were formulated via cosolvent/evaporation method. To add affinity to 
the formulated micelles, a biotin-functionalized poly(ethylene glycol)-b-poly(lactic acid) 
was synthesized and incorporated in micelle formulations. In developing hierarchical 
layer-by-layers of micelle, we utilized biotin-functionalized micelles as the network 
building blocks, complemented by addition of streptavidin in generating synthetic network. 
We demonstrated that the micelle self-organization process was driven through biotin-
streptavidin association, suggesting its specificity. Also, it was deduced that micellar 
structural configuration plays a critical role in impacting formation of LBL. This synthetic 
network formation ability is demonstrated in both synthetic and biological interfaces.  
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CHAPTER 5. STRUCTURAL AND BIOFUNCTIONAL EVALUATION OF 
SYNTHETIC MUCIN NEWORKS 
Based on the research article: 
S.P. Authimoolam, A.L. Vasilakes, N.M. Shah, D.A. Puleo and T.D. 
Dziubla, “Synthetic Oral Mucin Mimic from Polymer Micelle Networks”, 
Biomacromolecules, 2014, 15, (8), 3099-111.  
 
5-1. Introduction   
As earlier emphasized, structurally, mucins are randomly organized fibrous networks. Over 
mucosal surface, its network structure and its growth mechanism are highly heterogeneous 
and dynamic in nature. In synthetically recreating natural mucin structure via layer-by-
layer (LBL) self-organization process, both the physical properties of the LBL building 
blocks (e.g. shape, flexibility) and its molecular driving force can play a key role. For 
instance, multilayer depositions from highly flexible polyelectrolyte chains tend to form 
an irregularly segregated structure, resembling a “fuzzy layered assembly”.201 Thereby, 
choosing a building block with reduced chain flexibility could generate structurally less 
fuzzy or more distinctively segregated layers within its structure. However, in natural 
mucin networks the demarcation of layers is highly disordered, hence those structures 
could distinctively deviate in its morphological characteristics when cross-compared. Also, 
the availability of molecular binding sites in LBL building blocks can impact the multilayer 
structure and its formation mechanism. For instance, in polyelectrolyte based multilayers, 
the total net charge and its distribution along polymeric chains can affect its structural 
reversibility, causing dynamic re-arrangements.202 
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Among polymer based LBL self-assembling, charge driven polyelectrolyte based 
multilayers (PEM) systems are widely been studied for biological applications.203, 204 
Traditionally in biological applications, such PEMs are emphasized as a diffusional barrier 
coating over nanocarriers to tune its therapeutic drug release or as a bioactive coating over 
implant substrates.166, 205-207 Adopting a similar approach in developing mesoscopic thick 
synthetic mucin structures would require an exorbitantly high number of LBL additions. 
The molecular dimensions of LBL building blocks critically determines its thickness 
growth rate, for instance, for polyelectrolytes LBL growth per bilayer thickness growth is 
usually in orders of few angstrom. Thereby, in the current approach, a preassembled 
nanostructure (e.g. polymeric micelles in orders of few nanometers) was used as the 
network building block.  
For developing a stable network by reducing structural reversibility during LBL 
self-assembling, a strong affinity pairing (e.g. antigen-antibody, biotin-streptavidin) was 
preferred taking into consideration the morphological length scale of polymeric micelles 
(diameter ~250nm). Conventionally adopted molecular interactions (e.g. hydrogen, ionic 
bonds) could result in premature assembly destabilization with its weak molecular forces. 
However, the affinity driven molecular structures are expected to more rapidly grow into 
a mesoscopic self-assembly (microbarrier thickness) due to its high association or 
molecular recognizing capability (bio-specificity). 199, 200 
Further, selecting a suitable structural component (LBL building block) is critical, 
which upon self-organization should replicate the salient features of natural mucin 
networks. In our current work, the use of filamentous nanocarriers was expected to form a 
fuzzily organized yet more uniformly surface covered multilayers, similar to natural mucin 
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structures. Hence, to critically evaluate its biomimetic tendency, its structural and 
biofunctional properties were studied. It should be noted that the biomimetic tendency of 
synthetic mucin culminates from its physical properties of the network, and was not 
modified by adjusting the chemical properties of mucin networks. These physical 
properties of networks encompasses its morphology, pore size, thickness and 
heterogeneous network formation mechanism. Additionally, key biofunctional properties 
that were specific towards bulk characteristics of natural mucin such as hydration tendency 
and bacterial regulation effects were also investigated.   
5-2. Experimental Section 
5-2.1. Materials 
Protease derived from Streptomyces griseus (pronase), bovine serum albumin, curcumin 
(from curcuma longa), crystal violet, sodium chloride, and trichloroacetic acid were 
purchased from Sigma Aldrich (St. Louis, MO). Recombinant streptavidin (produced in E. 
coli) was purchased from Prospec-Tany (East Brunswick, NJ). Dimethyl sulfoxide 
(DMSO) and acetic acid were purchased from Fisher Scientific (Pittsburgh, PA). Iodogen® 
iodination reagent (1,3,4,6-tetrachloro-3α-6α-diphenylglycouril) was purchased from 
Thermo Scientific (Rockfort, IL). Staphylococcus aureus subspecies Rosenbach was 
purchased from ATCC (Manassas, VA). Chloroform was purchased from Acros Organics 
(Waltham, MA). Sodium phosphate, dibasic (Na2HPO4) and potassium phosphate, 
monobasic (KH2PO4) were purchased from Mallinckrodt Baker, Inc. (Phillipsburg, NJ). 
Potassium chloride was purchased from EMD Chemicals Inc. (Gibbstown, NJ). 
 
 93 
 
5-2.2. Fluorescence Microscopy of Layer-by-Layer Networks of Micelles  
In vitro FM-LBL and SM-LBL networks were deposited on larger diameter streptavidin 
adsorbed polystyrene 12-well microplates at room temperature. The procedure adopted in 
developing micelle-LBL networks is described in detail in Section 4-2.5. Networks are 
deposited independently using curcumin-loaded SM and FM with different number of LBL 
layers (NoL= 1, 3, 5 and 7). These micelle-LBL networks are visualized using 
epifluorescence microscopy (Nikon Eclipse LV100, FITC filter, NIS Elements) under 
different levels of magnification (10x/20x/50x objectives). Similarly, FM-LBL networks 
are deposited using nile-red loaded filamentous micelles under same settings, and imaged 
in TRITC filters.  
5-2.3. Scanning Electron Microscopy of Micelle-LBL Networks  
SM or FM-LBL networks with different NoL (1, 3, 5, 7) were deposited on a polystyrene 
substrate adopting the same procedure described under micelle-LBL networks formation 
(see Section 4-2.5). Excess micelles and streptavidin were removed by PBS rinses between 
each layer and finally rinsed off with DI water (0.2 µm filtered) post-network development. 
The micelle-LBL networks were visualized under a scanning electron microscope (SEM, 
S-4300, Hitachi), and images were taken at randomly selected locations at different 
magnifications. 
5-2.4. Evaluating FM-LBL Network Thickness 
FM-LBL networks were developed on streptavidin-adsorbed glass bottom culture-dishes 
adopting the same procedure as described above under micelle-LBL network formation 
(see Section 4-2.5). Preliminary visualization of network growth was carried out using 
confocal laser scanning microscopy (Leica TSP SP5 Confocal, Leica Microsystems, UV 
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Laser (405 Diode), GFP filter, under a 63x water objective). Optical sectioning was carried 
out along the x-y plane to generate z-stack images for evaluating the degree of 
heterogeneity within each sample prior to thickness measurement (Figure 5.12). Upon 
visual verification of LBL network formation and homogeneity, its thickness was 
determined by optical sectioning along the transverse x-z planes to generate y-stack (cross-
sectional) images. Throughout the imaging process, the samples were kept immersed in 
water to eliminate refractive index differences in the optical medium. CLSM imaging 
measurement parameters (during thickness measurements): 63x water immersion 
objective, xzy scanning mode with y-stacking, scan size Width (x) x Height (y) x Depth 
(z) = 110 x 110 x (50-60) µm, no. of optical sections = 46-65).  
5-2.5. FM-LBL Network Stability 
5-2.5.1. Radiolabeling Streptavidin 
Protein streptavidin was radiolabeled (125I-Streptavidin) using Iodogen® iodination 
reagent. Iodogen® (1,3,4,6-tetrachloro-3α-6α-diphenylglycouril) was added to a glass tube 
(2 mg/ml in chloroform, 200 μl) and was evaporated off using dry nitrogen gas to form a 
thin coat over the tube wall. To the Iodogen® coated test tube, streptavidin (1mg/ml in PBS, 
100 μl)  and radioactive iodine (125I) were added (~30 μCi) and incubated for at least 5 
minutes enabling iodination of tyrosyl groups in streptavidin.208 The free iodine was 
removed from radiolabeled streptavidin (125I-Streptavidin) by centrifugation of the solution 
through gel filtration columns (Biorad, Hercules, CA, Biospin® 6 Tris columns).  
To estimate free iodine and thereby the amount of radiolabel incorporated in protein 
streptavidin, a trichloroacetic acid (TCA) precipitation method was used. To the 
radiolabeled streptavidin (1 mg/ml in PBS, 2 μl), TCA (20% w/v in DI water, 1 ml) and 
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bovine serum albumin (BSA) (5% w/v in PBS, 1 ml) were added and incubated for at least 
10 minutes. TCA addition readily precipitates the protein (BSA and radiolabeled 
streptavidin) from supernatant containing free iodine. The precipitate was pelletized by 
centrifugation and the supernatant was collected. By measuring radioactive gamma counts 
(Perkin Elmer 2470 Wizard2) from the supernatant and precipitate separately, the extent of 
free iodine and the amount of radiolabel incorporated was determined. 
5-2.5.2. Streptavidin Destabilization from FM-LBL Networks 
FM-LBL networks were developed using a modified micelle-LBL network formation 
procedure, described below. FM-LBL network destabilization was studied by tracking loss 
of radiolabeled streptavidin (125I-streptavidin) from the network interlayers and from the 
lower-most streptavidin layer independently.  
For measuring the network interlayers, a non-radiolabeled streptavidin layer was 
first added to the base biotin layer, followed by alternating biotin-FM and 125I-streptavidin 
additions until the desired NoL (=7) were deposited. For measuring the lower-most layer, 
a similar procedure was adopted, except that 125I-streptavidin was added to the base biotin 
layer, while the overlaying layers were deposited using non-radiolabeled streptavidin. 
Networks were incubated in simulated saliva (100 µl of 1.3 mM KH2PO4, 16 mM 
Na2HPO4, 136.9 mM NaCl, pH= 6.75)209 or pronase (0.01% w/v, 100 µl) at 37ºC for 
different durations. Streptavidin mass remaining in the FM-LBL networks was measured 
using a gamma counter (Perkin Elmer 2470 Wizard2).  
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5-2.6. Wettability Measurement 
FM-LBL networks with different NoL (1, 3, 5, and 7) were deposited on a polystyrene 
substrate. These networks are visualized using fluorescence microscopy, adopting the 
procedure described in Section 5-2.2. (see fluorescence micrographs in Figure 5.16a). A 
sessile drop was microsyringed onto FM-LBL networks and on an unmodified polystyrene 
substrate (without FM-LBL network). The contact angle was measured using a goniometer 
(ramé-hart model 100, Drop image software, Succasunna, NJ), and the sessile drop was 
imaged to provide visual proof of the change in surface wettability. 
5-2.7. Bacterial Growth Studies 
5-2.7.1. In vitro Micelle-LBL Network Formation  
SM-LBL and FM-LBL networks (NoL= 7, 10 and 14) were deposited onto PS microplates 
using micelles (biotin-SM or biotin-FM) without curcumin loading, adopting the procedure 
as described in Section 4-2.5. To study the effect of drug on bacterial growth, micelles 
with curcumin loaded in their core were used. Curcumin-loaded SM-LBL and FM-LBL 
networks (NoL= 7) were deposited onto PS microplates. Note that 48-well tissue culture 
treated polystyrene plates (Becton Dickinson Biosciences, San Jose, CA) were used for all 
bacterial studies.  
5-2.7.2. Bacterial Growth on LBL Networks 
The protocol used for bacterial growth and quantification was adopted from Merritt et al.210 
Staphylococcus aureus Rosenbach strain (ATCC 25923, Manassas, VA) were cultured 
overnight in liquid BD Bacto Brain Heart Infusion (BHI) broth. To evaluate growth on the 
LBL networks an additional 1% w/v D-glucose and 2% w/v sodium chloride were added 
to the BHI broth to enhance biofilm growth. The overnight culture (S. aureus in BHI media) 
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was diluted in BHI medium to a workable optical density (0.5 OD at 600 nm) for cell-
counting, then to a working concentration of 105 cell forming units (CFU)/200μL. A total 
of 200 µL of culture suspension were added onto control substrate (without any LBL 
network) and onto the SM-LBL and FM-LBL networks, and incubated at 37ºC for 24 h to 
allow bacterial growth.  
5-2.7.3. Bacterial Growth Quantification Using Crystal Violet Assay 
 A 0.1% w/v crystal violet solution was prepared in DI water, and 40 µl were added to each 
well of the 48 well plates after bacterial growth for 24 h. After 10 minutes at room 
temperature, the supernatant was removed, and the substrates were washed with PBS three 
times. Acetic acid (200 µl, 30% v/v) was added and incubated for 10 minutes at room 
temperature to dissolve the crystal violet bound to the bacterial cell walls. The solution was 
then mixed using a pipet, and optical absorbance (Abs) values were measured using a 
spectrophotometer (BioTek Synergy Mx, Gen5 2.0, Winooski, VT) at λ = 600nm. The 
bacterial growth on the LBL networks was calculated as a percentage of bacteria on the 
untreated control substrate using the following equation: 
% bacterial Growth= 
�AbsLBL(bacteria)  - AbsLBL(no-bacteria)�
�AbsSubstrate(bacteria)  - AbsSubstrate(no-bacteria�
×100 
5-2.7.4. Evaluating Non-specific Crystal Violet Staining on Micelle-LBL Networks 
Without Bacterial Growth.  
A similar procedure was adopted as described above under bacterial growth quantification 
using crystal violet assay. 7, 10, and 14 layered micelle-LBL networks (SM-LBL, FM-
LBL), which possess relatively higher network-surface coverage was used. These micelle-
LBL were subjected to crystal violet staining without addition of bacteria to evaluate the 
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possibility of non-specific staining of the micelles. The staining of these FM-LBL and SM-
LBL networks were compared to those of control substrate surfaces (polystyrene surface) 
with and without any bacterial growth. The extent of crystal violet staining was measured 
via absorbance at wavelength, λ= 600 nm (BioTek Synergy Mx, Gen5 2.0, Winooski, VT). 
5-2.7.5. Planktonic Minimum Inhibitory Concentration (MIC) Assay for Free 
Curcumin 
From curcumin stock in DMSO, serial dilutions were made and added to 48 well plates 
(Thermo Scientific BioLite well plates), with the total DMSO content kept constant at 5% 
v/v. Then, an overnight culture of S. aureus was diluted using BHI medium and added to 
the well plate curcumin solutions to give 105 CFU/well. At this point, the initial time point 
(T0) was recorded at OD600 (Molecular devices spectramax M2). After 24 hours of 
incubation at 37ºC under orbital shaking (Thermo Scientific REVCO), the final time point 
(Tf) was recorded at OD600. 
5-3. Results and Discussion 
5-3.1. Structural Evaluation of Synthetic Mucin Networks 
5-3.1.1. Synthetic Network Formation Mechanism  
The structural formation mechanism in synthetic mucin networks is studied via an in-depth 
fluorescence and scanning electron microscopy imaging, for progressive LBL depositions. 
It was observed that the micelle-LBL network initially forms as localized zones of self-
assembled clusters (islands) that progressively spreads out to form a continuous network 
at higher number of layers (Figure 5.1, 5.2, 5.3, 5.4, 5.5, 5.6, 5.7, and 5.8). FMs can span 
much longer distances with their higher structural aspect ratio, thus permitting easier island 
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bridging and more rapid network development (Figure 5.1, 5.2, 5.3, 5.4, and 5.5). In 
contrary, SMs, due to their relatively lower structural aspect demonstrated a weak network 
formation ability (Figure 5.6, 5.7, and 5.8). This result serves as a visual proof in 
reinforcing the earlier finding (see Section 4-3.4.1, Figure 4.17), that micellar 
morphological shape substantially affects the network formation ability.  
In many of the conventional multilayer systems (e.g. inorganic platelets, 
polyelectrolytes),211, 212 the layer-by-layer process proceeds by forming homogenous (at 
the nanoscale) monolayers with each deposition cycle, commonly referred as normal 
growth mode. However, in colloidal or nanoparticulate-based systems, the self-assembly 
growth resulted from localized particulate clusters instead of monolayer deposition. In such 
systems, multilayers expand via lateral and vertical growth and is more commonly referred 
as lateral expansion mode.130, 211, 213 A similar network growth pattern was observed in the 
polymeric micelle based LBL systems. The multivalent polyelectrolyte based systems are 
structurally more comparable to the biotin-decorated filamentous micelles than the 
spherical micelles. This structural similarity of the filomicelles is expected to have 
critically contributed in improving its lateral expansion growth pattern, which was 
observable with its relatively better substrate coverage and its network formation ability. 
Interestingly, the network formation mechanism of the filomicelles is strikingly similar to 
oral salivary mechanisms, suggesting the importance of the filamentous structure to natural 
mucin subunits, i.e. mucin glycoproteins. In a recent study by Baek et al., dental pellicle 
(enamel-mucin coatings) formation over tooth surfaces was shown to develop through 
initial “island” like structures composed of oral salivary proteins and associated 
glycoprotein (mucin) deposition.214 Over time, these islands would bridge through 
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intermolecular complexation into a continuous film. The dental pellicle protects teeth from 
demineralization from acid attack.73, 214  
In nanoparticle-based systems, a similar lateral expansion growth pattern was 
observed due to electrostatic repulsive forces between particulates.211, 215 Due to this 
growth pattern, the extent of surface coverage is relatively poor in systems of particulate 
based system in comparison to polyelectrolyte based systems.211, 215 However, in 
particulate based LBL with higher deposition cycles, porous loosely held structures with 
high surface roughness and thickness can be achieved. 211, 215 These constructs can be 
relatively more pertinent for biological applications, for instance synthetic extracellular 
matrix requires porous structural mesh in forming tissue scaffolds. However, in 
polyelectrolyte based systems, due to their highly flexible polymeric chains, a more 
homogeneous coverage with reduced morphological irregularities is obtained.  
The synthetic approach for mucin network formation is facile, yet highly versatile 
and it generates cross-linked structural mesh with relatively fewer LBL additions due to 
the high affinity interactions. Further, biomolecules (e.g., growth factor, small molecule 
drugs and/or enzymes) can be incorporated into the micellar (FM or SM) cores to render 
desired bioactivity from the micelle-LBL networks. Also, the degree of network-
crosslinking can be altered by controlling the level of biotin that is decorated over micelles 
during the biotin-micelle synthesis. With high levels of biotin decoration, a more robust 
network with high network cross-linking and low porosity was expected.216 Among 
polymeric micelles, FM possess better shape aspect ratio (L/D) and are structurally 
analogous to the mucin glycoprotein. Thus, it was expected that filamentous micelles 
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would develop into the desired biomimetic mucin coating and also to serve as an 
experimental tool for studying structure-function relationships of natural mucin.   
Micelle-LBL network properties can also be tailored for different applications by 
incorporating functional moieties in the synthesized micelles through post modification 
methods (e.g., chemical modification via covalent coupling). For instance, byssal threads 
produced by mussels are rich in dihydroxyphenylalanine (DOPA) moiety, the main 
contributor for their property of strong adhesion. By chemically grafting DOPA molecules 
with polymeric micelle chains, the networks would be expected to possess superior 
adhesive property and enhanced film stability.157, 217 Those films can be applied as a robust 
implant coating capable of drug release.157 Similarly, charge properties of the network can 
be altered with careful selection of building blocks, which may impact bacterial adhesion. 
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Figure 5.1. Epifluorescence micrographs of micelle-LBL networks formed from curcumin loaded filamentous micelles under 
lower level of magnification 
Image showing effect of biotin and number of layers on FM-LBL network formation on polystyrene substrates at lower magnification 
(FITC channel, 10x magnification).  
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Figure 5.2. Epifluorescence micrographs of micelle-LBL networks formed from curcumin-loaded filamentous micelles under 
relatively higher level of magnification 
Image showing effect of biotin and number of layers on FM-LBL network formation on polystyrene substrates at relatively higher 
magnification (FITC channel, 20x magnification).  
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Figure 5.3. Scanning electron micrographs of micelle-LBL networks formed from biotinylated filomicelles  
Results illustrate the progressive micelle-LBL growth and formation of 3-dimensional porous structures with excellent surface coverage 
and homogeneity for networks with higher number of layer additions (NoL= 5 and 7). 
  
 
 
105 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4. Epifluorescence micrographs of micelle-LBL networks formed from nile red-loaded filomicelles under relatively 
lower magnification 
Image showing effect of biotin and number of layers on FM-LBL network formation on polystyrene substrates at relatively lower 
magnification (TRITC channel, 10x magnification). This closely follows the network formation trends as observed from curcumin-
loaded filomicelles (refer Figure 5.1). 
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Figure 5.5. Epifluorescence micrographs of micelle-LBL networks formed from nile red-loaded filomicelles under relatively 
higher magnification 
Image showing effect of biotin and number of layers on FM-LBL network formation on polystyrene substrates at relatively lower 
magnification (TRITC channel, 20x magnification). This closely follows the network formation trends as observed from curcumin-
loaded filomicelles (refer Figure 5.2).  
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Figure 5.6. Epifluorescence micrographs of micelle-LBL networks formed from curcumin-loaded spherical micelles under 
relatively lower magnification 
Image showing effect of biotin and number of layers on SM-LBL network formation on polystyrene substrates at lower magnification 
(FITC channel, 10x magnification).  
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Figure 5.7. Epifluorescence micrographs of micelle-LBL networks formed from curcumin-loaded spherical micelles under 
relatively higher magnification 
Image showing effect of biotin and number of layers on SM-LBL network formation on polystyrene substrates at relatively higher 
magnification (FITC channel, 20x magnification).  
  
 
 
109 
 
Figure 5.8. Scanning electron micrographs of micelle-LBL networks formed from biotinylated spherical micelles 
Results illustrate poor network formation tendency characterized by significantly lower surface coverage (higher heterogeneity). 
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5-3.1.2. Visualizing Homogeneity of the Micelle-LBL Network Coverage  
Since, micelle-LBL networks grew via lateral and vertical expansion, in order to compare 
apparent network pore size and lateral substrate growth, SM-LBL and FM-LBL networks 
were visualized using fluorescence microscopy and SEM. In the case of FM-LBL 
networks, the percent substrate coverage progressively increased with each micelle layer 
additions (NoL ≤ 3) and achieved a near complete coverage for higher micelle layers (NoL 
> 3) (Figure 5.1, 5.2, 5.3, 5.4, 5.5 and 5.9). This increasing coverage with NoL illustrates 
the networks lateral growth expansion. Interestingly, the FM-LBL networks with higher 
NoL demonstrated formation of a nanoporous network with an average pore diameter of 
~110 nm to 340 nm under SEM (Figure 5.11). In literature,67 the average mesh size in 
natural mucin networks (cervical) was reported to range between 20-200 nm with an 
average pore size of ~100 nm, this closely matches with synthetic networks. 
Unlike FM-LBL networks, the SM-LBL networks resulted in heterogeneous 
substrate coverage (Figure 5.3, 5.8 and 5.9), and would probably require a much higher 
NoL (>7) to achieve complete coverage. The improved coverage by the FM-LBL networks 
was visually evident under both fluorescence microscopy and SEM, where it was deduced 
that 5 layer additions resulted in ~100% coverage, whereas SM-LBL networks achieved 
only ~38% coverage (Figure 5.9).  
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Figure 5.9. Estimating extent of lateral growth expansion in micelle-LBL networks 
by studying percent substrate coverage changes with increasing number of layer 
additions 
A more rapid network lateral growth expansion was observed from filomicelles in 
comparison to spherical micelles. FM-LBL networks provided complete surface coverage, 
whereas SM-LBL networks showed a significantly lower surface coverage for same 
number of layer additions. Percent surface coverage was deduced from ImageJ post-
processing where network coverage and unoccupied substrate surface area at different 
levels of magnification was obtained (refer Figure 5.10). 
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Figure 5.10. ImageJ post-processing procedure adopted in deducing network 
substrate coverage 
Illustrative figure shows from 3 layered FM-LBL network used in deducing the percent 
network substrate coverage. Using ImageJ post-processing software, the extent of network 
occupied and substrate exposed (network unoccupied) sites were distinguished. 
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Figure 5.11. Demonstrating formation of nanoporous fused structures from layer-by-
layer networks of filamentous micelles 
Closer examination under scanning electron microscopy revealed that FM-LBL networks 
from relatively higher number of additions (NoL ≥5) formed a nanoporous structure. The 
illustrative figure shows a 7-layered FM-LBL network with mesh size ranging ~110 - 340 
nm. 
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5-3.2. Micelle-LBL Network Thickness 
Thickness measurements of the more homogeneous FM-LBL network using confocal laser 
scanning microscopy (CLSM) showed a linear growth with increasing number of layer 
(Figure 5.13), where networks with 7 layer additions were ~4 µm thick. The growth in 
total network thickness serves as an illustration of networks vertical growth expansion. 
Interestingly, the thickness of natural mucin networks vary from 70-1000 µm, depending 
on the region within oral cavity.65, 218 Structurally, mucin multilayers possess loosely held 
outer layers that are prone to bacterial colonization, and are constantly subjected to 
dynamic removal and reformation. This contrasts with the more structurally intact 
epithelial-bound innermost layer that is devoid of bacteria.56, 57, 219 Transitioning the current 
approach from micro-to-mesoscopic length scale may require a higher number of oral rinse 
cycles or, more feasibly, incorporation of simple modifications in the preassembly 
structures (e.g., inclusion of hydrating polymers). Therefore, by ensuring network stability 
in synthetic mucin networks, they can serve as an effective model to structurally recreate 
the more firmly held mucosal adjoining layers.  
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Figure 5.12. Confocal laser scanning micrographs of micelle-LBL networks formed from curcumin-loaded filomicelle 
Curcumin loaded FM-LBL networks with different number of layer depositions (NoL = 3, 5, 7 and 14 layers) were formed using 
biotinylated FM, and a 14-layered network was formed from filomicelles without biotin (control). The networks were visualized for its 
homogeneity, prior to performing thickness measurements.  
 116 
 
 
 
 
 
 
 
Figure 5.13. Thickness measurement on FM-LBL networks 
Network thickness measurements from fluorescence image stacks obtained using confocal 
laser scanning microscopy (CLSM) demonstrate a linear increase in thickness with number 
of layers, where a 7-layered micelle-LBL self-assembly showed a ~4µm thick network. 
(CLSM imaging measurement parameters: 63x water immersion objective, xzy scanning 
mode with y-stacking, scan size Width (x) x Height (y) x Depth (z) = 110 x 110 x (50-60) 
µm, no. of optical sections = 46-65).  
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5-3.3. Chemical Stability of FM-LBL Networks 
In the oral environment, the micelle-LBL networks are exposed to both salivary fluid and 
bacterial proteases. Bacterial colonization in the oral cavity produces a highly proteolytic 
environment causing the natural mucin to transition into a more loosely-held network. 
These result from cleavage of the intermolecular protein linkages, causing a more rapid 
mucin removal (peel-out).57 Therefore, to assess the durability of the LBL networks against 
the chemical onslaughts, 7-layered FM-LBL networks were deposited on polystyrene (PS) 
substrates, and subjected to network destabilization in bacterial proteolytic enzyme 
(pronase) and in simulated saliva. The FM-LBL network stability was monitored by 
independently quantifying streptavidin loss from the innermost base streptavidin layer and 
from the overlaying network layers (scheme shown in Figure 5.14).  
In our previous work,91 we showed that the base streptavidin layer without any 
overlaying micelle-LBL network destabilizes rapidly upon direct protease exposure, 
resulting in ~90% loss (after ~42 h). However, when a micelle-LBL network was 
developed over this base layer, it functioned as a protective barrier to shield the innermost 
streptavidin layer from destabilization. We observed that nearly 45% of the streptavidin 
mass remained (for ~44 h) in the networks without being destabilized by the harsh protease 
(Figure 5.15).  
Expectedly, the proteolytic enzyme, pronase, possesses relatively higher 
destabilization effect on the protein cross-linked LBL networks than the simulated saliva. 
The innermost streptavidin layer loss was nearly 56% less (after ~2 days) under simulated 
saliva than in pronase. A similar effect was observed on the streptavidin in the overlaying 
micelle layers, where the loss was nearly 39% lower (after ~2 days) under simulated saliva. 
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Interestingly, streptavidin removal from the innermost and the overlaying FM-LBL 
network layers showed only moderate reduction, with insignificant differences between the 
two locations. This suggests accessibility of the innermost layers of the FM-LBL networks 
to the proteolytic enzyme. This level of accessibility can be attributed to the porosity of the 
LBL network akin to that of natural mucin. 
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Figure 5.14. Scheme showing the procedure used in studying stability of synthetic 
mucin network under simulated oral environment 
Destabilization of innermost streptavidin layer and overlaying streptavidin layers was 
tracked independently using radiolabeled streptavidin (125I-streptavidin) in evaluating 
overall network stability under simulated salivary and protease environment.   
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Figure 5.15. In vitro chemical stability of FM-LBL networks under simulated oral 
environment 
Destabilization of innermost streptavidin layer and overlaying streptavidin layers was 
tracked independently to study overall network stability under simulated salivary and 
protease environment. From results, streptavidin layer without possessing any overlaying 
FM-LBL layers resulted in a rapid protein destabilization with direct exposure to 
proteolytic pronase. On developing FM-LBL over this inner-most streptavidin layer, due 
to the effects of overlaying polymeric network barrier property, a reduction in protein 
destabilization was readily observed to suggest enhanced stability of networks. Further, the 
stability of the overlaying streptavidin layer was tracked and their destabilization trend was 
found to closely match the innnermost strepavidin layer loss, under both protase and 
simulated salivary environment. This suggests formation of porous networks akin to that 
natural mucin networks. 
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5-3.4. Wettability Studies 
In the mucin networks, the hydrophilic protein domains are exposed to outer environment 
to yield a hydrated surface.220, 221 In patients suffering from loss of the mucin barrier, 
surface hydration is poor with reduced wettability. To study the degree of wettability of 
our synthetic mucin, FM-LBL networks with different NoL (1, 3, 5 & 7) were developed 
on PS substrates. As expected, the unmodified hydrophobic PS substrate showed a high 
water contact angle (~90°) demonstrating poor wettability. However, as the synthetic 
mucin (FM-LBL) network was self-assembled over the substrate, a substantial reduction 
in contact angle was observed, confirming wettability. The contact angle progressively 
decreased to 34.5° with an increase in NoL from 1 to 3, indicating that the progressive 
increase in surface coverage impacted wettability. These observations are congruent with 
our earlier observations with SEM and fluorescence microscopy imaging where networks 
with NoL ≤ 3 layers achieved incomplete surface coverage, though coverage increased 
with the number of layer additions (Figure 5.9). Beyond 3 micelle layer additions (NoL ≥ 
5), FM-LBL networks achieved near complete substrate coverage (NoL ≥ 5), yielding a 
consistently low contact angle of 29° (Figure 5.16). The high wettability of FM-LBL 
networks is due to hydrophilic contributions from the exposed PEG micellar chains and 
hydrophilic domains of the protein streptavidin. 
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Figure 5.16. Studying hydration effects of filamentous networks using contact angle 
measurements 
a) FM-LBL networks were visualized through epifluorescence microscopy, prior to 
performing the contact angle measurements. Images verify formation of FM-LBL 
networks as observed previously. In the above figure, FM-LBL networks with no. of biotin-
FM layer additions (NoL= 1, 3, and 7) were shown. b) Evaluating wettability of FM-LBL 
networks using sessile drop-contact angle measurement. A significantly lower contact 
angle (°) was observed when the surface was modified with a FM-LBL network. Also, the 
contact angle plateaued at ~29° for number of layers ≥ 5.  
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5-3.5. Bacterial Growth Studies 
Natural oral mucin alters the growth of microbial flora, permitting adherence and 
proliferation of certain microbes while also acting as a clearing agent.16 As described 
earlier, the outer layers of mucin networks are less structurally intact and form an expanded 
volume.57 These outer mucin layers are prone to bacterial colonization and subsequently 
function as a sacrificial barrier. Such a mucin coat when coupled with persistent salivary 
flow reduces oral bacterial residence time to deter undesirable biofilm formation.222 In 
patients lacking the protective mucin barrier, there is an increased susceptibility to 
excessive bacterial colonization and biofilm formation leading to oral infections.93, 95, 223    
FM-LBL networks promoted adhesion of S. aureus bacteria compared to SM-LBL 
networks, most likely due to higher surface area availability and network porosity. On the 
other hand, the inhomogeneous SM-LBL networks did not significantly alter bacterial 
growth compared to control substrates without any LBL networks (Figure 5.17). 
Interestingly, such enhanced bacterial adhesion on FM-LBL networks would be typically 
unexpected for a network system composed of PEG, which is well-known for its anti-
adhesion properties. This outcome highlights a critical biomimetic property of the FM-
LBL networks in that they support bacterial growth by recreating the morphology and 
function of natural mucin.161, 224  
Another advantage of the FM-LBL network is its ability to serve as a drug delivery 
vehicle. This may be useful as an alternative method to control bacterial growth, in 
particular when unhealthy infections need to be controlled. To demonstrate this ability, 
LBL networks were created using curcumin-loaded SM and FM. Curcumin is a natural 
antioxidant with known antimicrobial properties.225 The curcumin-loaded FM-LBL 
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networks resulted in ~31% reduction in bacterial growth, whereas the relatively less 
homogeneous curcumin-loaded SM-LBL networks did not significantly reduce bacterial 
adherence (Figure 5.18). Again, this can be attributed to the poor network formation of 
SM-LBL network that resulted in lower drug content and insignificant effects on bacteria. 
FM-LBL networks with better self-assembly, and thereby increased drug content, thus 
resulted in a reduced bacterial growth. 
Additional control layer-by-layer networks of spherical and filamentous micelles 
were also studied independently without bacterial addition to account for non-specific 
crystal violet staining of the micelles. The control substrates with bacterial growth (no-
networks) showed a significantly higher crystal violet staining. SM-LBL and FM-LBL 
networks without bacteria showed a slightly elevated level of staining compared to blank 
substrates (also without bacteria). Although, this effect was statistically insignificant, it 
was accounted for in the % bacterial growth calculation (Figure 5.19).  
To corroborate the effect of curcumin on inhibiting bacterial growth, the results 
from micelle-LBL networks were compared to the planktonic antimicrobial activity of free 
curcumin. The minimum inhibitory concentration required to suppress 90% bacterial S. 
aureus growth (MIC90) was found to be ~50 µg/ml for free curcumin, which indicates a 
strong antimicrobial effect (Figure 5.20). FM-LBL and SM-LBL networks were expected 
to yield a curcumin solution concentration of ~24.5 µg/ml and ~7.5 µg/ml respectively at 
24 h drug release. Based on the planktonic MIC90 plot, these concentrations were expected 
to inhibit ~31.5% and ~0% bacterial growth for FM-LBL and SM-LBL, respectively. 
Effects of released curcumin were comparable with those observed from the inhibition 
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study with bacteria seeded directly on curcumin-loaded micelle-LBL networks, confirming 
the antibacterial role played by curcumin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 126 
 
 
 
 
 
 
 
 
Figure 5.17. Effect of bacterial growth on FM-LBL and SM-LBL networks developed 
using micelles without curcumin loading 
FM-LBL and SM-LBL networks with increasing number of layers (7, 10 and 14) were 
deposited on polystyrene substrate, and bacterial growth on these micelle-LBL networks 
was measured using crystal violet stain, after treatment duration of ~24 h. Bacterial growth 
was significantly higher on FM-LBL networks than the SM-LBL networks (NoL= 10, 14), 
which is likely due to increased surface area available for bacterial growth. 
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Figure 5.18. Effect of curcumin loading in micelles in inhibiting bacterial growth on 
SM-LBL and FM-LBL networks 
7-layered FM-LBL and SM-LBL networks with- and without curcumin loading was 
deposited on polystyrene substrate, and bacterial growth on these micelle-LBL networks 
was measured using crystal violet stain, after treatment duration of ~24 h. From above 
results, a reduction in bacterial growth was observed on curcumin-loaded FM-LBL 
networks, indicative of curcumin antibacterial activity. 
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Figure 5.19. Determining the extent of non-specific crystal violet staining effect on 
micelle-LBL networks 
Crystal violet staining of LBL networks of spherical (SM-LBL) and filamentous (FM-
LBL) micelles without bacteria, to determine the possibility of non-specific crystal violet 
staining of the micelles. 7, 10, and 14 layered LBL networks that possess relatively higher 
network-surface coverage were used. SM-LBL and FM-LBL networks without bacteria 
showed a slightly elevated level of staining compared to blank substrates (also without 
bacteria). However, blank substrates with bacterial growth showed a significantly higher 
staining compared to networks and blank substrate without bacteria. This clearly indicates 
the specificity of crystal violet for staining bacterial components. A 2-sample t-test 
performed using a statistical software (Minitab), found differences between networks and 
substrate (without bacteria) to be insignificant, while between systems (with and without 
bacterial growth) to be significant. The differences were considered significant (*) only 
when p-value < 0.05. 
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Figure 5.20. Planktonic minimum inhibitory concentration (MIC) assay for free 
curcumin 
Optical density, OD600 at initial time point (T0) and after 24 h incubation (Tf) were recorded 
and used in studying extent of planktonic inhibition at different free curcumin 
concentrations.   
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5-4. Conclusion 
Micelle-LBL networks can be developed to recreate the structural and network formation 
properties of oral mucin barriers. The structure, stability, and microbial capture capabilities 
were evaluated as a function of network properties. By keeping the surface chemistry 
constant, we have demonstrated that changes in network properties could be achieved by 
simply adjusting the structure of the starting micelle without requiring changes to the 
micelle chemistry. Layer-by-layer networks of filamentous micelles formed a 3-
dimensional nanoporous structure via fusion of micelles mimicking natural mucin. These 
synthetic mucin network possessed excellent surface hydration property and remained 
stable under harsh proteolytic and salivary environments. Further, it was found that 
network structure alone was sufficient for bacterial capture, even with networks composed 
of the adhesion resistant polymer, poly(ethylene glycol). By incorporation of a suitable 
antibacterial drug within the network, it provides a way to control bacterial growth and 
inhibit undesirable biofilm formation. These synthetic networks provide an excellent, yet 
simple, means of independently characterizing mucin network properties (e.g., surface 
chemistry, stiffness, and pore size). Also, the tunable characteristics of these networks open 
up a range of potential applications and studies that are not currently possible with other 
analog systems.  
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CHAPTER 6. SYNTHETIC MUCINS AS FUNCTIONAL DRUG RELEASING 
NETWORK 
Based on the research articles: 
S.P. Authimoolam, D.A. Puleo and T.D. Dziubla, “Affinity Based 
Multilayered Polymeric Self-assemblies for Oral Wound Applications”, 
Advanced Health Care Materials, 2013, 2, (7), 983-92. 
S.P. Authimoolam, D.A. Puleo and T.D. Dziubla, “Layer-by-layers of 
Polymeric Micelles as a Biomimetic Drug-Releasing Network”, 
Macromolecular Bioscience, 2015.  
 
6-1. Introduction 
Fabricating synthetic mucin structures from drug carriers, apart from its role as a biomimic 
or model structures,24 also possess high relevancy in the areas of bioactive coatings and in 
drug delivery. The current approach uses polymeric micelles as a network building block, 
which is well known for its drug-delivery potential. Therefore, by utilizing its ability to 
encapsulate small molecule drug or protein, they could develop into a functional drug 
eluting network. Much emphasis on previous chapters (4, 5) was on demonstrating ability 
to develop synthetic mucin-like structures from polymeric micelles, and thereby evaluate 
its structural properties (e.g. morphology, thickness, mesh size). However, in this chapter, 
apart from the biomimetic relevance of micellar-networks, its ability to function as a drug 
releasing network is demonstrated. Since, the network formation process is instantaneous, 
as they are driven through highly bio-specific biotin-streptavidin affinity linkages, it 
provides an additional opportunity for administrating via buccal rinse cycles in developing 
oral biofunctional coats. 
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In impacting the drug release from synthetic mucin networks or in generating 
desired release kinetics, additional polymer based barriers were formed using affinity based 
self-assembling approach (Figure 6.1). These barriers were formed without resorting to 
traditional approaches such as photo-crosslinking, chemical or thermal based post-
modification methods. The formation of these fused fibrillar nanoporous structures into 
such tunable networks would require relatively higher number of layer addition cycles. 
Hence, for practical application, alternatively they can be utilized as drug releasing 
biofunctional coats (e.g. in vaginal rings or implants) or as a drug-eluting patch with 
additional mucosal adhering layer (e.g. buccal mucoadhesive patch).  
The tunable networks were evaluated for its chemical intactness under simulated 
oral conditions, for potentially serving as a topical oral coats, offering barrier protection 
and tissue hydration. These affinity based FM networks were investigated for its ability to 
demonstrate tunable release kinetics from the effects of polymeric capping barriers.  
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Figure 6.1. Scheme showing hierarchical self-assembling approach adopted in developing a synthetic biomimetic network  
By utilizing highly specific biotin-streptavidin interactions, the drug loaded biotinylated micelles are crosslinked in forming networks 
that mimic natural oral mucin networks. These synthetic mucin are proposed to function as a drug releasing network in oral delivery. 
By incorporating polymeric capping barriers, these synthetic networks are expected to offer a tunable drug release.  
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6-2. Experimental section 
6-2.1. Materials 
Poly(acrylic acid sodium salt) (MW 225,000 Da) and poly(acrylic acid) (PAA) (MW 
90,000 Da) were purchased from Polysciences, Inc. (Warrington, PA) and was lyophilized 
prior to use. All other chemicals were used as purchased without any further purification 
unless stated. Bovine serum albumin (BSA), N-(3-dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride (EDC.HCl), 2-(4-hydroxyphenylazo) benzoic acid 
(HABA), crystal violet, curcumin (from curcuma longa), 2-(N-morpholino)ethanesulfonic 
acid (MES), glucose, mucin (from bovine submaxillary glands), protease derived from 
Streptomyces griseus (pronase) and trifluoroacetic acid (TCA) were purchased from Sigma 
Aldrich (St.Louis, MO). Iodogen® iodination reagent (1,3,4,6-tetrachloro-3α-6α-
diphenylglycouril) and pentylamine-biotin were purchased from Thermo Scientific 
(Rockfort, IL). Recombinant streptavidin (produced in E.Coli) was purchased from 
Prospec-Tany (East Brunswick, NJ). N-hydroxysuccinimide (NHS) was purchased from 
Acros Organics (Waltham, MA). Staphylococcus aureus subspecies Rosenbach was 
purchased from ATCC (Manassas, VA). Avidin (from egg whites) was purchased from 
Life TechnologiesTM (Grand Island, NJ).  
6-2.2. Scanning Electron Microscopy on Synthetic and Natural Mucin Depositions 
Filamentous micelles (FM) were synthesized as described under biotin-micelle synthesis 
(Section 4-2.4). Using biotin-FMs, in vitro FM-LBL networks (NoL=7) were developed 
on polystyrene plates at room temperature, as detailed in Section 4-2.5. Excess micelles 
and streptavidin were removed by PBS rinses between each layer and finally rinsed off 
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with DI water (0.2 µm filtered) post-network development, similar to the procedure 
adopted in Section 5-2.3. In forming natural mucin depositions, glycoproteins (from 
bovine submaxillary glands) (0.1 wt% in DI water) were allowed to adsorb onto the 
polystyrene substrates (~6 h incubation). The excess mucin was gently rinsed off using DI 
water rinses (0.2 µm filtered), and the networks were allowed to dry off at room 
temperature.    
The micelle-LBL networks and natural mucin depositions were visualized under a 
scanning electron microscope (SEM, S-4300, Hitachi), and images were taken at randomly 
selected locations at different magnifications.  
6-2.3. Atomic Force Microscopy of Layer-by-Layer Networks of Filomicelles  
7-layered FM-LBL networks (NoL=7) were developed on polystyrene plates at room 
temperature, as detailed in Section 5-2.3. The topography and surface roughness were 
imaged in a non-contact (tapping) mode AFM (Agilent Technologies, Series 4500), before 
and after network formation over the substrate. The networks were imaged in air medium 
(non-liquid mode) using a long cantilever (T190) (VISTAprobes® Phoenix, AZ) with a 
radius of curvature less than 10 nm (Spring constant- 48 N/m, resonant frequency-190 kHz, 
length- 225 µm, width- 40 µm, tip height- 14 µm). To visualize network morphologies at 
different length scales, the scans were performed using large and small area scanners. 
Under larger area scans 10 µm x 10 µm, and using smaller area scans 2 µm x 2 µm and 0.5 
µm x 0.5 µm networks surface area were visualized. For image visualization and analysis, 
Gwyddion software was used. 
 136 
 
6-2.4. Synthetic Mucin Network Formation from Spherical-Filamentous Micelle Co-
mixtures 
Spherical (SM) and filamentous micelles (FM) were synthesized as described under biotin-
micelle synthesis (Section 4-2.4). The micelle formulations were blended to form different 
compositional ratios (0%, 20%, 40%, 60%, 80% and 100% w/w of worms). These micelle 
blends were used in the formation of synthetic mucin networks, adopting the same 
procedure as described earlier for micelle-LBL network formation (Section 4-2.5).  
6-2.5. Visualization of Networks Formed from Spherical-Filomicelle Blend 
7-layered micelle-LBL networks were formed from spherical-filamentous micelle 
commixtures (refer Section 6-2.4), on polystyrene 12-well plates, under similar conditions. 
The networks were visualized under epifluorescence microscopy (Nikon Eclipse LV100, 
FITC filter, under 10x/20x objectives, NIS Elements). 
Similarly, for visualization under scanning electron microscope (SEM, S-4300, 
Hitachi), the 7-layered micelle-LBL networks were formed from micelle commixtures on 
a polystyrene substrate. During network formation via LBL process, the excess micelles 
and streptavidin were removed by PBS rinses between each layer and finally rinsed off 
with DI water (0.2 µm filtered) post-network development. The images were taken at 
randomly selected locations at different magnifications. 
6-2.6. Bacterial Growth Inhibition Studies from Networks of Micelle-Commixtures 
6-2.6.1. Bacterial Growth on Networks Formed from Commixtures 
 7-layered micelle-LBL networks were formed from different spherical-filomicelle blend 
ratios (0%, 20%, 40%, 60%, 80% and 100% of filomicelles) on a polystyrene 48-well 
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microplate (Becton Dickinson Biosciences, San Jose, CA), adopting the procedure as 
described in Section 6-2.4. Curcumin loaded biotin-functionalized micelles (2.65 wt %) 
were used for the LBL network formation process. Bacterial growth on drug loaded 
networks was conducted, as detailed in Section 5-2.7.2. Similar to the previous study, 
Staphylococcus aureus Rosenbach strain was used as the bacterial test strain. For allowing 
bacterial growth, the culture was added to each micelle-LBL network on the microplate 
wells, covered, and incubated for 24 h.  
6-2.6.2. Crystal Violet- Biofilm Quantification Assay 
The crystal violet quantification assay was performed as previously detailed in Section 5-
2.7.3. After 24 hr bacterial growth over networks, the crystal violet (0.1% w/v in DI water, 
40 µl/well) was added to each well. After 10 minutes at room temperature, the supernatant 
was removed, and the substrates were washed with PBS three times. Acetic acid (200 µl, 
30% v/v) was added and incubated for 10 minutes at room temperature to dissolve the 
crystal violet bound to the bacterial cell walls. The solution was then mixed using a pipett 
and optical absorbance (Abs) values were measured using a spectrophotometer (BioTek 
Synergy Mx, Gen5 2.0, Winooski, VT) at λ = 600nm. The bacterial growth on the LBL 
networks was calculated as a percentage of bacteria on the untreated control substrate using 
the following equation: 
% bacterial Growth= 
�AbsLBL(bacteria)  - AbsLBL(no-bacteria)�
�AbsSubstrate(bacteria)  - AbsSubstrate(no-bacteria�
×100 
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6-2.7. Developing Affinity based Polymeric Layer-by-layer Thin Films 
6-2.7.1. Polymer Biotinylation Synthesis 
Biotin moieties were covalently grafted to poly(acrylic acid) chains using carbodiimide 
coupling chemistry as established in our previous work.226  Poly(acrylic acid) of molecular 
weights ~90,000 & 220,000 Da was conjugated with pentylamine-biotin via N-(3-
dimethylaminopropyl)-N’-ethylcarbodiimide- hydroxysuccinimide (EDC-NHS) coupling 
reaction. During this reaction, the molar ratio of PAA:EDC:NHS was fixed at 1:10:20. 
And, the carboxylic acid (in polyacrylic acid chains) to pentylamine biotin was maintained 
at 2.5:1 molar ratio for achieving a relatively high biotin conjugation. Poly(acrylic acid), 
EDC and NHS were dissolved in MES buffer (50 mM), and the pH was regulated to ~5.0-
6.0. During this process, EDC activates the carboxylic acid groups in the PAA chain. 
Subsequently, pentylamine biotin was added to this acid-activated PAA chains and the pH 
was adjusted to ~7.0-8.0. This results in the formation of a stable amine bond by facilitating 
the reaction between carboxylic acid and amine groups. The reaction was allowed to 
proceed for 24 hr.  
6-2.7.2. Biotinylated Polymer Purification and Characterization  
The biotinylation reaction mixture was filtered to remove the byproduct precipitate (N-acyl 
urea). Subsequently, the reaction sample was subjected to ultrafiltration (Millipore, 
Billerica, MA). A regenerated cellulose membrane (Millipore, Billerica, MA) with 
molecular weight cutoff of ~10,000 Da was used for this size based exclusion. During the 
ultrafiltration process, the unreacted pentylamine-biotin, excess EDC and NHS were 
excluded from the desired polymer product.  
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To ensure complete removal of the unreacted chemicals, a reverse-phase high 
pressure liquid chromatography (RP-HPLC) (Shimadzu Prominence) technique was used. 
For this separation process, an isocratic mode with acetonitrile (15% v/v) and water with 
(1% v/v trifluoroacetic acid) (85% v/v) as the respective organic and polar phase was used. 
Under this constant solvent composition mode, an easier detection of free pentylamine 
biotin in the purified product was observed. The ultrafiltration procedure was performed 
till complete removal of free pentylamine biotin was ensured.  
Upon verification of product purity from RP-HPLC analysis, the biotinylated 
polymer product was characterized for its degree of biotinylation via 2-(4-
hydroxyphenylazo) benzoic acid (HABA)-avidin assay. The biotinylated polymer 
(Biotin/PAA90 or Biotin/PAA220) was added to the HABA-avidin working solution. The 
terminology Biotin/PAA90, Biotin/PAA220 refers to biotinylated poly(acrylic acid) with 
respective molecular chain lengths of 90 and 220 kDa. During biotinylated polymer 
addition to the HABA-avidin working solution (also refer Section 4-2.3), a color change 
was observed due to the formation of more stable biotin-avidin complex. This color shift 
was measured through changes (decrease) in absorbance (at λ=500 nm) using a 
spectrophotometer (Cary WinUV). The absorbance shift was correlated to biotin 
calibrations of known concentration through which average number of biotin molecules 
grafted per PAA chain was estimated.  
6-2.7.3. Formation of Polymeric Layer-by-layer Thin Films 
A monolayer base streptavidin layer is formed on PS substrate (1 mg/ml streptavidin in 
PBS, 2 minute static incubation), and the excess protein is removed by PBS rinses. BSA 
blocking is provided to avoid non-specific adsorption during assembly growth (5 wt% in 
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PBS, 100 μl, 2 minute incubation). Subsequent additions were provided using alternating 
biotin functionalized poly(acrylic acid) (Biotin/PAA 90) (PAA ~1mg/ml, 100 μl, 1 minute 
incubation) and streptavidin (2 μM, 100 μl, 2 minute incubation). This process of 
complementary additions and rinse-off cycles were repeated until desired number of 
polymeric LBL additions (NoLpolymer) was achieved.  
6-2.7.4. Atomic Force Microscopic Imaging on Polymeric-LBL Thin Films 
In forming polymeric-LBL thin films, a similar procedure as described in Section 6-2.7.3 
was used. A non-treated hydrophobic polystyrene substrate was used for the initial base 
streptavidin adsorption, and subsequently polymeric layer-by-layer assembly growth 
(polymeric-LBL) was performed over this protein base layer. All materials 
(polymers/protein/PBS/BSA) used during assembly growth were filtered through 0.2 μm 
syringe filters prior to its use. After forming LBL self-assemblies of desired number of 
layer additions, a final rinse was provided using DI water under sink conditions. These 
films were dried at room temperature prior to AFM imaging.  
LBL assembly topography and surface roughness was imaged in a non-contact 
(tapping) mode AFM (Agilent Technologies, Series 4500). LBL self-assemblies were 
imaged in air medium (non-liquid mode) using a Tap 300Al-G cantilever (Budget 
Sensors®, Bulgaria) with a radius of curvature less than 10 nm (force constant- 40 N/m, 
resonant frequency-300 kHz). The images were processed using Gwyddion software for 
visualization and analysis. The only image correction tool employed was plane leveling 
and line correction.  
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6-2.7.5. Polymeric-LBL Capping Barriers over FM-LBL Networks  
In vitro 7-layered FM-LBL networks were deposited on biotin-coated polystyrene plates 
(Thermo Scientific Pierce, Rockford, IL, preblocked 96-well strip plates) from alternating 
additions of biotin-micelles and streptavidin, adopting the same procedure as described 
under micelle-LBL networks formation (refer Section 4-2.5). To these preassembled 
structures, capping layer additions were provided by alternative rinsing from biotinylated 
poly(acrylic acid) (Biotin/PAA220) (~1 mg/ml, 100 μl/well, 1 min incubation) and 
streptavidin (~1mg/ml, 100 μl/well, 1 minute incubation), similar to procedure as described 
in Section 6-2.7.3. This rinsing cycle was repeated until a desired number of polymer 
capping layers were achieved. Excess biotin-PAA and streptavidin were removed by rinses 
with PBS between each additions.  
6-2.7.6. Demonstrating Polymeric-LBL Capping Growth over FM-LBL Networks 
A modified capped-FM network formation procedure as described in Section 6-2.7.5 was 
used. FM-LBL networks were deposited on biotin-coated polystyrene plates from 
alternating depositions of biotin-micelles and non-radioactive streptavidin, till networks 
with desired number of layer additions (NoL=7) were formed. Excess biotin-micelles and 
streptavidin were removed by providing PBS rinses between additions. This was followed 
by capping barrier growth from complementary rinses of (Biotin-40/PAA220) (~1 mg/ml 
PAA, 100 μl/well, 1 min incubation) and radiolabeled streptavidin (125I-streptavidin) 
(~1mg/ml in PBS, 100 μl/well, 1 minute incubation), till a desired number of capping layer 
(1, 3, 5 and 7) additions was achieved over the networks. Excess biotin-PAA and 125I-
streptavidin were removed by providing PBS rinses between additions. As a control, non-
biotinylated polymer (Biotin-0/PAA220) was used for forming capping barrier growth over 
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FM-LBL networks. Streptavidin mass in capping layers were tracked using a gamma 
counter (Perkin Elmer 2470 Wizard2) for different number of polymeric layer additions 
(NoLcapping = 1, 3, 5 and 7) (refer Section 5-2.5.1 for procedure adopted in radiolabeling 
streptavidin). 
6-2.7.7. Evaluating Stability of Capping Barriers  
The capping barriers were selectively formed using 125I-streptavidin, using the above 
described procedure (Section 6-2.7.6). The capped-FM networks (3, 5, and 7) are formed 
over the preassembled 7-layered FM network. These capped-FM networks formed from 
biotinylated polymer (Biotin-40/PAA90) and non-biotinylated polymer (Biotin-0/PAA90) 
with different no. of polymeric layer additions (NoLcapping= 3, 5 and 7) were incubated 
under proteolytic pronase (0.01 w/v%, 100 µl) environment, at 37 ºC for different times. 
The capping layer stability in FM networks was quantified from extent of radioactive 
streptavidin mass loss from its layers, which was tracked using a gamma counter (Perkin 
Elmer 2470 Wizard2). 
6-2.8. Effect of Capping Barrier on Chemical Stability of FM-LBL Networks 
Capped-FM networks were developed using a modified formation procedure, as described 
below. The effect on capping barrier on network destabilization was studied by tracking 
independently the loss of radiolabeled streptavidin (125I-streptavidin) from the network 
interlayers and the base streptavidin layer.  
For measuring the network interlayers, a non-radiolabeled streptavidin layer was 
first added to the base biotin layer (~1 mg/ml in PBS, 100 µl/well, and 2 min incubation), 
followed by alternating biotin-FM (~5 mg/ml in DI water, 100 µl/well, and 1 min 
incubation) and 125I-streptavidin additions (~1 mg/ml in PBS, 100 µl/well, and 1 min 
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incubation) until the desired NoL (=7) were deposited. To these modified FM-network, the 
capping layers were developed from complementary biotinylated poly(acrylic acid) (~1 
mg/ml in DI water, 100 µl/well, and 1 min incubation)  and non-radioactive streptavidin 
additions (~1 mg/ml in PBS, 100 µl/well, and 1 min incubation), till a desired number of 
capping layers (NoLcapping= 1, 3, 5 and 7) were achieved. For measuring the base layer 
loss, a similar procedure was adopted, except that 125I-streptavidin was added to the base 
biotin layer, while the overlaying network interlayers and capping layers were deposited 
using non-radiolabeled streptavidin. 
These capped-FM networks were incubated in simulated saliva (100 µl of 1.3 mM 
KH2PO4, 16 mM Na2HPO4, 136.9 mM NaCl, pH= 6.75)24, 209 or pronase (0.01% w/v, 100 
µl) at 37 ºC for different durations. Streptavidin mass remaining in the networks was 
measured using a gamma counter (Perkin Elmer 2470 Wizard2).  
6-2.9. Drug Release Studies from FM-LBL Networks 
FM-LBL networks with- and without polymeric-LBL capping barriers were deposited on 
biotin-coated polystyrene plate separately, adopting the procedure as described in the 
earlier sections (Section 6-2.7.6). For drug release studies, the FM-LBL and Capped-FM 
networks were developed from non-radioactive streptavidin.  
In evaluating drug release without capping layers, FM-LBL networks with varying 
number of layer depositions (1, 3, 5, and 7) were formed. While, for assessing drug release 
with capping layers, 7-layered FM network with varying number of polymeric capping 
addition (NoLcapping= 1, 3, 5, 7, 10, and 15) were formed seperately.  
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Drug release from these synthetic mucin networks were carried out separately under 
in vitro oral chemical conditions, either by incubating under simulated salivary (100 µl of 
1.3 mM KH2PO4, 16 mM Na2HPO4, 136.9 mM NaCl, pH= 6.75) or proteolytic pronase 
(0.01 w/v%, 100 µl) environment, for different times. The medium was replaced 
intermittently between readings, and was maintained at 37 ºC. To determine the curcumin 
mass remaining within the networks after drug release, the entire surface area was mapped 
using fluorescence area scans using a microplate spectrophotometer (Ex/Em: 420/500 nm, 
top/bottom read, BioTek Synergy Mx, Gen5 2.0, Winooski, VT).   
6-3. Results and Discussion 
6-3.1. Layer-by-layer Networks of Micelle and its Structural Relevance to Natural 
Mucin  
In natural mucin networks, the structural properties (e.g., pore size, thickness, viscosity, 
and anisotropy) vary across different epithelial regions, primarily dictated by the local pH 
and ionic environment. Interestingly, these physical properties can be highly deterministic 
of its biological function. In general, the structure of human and pig gastric mucins is 
similar to a beaded necklace.54, 59 Hong et al (2005) examined the mucin aggregation 
tendency as a function of pH and suggested that it bears a striking similarity to micellar 
aggregates.54 Importantly, the FM networks fabricated in the present studies possessed a 
striking similarity to natural mucin glycoproteins, which form a continuous reticulated 
structure (Figure 6.2 and 6.3). 
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Figure 6.2. Cross-comparison of networks from natural mucin depositions with FM-LBL networks as its synthetic analog 
a) SEM micrographs of in vitro natural mucin network depositions recapitulated under similar conditions as synthetic mucin networks 
formation over the polystryene substrate. b) Synthetic mucin networks formations were visualized under different levels of magnification 
in demonstrating porous network formation.
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To more distinctively visualize surface irregularities and measure surface 
roughness, the 7-layered FM-LBL network was studied using atomic force microscopy 
After network deposition onto polystyrene surface, the substrate height topography and 
texture was modified (Figure 6.3 and 6.4), where a significant increase (165 nm) in the 
height topography was observed. The observed phase-shift intensity is due to the hard 
hydrophobic polystyrene surface being replaced by the more compliant, hydrophilic PEG 
coating of the FM micelles (Figure 6.4). Substrate-network confluency was observed, with 
a near complete coverage (~100%). 
In general, the topographical features of nanoparticle-based multilayered systems 
possess high surface roughness owing to their distinctive lateral-growth pattern.211, 213 
However, in FM networks it was determined that the topographical irregularities were only 
at nano length scales (Figure 6.5).24 The surface roughness factor can play an important 
role in the performance of biomaterials (e.g., implants and biofunctional coatings) by 
significantly altering biological responses (e.g., bacterial adherence or macrophage 
invasion). For instance, with intraoral implant materials, it is documentated in literature 
that above a threshold surface roughness (Ra) of 200 nm, significant bacterial adhesion and 
retention is observed.227 For implant coatings, reducing the surface roughness can improve 
wear resistance, where the recommended root mean squared (RMS) roughness is <50 
nm.228 Although the current FM network is suggested as a topical delivery system, its 
substrate growth tendency can also be extended to surface coating applications (e.g., as 
implant or stent coatings). These FM networks possess a surface roughness (Ra) of 55 nm 
and a RMS value of 70.9 nm, which suggests a relatively smooth surface topography. 
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Figure 6.3. Visualization of synthetic mucin networks under atomic force microscopy 
FM-LBL networks were visualized under tapping mode atomic force microscopy (AFM) imaging at different levels of magnification. 
a)  Topographic images showing network surface features b) AFM phase imaging demonstrating homogeneity of network–substrate 
coverage observed from phase (deg) values.  
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Figure 6.4. Visualizing changes in substrate morphology before and after FM-LBL 
network formation under atomic force microscopy 
Visualization of FM-LBL networks using tapping mode-atomic force microscopy. a) 
Cross-comparison of surface topography before and after synthetic network formation over 
the polystyrene substrates. b) Cross-comparison of AFM phase imaging before and after 
synthetic network formation over the polystyrene substrates.  
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Figure 6.5. Line profiling analysis in deducing length-scale of topographical irregularities within FM-LBL networks  
Line profile analysis on synthetic mucin networks showed only a nanoscopic topographical variation, which demonstrates uniformity 
of network-substrate distribution (a) Larger area visualization (b) Smaller area visualization. 
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6-3.2. Synthetic Mucin Networks from Micellar Compositional Blends 
6-3.2.1. Formation of Micelle-LBL Network from Various Compositional Blends 
of Spherical-Filamentous Micelle Commixtures 
Successful functioning of mucin networks is determined by their morphology. Key 
variables that determine morphology include mucin chain length, polydispersity, degree of 
glycosylation, and pH.59, 64 For instance, Menarguez et al. (2003)61 observed four distinct 
structural nanomorphologies in cervical mucin networks. Subsequent studies by Brunelli 
et al. (2007)60 further demonstrated that structural transitions in cervical mucus occur in 
response to changes in the menstrual cycle, where during ovulation the mucin network is 
highly porous, highly permeable, and contains less continuous spherical aggregates. In the 
preovulatory stage, however, a compact, less permeable, continuous fibrillar (pearl-like) 
networks are observed, which hinders spermatozoa migration. In the previous chapter 
(Chapter-5, Section 5-3.1), the network formation mechanism from spherical and 
filamentous structures were studied and cross-compared independently (Section 5-3.1.1). 
Comparable to cervical mucus, the filomicelle networks were aided by a high aspect ratio 
(micelle length to diameter ratio, L/D), which enabled more ready bridging to form a 
continuous, cross-linked, fibrillar network. Spherical micelles, on the other hand, with 
relatively low aspect ratio showed poor network formation tendency and resulted in a non-
continuous spherical aggregate. 
This shape-based network growth dependence was further studied by forming 
networks using different FM-SM micelle blends. The micelles were synthesized to contain 
a small molecule, curcumin (2.65% w/w), which is a fluorophore that facilitates 
visualization. Additionally, curcumin is a well-known natural curuminoid with a versatile 
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therapeutic capability (e.g., antiinflammatory, antimicrobial, anticancer, and antiarthritic). 
The synthesized SM possess an average particle diameter of 240±5.5 nm, while the 
predominant length distribution of FM ranges from 5-35 µm (Figure 4.13).  
Utilizing these synthesized micelles, as a proof of concept, 7-layered networks were 
developed from different SM/FM blends (0, 20, 40, 60, and 100 wt% FM) and visualized 
for their network formation ability and lateral growth (homogeniety of coverage). The 
biotin functionalized micelles (FM and SM) were synthesized from amphiphilic 
poly(ethylene glycol)-b-poly(lactic acid) (PEG-b-PLA) based diblock copolymers, as 
elaborated earlier under Section 4-2.4. SEM and fluorescence imaging of blends having 
increasing percentage of FM showed a logarithmic improvement in lateral network growth 
(Figure 6.6, 6.7, and 6.8). The networks formed from predominant spheres (≤20% FM) 
possessed a network-substrate coverage of 53-71%, while micelle-LBL networks formed 
from mixtures containing 40-60% FM had significant improvement in lateral growth, with 
a substrate coverage of 80-90%. For the high FM containing networks, filomicelles likely 
functioned as a structural scaffold facilitating an easier bridging of spherical aggregates. 
As expected from these observations, the networks formed from 100% FM showed a near 
complete confluency in network-substrate coverage (~100%) (Figure 6.9).  
Jeon et al. (2006)211 performed molecular dynamics simulations studying 
independently the charge driven LBL growth mechanism from particulate systems (e.g. 
nanoparticles (NP), polyelectrolytes (PE), and nanoparticle-polyelectrolyte systems)211, 215. 
Driven by charge-based interactions, a lateral expansion growth pattern was observed due 
to electrostatic repulsive forces. These results were consistent with the experimental work 
performed by Ostrander et al. (2001).213 In those systems, the extent of surface coverage 
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during multilayer depositions improved in the following order: NP-NP < NP-PE < PE-NP 
< PE-PE. 
Interestingly, the substrate coverage improvement with increasing percentage of 
FM is strikingly similar to the trends observed in the particulate systems described above. 
Here, the FM serves the role of the flexible polyelectrolyte with better structural aspect 
ratio, while NP size is comparable to the SM. In affinity-based multilayer systems, the 
lateral growth improves in the following order: 0% FM (or spherical-spherical) < 20-40% 
FM (or predominant spheres) < 60% FM (predominant filomicelle) < 100% FM 
(filomicelle-filomicelle) (Figure 6.9). These results suggests that the relative spherical to 
filomicelle ratios plays a significant role in determining network structure and substrate 
surface coverage. For synthetically developing well-formed mucin networks, it is 
recommended for micellar population to possess at least 40% FM during LBL 
development. 
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Figure 6.6. Epifluorescence micrographs of synthetic mucin networks formed from different micellar compositional blends 
Epi-fluorescence micrographs of 7-layered micelle-LBL networks formed from different spherical-filomicelle compositional blends 
ratios (% filomicelle = ~0, 20, 40, 60, 80 and 100) (FITC channel, 20x magnification). 
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Figure 6.7. Scanning electron micrographs of synthetic mucin networks formed from different micellar compositional blends 
under relatively lower magnification level 
7-layered micelle-LBL networks were formed from different spherical-filomicelle compositional blends ratios (% filomicelle = ~0, 20, 
40, 60, 80 and 100) and visualized at a lower magnification level (Scale bar = 20 µm).  
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Figure 6.8. Scanning electron micrographs of synthetic mucin networks formed from different micellar compositional blends 
under relatively higher magnification level 
7-layered micelle-LBL networks were formed from different spherical-filomicelle compositional blends ratios (% filomicelle = ~0, 20, 
40, 60, 80 and 100) and visualized at a higher magnification level (Scale bar = 5 µm). 
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Figure 6.9. Estimating extent of lateral growth expansion in micelle-LBL networks 
formed from different micellar compositional blends 
Percent substrate coverage from 7-layered micelle networks formed by varying % 
filomicelle in micellar compositional blends was deduced using ImageJ post-processing. 
With increasing % filomicelle in the micellar blends better network-substrate coverage was 
achieved. 
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6-3.2.2. Bacterial Adherence Studies on Synthetic Mucin Networks from Micellar 
Compositional Blends  
Oral cavity has a diverse variety of bacterial flora (refer Section 2-4). Under diseased 
conditions and with loss of those mucin barriers (e.g. xerostomia, candidiasis), the subjects 
face an increased risk of bacterial colonization. In the previous chapter (refer Section 5-
3.5), it was demonstrated that the bacterial growth inhibition effect from filamentous 
networks (FM-LBL) to have resulted primarily from the release of anti-bacterial curcumin 
payloads from its micellar structures.  
In the present work, synthetic networks formed from different spherical–filomicelle 
blends were studied for their bacterial inhibition capacity. As the network formation ability 
improves with increasing filomicelle content, curcumin drug content within the bulk 
structure also increased in proportion to the percentage of FM. Therefore, the networks 
formed from micelle mixtures with predominant spheres (<40% filomicelle) possessed low 
overall drug content of ~10 µg/ml, and demonstrated a weak bacterial inhibition effect of 
11.55 ±7.24%. This was followed by a relatively moderate growth inhibition of 18.86 
±7.38% from networks formed from 40 to 60% filomicelle population possessing drug 
content of ~19.5 µg/ml. Consistent with our earlier results, the networks formed from 
predominant filomicelles (≥ 80% FM) (see Figure 6.10) contained higher curcumin drug 
content (~22 µg/ml) within their networks, and resulted in higher bacterial growth 
inhibition (34.7 ±7.88%). These antibacterial studies exemplify the biofunctional 
properties of synthetic network coatings.  
  
 
158 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.10. Bacterial growth inhibition studies on curcumin loaded micelle-LBL networks formed using different micellar 
compositional blends 
Bacterial growth on curcumin-loaded synthetic networks measured using crystal violet stain, after 24 h bacterial exposure. 7-layered 
networks were deposited using varying micellar compositional blends (filomicelle: sphere ratio). As FM content increased, there was 
an observable decrease in bacterial development. A 2-sample t test was performed comparing bacterial growth in substrate control with 
different micelle-commixture networks. The * represents significant difference from the substrate (control) with p <0.05, while ** 
represents p <0.1.  
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6-3.3. Polymeric Layer-by-Layer Capping Barriers over Synthetic Mucin Networks 
6-3.3.1. Biotinylated Poly(acrylic acid) Synthesis and Characterization 
Biotinylated poly(acrylic acid) (Biotin-PAA) synthesis and characterization was performed 
as established in our previous work 91. Pentylamine biotin was conjugated to poly(acrylic 
acid)  (PAA) (MW~ 90,000 and 220,000 Da) using carbodiimide coupling chemistry 
(Figure 6.11). 1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride 
(EDC.HCl), a zero-length coupling cross-linker results in formation of stable amide bond 
by reacting carboxylic acid in poly(acrylic acid) with amino group in pentylamine biotin. 
Intermediate (N-acyl urea) formed during the course of reaction was filtered off, and the 
reaction mixture was subjected to ultrafiltration to remove unreacted pentylamine biotin 
and other reactants. Since, the presence of unreacted pentylamine biotin can competitively 
inhibit layer-by-layer growth by occupying the streptavidin binding sites, its removal from 
biotinylated product (Biotin-PAA225k) needs to be ensured. Therefore, the purified 
product was subjected to ultra-purification till complete removal of pentylamine biotin was 
noted from reverse phase HPLC analysis (Figure 6.12). 
In determining extent of biotin conjugation, 4’hydroxyazobenzene-2-carboxylic 
acid (HABA)-avidin assay was performed. HABA assay was performed adopting 
procedure from Shuvaev et al. 98. HABA forms a weak complex with protein avidin. On 
addition of biotinylated polymer (Biotin-PAA90k, Biotin-PAA225k), the weak HABA-
avidin complex is readily replaced by biotin to form a more stable biotin-avidin complex. 
This complexation is accompanied by concomitant release of free HABA. The formation 
of biotin-avidin complex results in a colorimetric shift which was used in ascertaining the 
extent of biotin conjugation onto PAA chain. In PAA of chain length ~90,000 Da, it was 
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estimated that ~32 biotin molecules were grafted per polymer chain (Biotin-32/PAA90k), 
and PAA (225,000 Da) contains nearly 40 biotin molecules per polymer chain (Biotin-
40/PAA225k) (Figure 6.13). Here, the nomenclature for biotinylated polymer is 
represented as Biotin-x/PAA y, where “x” refers to number of biotin molecules which were 
covalently grafted per PAA chain length “y” kDa.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 161 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.11. Reaction scheme for poly(acrylic acid) biotinylation using carbodiimide 
coupling chemistry 
Poly(acrylic acid) of relatively high molecular weight (MW~ 225,000 Da) was used, and 
the functional moiety pentylamine biotin was grafted to the polymeric chain via EDC-NHS 
coupling chemistry  
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Figure 6.12. Evaluating the purity of synthesized biotinylated poly(acrylic acid) using 
RP-HPLC analysis 
Complete removal of unreacted pentylamine biotin was deduced in ensuring purity of 
biotinylated poly(acrylic acid) (MW ~225,000 Da). Presence of free pentylamine biotin 
along with desired product can competitively hinder the multilayer formation during LBL 
growth process. Similar purity analysis was performed for Biotin-PAA (MW~90,000 Da) 
(Figure not shown).  
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Figure 6.13. Evaluating the extent of biotin conjugation onto poly(acrylic acid) chains  
HABA-Avidin assay was performed on biotinylated poly(acrylic acid), where it was 
estimated that nearly 40 biotin molecules were conjugated per PAA chain (MW ~225,000 
Da).  Similar analysis was also performed on biotin-PAA (MW~90,000 Da), where nearly 
7 biotin molecules were conjugated per PAA chain (MW~ 90,000 Da) (Data not shown).  
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6-3.3.2. Atomic Force Microscopy on Polymeric-LBL Films Formed Over 
Synthetic Substrate 
In forming ultrathin polymeric-LBL films, an initial streptavidin base layer was adsorbed 
onto polystyrene substrate. The unoccupied sites were blocked using globular protein, 
bovine serum albumin, ensuring polymeric self-assemblies were grown from surface 
adsorbed streptavidin base layer. By providing alternating addition/rinse-off cycles from 
biotinylated poly(acrylic acid) and its complementing protein streptavidin, polymeric-LBL 
self-assemblies with desired number of bilayer additions (0, 5, 9) were formed. These 
polymeric-LBL multilayers were visualized using tapping-mode AFM scans. From 
topographic images, a distinct change in surface morphology and roughness can be 
observed with polymeric LBL growth. The surface roughness increased from uncoated 
substrate with progressive bi-layer addition during LBL growth. And, cross comparing, 
protein streptavidin base layer with different polymeric-LBL clearly demonstrates the thin 
film growth (Figure 6.14). Also, from AFM phase images, there is a drastic phase shift on 
the substrate before and after protein streptavidin adsorption, and considerable phase shift 
with polymeric-LBL growth (Figure 6.15). Such phase shift was indicative of the change 
in surface properties due to protein/polymer depositions, thereby suggesting its more 
homogenous distribution on the surface.  
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Figure 6.14. AFM topographic imaging on polymeric layer-by-layer assemblies developed from additions of biotinylated 
poly(acrylic acid) and protein streptavidin over the polystyrene substrate 
(Top) Shows affinity based polymeric LBL growth procedure using complementing additions of streptavidin and biotinylated 
poly(acrylic acid). (Bottom) Topographic visualization of polymeric-LBL self-assemblies under tapping-mode AFM. A significant 
change in topography and surface roughness (from RMS value) was observed with increasing number of bi-layer deposition, suggesting 
formation of polymeric LBL thin-films.  
 
  
 
166 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.15. AFM phase imaging on polymeric layer-by-layer assemblies developed from additions of biotinylated poly(acrylic 
acid) and protein streptavidin 
(Top) Scheme showing affinity based polymeric-LBL self-assemblies formed over the polystyrene substrate. (Bottom) Phase imaging 
of polymeric-LBL self-assemblies under tapping-mode AFM. A drastic phase shift was observed by comparing uncoated substrate with 
protein streptavidin adsorbed base layer, also a considerable phase shift was noticed with subsequent polymeric-LBL growth (5, 9-
Bilayers). This clearly indicates the change in surface properties with LBL substrate depositions and further demonstrates the 
homogeneity (coverage) of the multilayered film across substrate surface.   
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6-3.3.3. Developing Polymeric Capping Barriers over Synthetic Networks 
7-layered FM-LBL networks were formed to serve as a model representation of 
synthetic mucin structures. The polymeric capping barriers were formed over the pre-
assembled 3-D synthetic mucin networks via a polymeric layer-by-layer (polymeric-LBL) 
deposition process (Figure 6.16). As illustrated earlier (refer Section 6-3.3.2), the 
polymeric-LBL process involves alternating depositions of streptavidin and biotinylated 
poly(acrylic acid), where its self-organization was driven by biotin-streptavidin affinity 
interactions. In the current study, these polymer-based capping barriers were expected to 
improve the overall stability in synthetic mucin network and offer additional diffusional 
resistance for tuning the network-drug release.   
In the previous detailed work on affinity based polymeric LBL self-assemblies 91, 
226 using biotinylated poly(acrylic acid)/streptavidin based systems, it was deduced that its 
multilayer barrier stability against harsh chemical environment or under mechanical testing 
is highly dependent on its polymeric molecular properties. These critical molecular 
parameters include polymer molecular weight (MW), extent of biotin conjugation and 
number of LBL layers. The barrier protection against degrading chemical environment 
(proteolytic and salivary) resulted from contributions of polymer molecular weight and 
number of layers (NoL) in the LBL self-assembly. With increasing NoL in LBL self-
assembly (barrier thickness), a concomitant improvement in barrier protection was 
observed. Similarly, by increasing the polymer molecular weight, polymeric-LBL self-
assemblies with better barrier intactness was formed. However, for mechanical robustness, 
apart from MW and NoL, its biotin conjugation extent played a key role.91, 226   
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Taking cue from these results, in the current work, longer poly(acrylic acid) chains 
(MW~ 225,000 Da) containing better biotin grafting (40 # Biotin/PAA chain) was 
synthesized (refer Section 6-2.7.1), and used in developing an effective capping barrier 
over FM-LBL networks (Figure 6.16). The ability to form capping barriers over these 
synthetic networks was demonstrated by comparing the capping growth from biotinylated 
polymer (Biotin-40/PAA225k) and control non-biotinylated polymer (Biotin-0/PAA 
225k). Here, the capping layer growth was studied by tracking the increase in radiolabeled 
streptavidin mass in capping layer with increasing deposition cycles. This is represented in 
terms of fractional streptavidin mass from FM-LBL networks “ML /M1”. Due to lack of 
specific affinity linkages, the non-biotinylated poly(acrylic acid) (Biotin-0/PAA 225k) 
could not develop any capping layers over FM-LBL networks. However, the biotinylated 
polymer (Biotin-40/PAA 225k) showed a linear increase in protein streptavidin mass with 
increasing number of capping layer depositions (NoLcapping= 1, 3, 5, and 7) (Figure 
6.17). Therefore, the 7-layered capping layer additions from these biotinylated polymers 
showed nearly 7.75 fold higher protein mass increase than that of the non-biotinylated 
polymers, which demonstrates formability of capping barriers.  
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Figure 6.16. Scheme showing synthetic mucin networks with different number of polymeric layers capping layers 
7-layered FM-LBL networks were pre-assembled over which polymeric capping barriers were formed through layer-by-layer 
depositions from biotinylated poly(acrylic acid) and protein streptavidin, until desired number of capping layer (NoLcapping = 1, 3, 5 
and 7) were formed.  
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Figure 6.17. Demonstrating polymeric capping layer growth over synthetic mucin 
networks 
Biotinylated polymer (Biotin-40/PAA225k) self-assembled forming protective capping 
layers over preassembled synthetic mucin networks (7-layered FM-LBL). The non-
biotinylated polymer (Biotin-0/PAA225k) due to lack of biotin-streptavidin affinity 
linkages was unable to develop any capping layers. 
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6-3.3.4. Stability of Polymeric Capping Barriers 
The barrier stability was studied by tracking 125I-streptavidin loss from the capping layers. 
Since capping barriers were formed over 7-layered FM networks using streptavidin based 
cross-links, its stability was evaluated under proteolytic (pronase) conditions. Also, oral 
cavity under effects of increased bacterial colonization forms protease rich environment. 
The extent of barrier stability was measured by selectively tracking 125I-Streptavidin loss 
(%) from its capping layers.  
Capping layers formed from non-biotinylated polymer (Biotin-0/PAA225k) 
possessed a weak barrier (Figure 6.18). The unconjugated polymers lacked affinity-based 
functional moieties, which resulted in a weakly held polymeric layer over synthetic 
networks via charge based polymer poly(acrylic acid)-protein streptavidin interactions. 
Due to this non-specific barrier, resistance to protein loss did infact increase with 
increasing the number of capping layers (NoLcapping= 3, 5, and 7). 
However, with biotinylated polymer (Biotin-40/PAA225k), barriers with more than 
3 capping layers demonstrated a more substantial reduction in protein loss, where nearly 
60-65% of streptavidin remained intact after 24 hr of exposure to proteolytic enzyme, 
suggesting considerable capping robustness due to the affinity interactions (Figure 6.18).  
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Figure 6.18. Evaluating stability of polymeric capping barriers formed over synthetic mucin networks 
The capping layer loss was tracked specifically to evaluate its stability under destabilizing harsh protease. The capping barrier coatings 
from biotinylated polymer (Biotin-40/PAA225) demonstrated better barrier stability, whereas weakly adsorbed non-biotinylated 
polymers due to lack of affinity interactions demonstrated a relatively weak capping barrier intactness.  Such barrier tendency offered 
by capping layers was expected to shield the underlying protein-based synthetic mucin network via its polymeric properties (e.g. chain 
length or molecular conformation) and was expected to improve its bulk structural stability. 
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6-3.4. Effect of Polymeric Capping Barriers on Micelle-LBL Network Chemical 
Stability. 
In studying the effect of polymeric barriers on chemically induced network destabilization, 
7-layered FM network with variable number of capping layers (NoLcapping= 0, 3, 7 and 
15) were formed. These chemical stability tests were performed under proteolytic pronase 
and simulated salivary environment due to its high relevancy as intra-oral conditions. The 
extent of protein destabilization from those capped-FM networks was independently 
tracked from its network interlayers and base layer. By tracking the protein loss from 
network interlayers, the impact of capping on bulk synthetic mucin structures could be 
evaluated (Figure 6.19).  
The 7-layered FM network without cappings (NoLcapping=0) acts as a protective 
barrier over the base streptavidin layer. The diffusion of a large proteolytic enzyme (MW 
~20,000 Da) was greatly hindered due to the thick FM networks and thus was unable to 
readily reach the base streptavidin layer. By addition of a soluble polymeric capping layer 
over the FM network created a smaller network mesh size. These additional polymeric 
capping barriers further reduced the accessibility into the base streptavidin layer. Hence, 
such polymer shielding from chemical effects contributed to a reduced base streptavidin 
destabilization, improving overall network intactness. Thus, under both protease and 
salivary environment, a reduction in base streptavidin layer destabilization was observed 
with increasing capping layer, suggesting reduced network disassembly. This trend can be 
readily noted by comparing streptavidin loss with and without capping layers (Figure 
6.20a), where the 7-layer capped networks showed nearly 29% lesser protein loss than the 
uncapped structures after 26 hr incubation with protease. Such structural stability 
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improvement due to cappings was even more pronounced under simulated salivary 
environment, where nearly 45% less mass loss from no-capped structures was observed at 
26 hr. 
Similarly, in FM network layers that immediately underlay the capping layers, the 
effect of this polymer barrier effect was pronounced under the simulated salivary 
environment. For instance, the 7-layered capped networks showed nearly 43% less protein 
loss than uncapped structures at 26 hr. A reduced streptavidin destabilization was observed 
with increasing number of capping layers. Interestingly, the capping effect was relatively 
less pronounced under protease exposure compared to salivary environment (Figure 
6.20b). For instance, in a proteolytic environment the 7-layered cappings showed only 12% 
less protein loss from uncapped structures at 26 hr. The proteolytic environment resulted 
in a relatively higher destabilization effect on protein-based network cross-links in 
comparison to simulated salivary environment. Due to this high destabilizing potential, the 
barrier effects were relatively less pronounced in the FM layers directly underlying the 
capping layers as opposed to the base layer. 
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Figure 6.19. Scheme used for evaluating the effect of polymeric capping layers on synthetic mucin network stability under 
simulated oral environment 
7-layered FM-LBL networks were preassembled over which capping barriers with different number of polymeric layer additions (NoL 
capping = 0, 3, 7 and 15) were formed. Destabilization of innermost streptavidin layer and overlaying streptavidin layers was tracked 
independently by using radiolabeled streptavidin (125I-streptavidin), and the network stability was studied under simulated salivary and 
protease environment.   
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Figure 6.20. In vitro chemical stability of synthetic mucin networks with polymeric capping barriers under effects of simulated 
oral environment 
7-layered filomicelle networks with polymeric capping barriers (NoLcapping = 0, 3, 7 and 15) were formed. a) Network destabilization 
was tracked independently from base streptavidin layer under in vitro salivary and protease environment.  b) Network destabilization 
was tracked independently from streptavidin loss from FM network interlayers under in vitro salivary and protease environment. The 
effect of different number of polymeric capping layers on network destabilization under chemical effects was illustrated. 
 177 
 
6-3.5. Drug Release from Synthetic Mucin Networks and the Impact of Affinity 
based Polymeric Capping Barriers 
The commonly adopted strategies used for fabricating LBL delivery platforms with tunable 
drug release can be broadly categorized as: 1) stimuli triggered release (e.g., temperature 
and pH), 2) release dependent on inherent properties of the building blocks (e.g., 
biodegradability), and 3) incorporating barriers for controlling release (e.g., post-
modifications such as covalent/thermal crosslinking). For instance, a recent study by Zhu 
et al. (2013)9 demonstrated stimulus induced on-demand drug release using thermo-
responsive spherical micelles with anticancer drug loadings. In conventional multilayered 
systems, the drugs were loaded from complementary charge compensations or via passive 
loading within the self-assembled structure. Therefore, to control drug diffusion from 
relatively weak loading, a more rigorous post-modification process is commonly employed 
(e.g., covalent crosslinking via thermal or chemical methods). For instance, Wood et al. 
(2006) used thermal crosslinking methods to demonstrate the ability to control interlayer 
drug diffusion within a polyelectrolyte multilayer (PEM) network.229    
However, these post-modification methods may be not recommended when 
functional coatings require milder processing conditions (e.g., in protein/peptide-based 
coatings). Such processing difficulty can be avoided in the present system through 
formation of robust capping barriers via highly specific biotin-streptavidin non-covalent 
linkage. Additionally, controlling polymeric molecular properties or altering the thickness 
of capping barriers helps tune the drug release from the network.  
Unlike the traditional PEM-based networks, in the current systems the interlayer 
drug diffusional issue can be regulated by controlling the release kinetics from micellar 
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core. Here, the PEG chains form an external barrier which along with curcumin drug-PLA 
core interactions help form the major (primary) diffusional barrier. To further modify 
release kinetics, a secondary diffusional barrier was created over the primary barrier via 
polymeric capping.  
6-3.5.1. Drug Release from Synthetic Mucin Networks without Capping Barriers 
The release of curcumin from FM networks remained unhindered despite increasing the 
network thickness (NoLFM-LBL= 1, 3, 5 and 7). In nanoporous FM networks without a 
secondary diffusional barrier, the overlaying micellar structures did not impact diffusional 
curcumin release. As such, no observable difference was observed under both salivary 
(Figure 6.22) and protease environments (Figure 6.23).  
Combining the recent advancements in drug carrier formulation or release 
strategies, for instance by modifiying the primary barrier through crosslinked shell or using 
polymer-drug conjugate, can significantly alter the drug release kinetics of the network.230-
232 These changes in primary barrier properties can be incorporated for developing a 
biofunctional scaffold or an implant coating that requires a sustained delivery (e.g., weeks 
to months) (Figure 6.21).166, 233  
6-3.5.2. Drug Release from Synthetic Mucin Networks with Capping Barriers 
In order to develop a secondary diffusional barrier (polymer-LBL) over FM-LBL network, 
biotinylated polymeric chains were self-organized to form capping layers via affinity 
linkages (NoLcapping= 1, 3, 5, 7, 10, and 15). The role to these capping barriers were only 
intended to elicit a diffusional change in drug release from primary barrier with a possible 
improvement in network stability. These barriers were not formed to significantly modify 
 179 
 
the overall network properties by overshadowing effects of primary barrier. While, such 
systems can also be developed with response from higher number of capping barriers, 
although this may require very large number of biotinylated polymer-streptavidin rinse 
cycles, thus may reduce the overall practical effectiveness of the approach.  
To study the effects of the secondary barriers on drug release without significantly 
overshadowing the effects of the primary barrier, 7-layered FM networks with increasing 
number of capping barrier depositions (NoLcapping= 1, 3, 5, 7, 10, and 15) were formed 
separately. Interestingly, even with the low number of polymeric capping layers, a 
significantly modified drug release profile was observed from FM networks, suggesting an 
added diffusional resistance that delayed release. This capping layer effect was observed 
under both salivary (Figure 6.22) and proteolytic conditions (Figure 6.23). Also, more 
importantly the self-assemblies showed significant robustness under both chemical 
environments (Figure 6.24 and 6.25), where the drug release primarily remained a 
diffusion controlled process as opposed to network destabilization based drug release.   
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Figure 6.21. Potential prospects of synthetic mucin networks as a drug delivery system 
The approach can be utilized in a variety of drug delivery applications, utilizing its barrier property and drug delivery potential, and 
different mode of administration can be employed ranging from its use as a functional coat as a drug-releasing stent or as drug-eluting 
buccal patch, or as a non-viscous topical oral rinse solution in forming thin-film functional barriers.  
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Figure 6.22. Drug release studies from synthetic mucin networks and effect of polymeric capping barrier in tuning its drug 
release under simulated salivary environment 
a) Synthetic mucin networks are developed over the polystyrene substrate with increasing number of layer additions (or network 
thickness) (No. of micelle layers = 1, 3, 5 and 7). The curcumin drug release from those networks was studied under simulated salivary 
environment without incorporating any polymeric capping barriers. b) Drug release from 7-layered synthetic mucin network was studied 
under simulated salivary environment after incorporating polymeric capping barriers (No. of polymeric capping layers = 1, 3, 5, 7, 10 
and 15  
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Figure 6.23. Drug release studies from synthetic mucin networks and effect of polymeric capping barrier in tuning its drug 
release under protease environment 
a) Synthetic mucin networks are developed over the polystyrene substrate with increasing number of layer additions (network thickness) 
(No. of micelle layers = 1, 3, 5 and 7). The curcumin drug release from those networks was studied under protease environment without 
incorporating any polymeric capping barriers. b) Drug release from 7-layered synthetic mucin network was studied under protease 
environment after incorporating polymeric capping barriers (No. of polymeric capping layers = 1, 3, 5, 7, 10 and 15).  
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Figure 6.24. Visualizing destabilization of synthetic mucin networks under protease environment 
Scanning electron micrographs of 7-layered synthetic mucin networks after subjecting to destabilizing chemical effects of protease 
environment a) at T= 0 hr b) at T= 6 hr  and c) at T= 24 hr.  
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Figure 6.25. Correlating drug release from networks with its bulk degradation 
Evaluating overall network stability by correlating drug release (%) with streptavidin loss (%) from networks, under simulated salivary 
environment (left) and protease environment (right).  
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6-4. Conclusion 
The ability to form synthetic networks from different compositions of polymer micelle 
commixtures was demonstrated, and its structural characteristics was thoroughly 
investigated. These networks were illustrated for its biofunctional capability by performing 
bacterial inhibition studies. And, an indepth characterization was performed on filamentous 
layer-by-layer networks using atomic force microscopy in studying its surface properties. 
Filamentous networks possessed topographical surface variations only at nanoscopic 
lengthscales, which suggested a low surface roughness. In addition, a structural cross-
comparison was performed between depositions of natural mucin glycoproteins and 
synthetic mucin analogs, to illustrate its physical structural relevance.  
In investigating the role of synthetic networks as a drug delivery vehicle, release 
studies were performed. And, for demonstrating the networks capability to offer a tunable 
drug release kinetics, additional polymer based capping barriers were formed over the pre-
assembled synthetic mucin network. The formation of such capping barriers and its ability 
to remain significantly intact under in vitro chemical environment were demonstrated. 
Also, the effect of the capping barriers in impacting the bulk synthetic network stability 
was demonstrated. These barriers altered the diffusional drug release from synthetic mucin 
networks demonstrated from its modified release kinetics.  
For practical applications, synthetic networks with capping barriers can be applied 
as a biofunctional coat for drug delivery applications, utilizing the facile network formation 
dynamics. Thus, these prospective approaches possess high relevance in the field of 
regenerative medicine especially among subjects with either diseased or compromised oral 
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mucosal surface (e.g. xerostomia, oral mucositis, and gingivitis). Due to its potential non-
invasive administration approach (e.g. buccal rinses or adhesive patch or implant coats), 
they can also be utilized in providing a sustainable or localized payload delivery, providing 
exciting possibility as drug eluting coats. 
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CHAPTER 7. CONCLUSION AND FUTURE STUDIES 
 
In this work, a modular yet facile approach was developed to create a synthetic mucin 
system which mimics the complex and randomly interconnected mucin fibers. The goal of 
these synthetic structures was to serve as an artificial model, which can decouple chemical 
and physical properties, enhancing a better understanding of structural and functional 
properties of natural mucin systems. The approach utilized polymeric micellar structures 
as principal building blocks, which were formulated from custom-synthesized amphiphilic 
diblock copolymers. Through a layer-by-layer (LBL) deposition process and by utilizing 
highly biospecific affinity linkages of biotin-streptavidin, it was demonstrated that the 
micellar structures can be hierarchically self-organized in forming multilayered cross-
linked structures in both synthetic and biological substrates.  
In understanding the structural characteristics of those synthetic networks, an 
indepth study on its physical properties (e.g. morphology, network coverage, mesh size, 
thickness, and growth mechanism) and its relevance to natural mucin structures was 
studied. It was ascertained that the networks structural characteristics and its formation 
ability can be significantly impacted by the shape based effects of polymeric micelles 
(spherical vs filamentous micelles). The fibrillar networks formed from filamentous 
micelles were more replicative of the physical characteristics (morphology and growth 
mechanism) of natural mucin glycoprotein. These filomicelle network possessed an 
average mesh size of ~110-340 nm in coherence with pore size observed in natural mucin 
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structures, and even for low number of LBL depositions (7-layered), it formed a ~4 µm 
thick barrier. Further, the significance of the filomicelle networks to potentially elicit a 
biofunctional response such as surface hydration and bacterial capture tendency was 
studied. Upon filomicelle network deposition, the surface hydration characteristics 
(wettability) was shown to significantly improve over the uncoated surface (contact angle 
changed from 90° to 29°). And, it was demonstrated that the synthetic network structure 
alone was sufficient for bacterial capture, however by incorporating an antibacterial drug 
like curcumin, it can be also used favorably to inhibit the extent of bacterial growth. 
For potential practical application, it was suggested that these structural 
development can be used either as a buccal patch or administered as a series of topical 
mouth rinse for controlled growth over buccal soft tissues. Therefore, the robustness of 
these mucin-like structures was investigated under simulated oral chemical conditions, 
which exhibited a robust network stability. As the synthetic mucins were formed from 
polymeric micelles, which is well-known for its drug carrier potential, its ability to function 
as a drug eluting networks was thoroughly studied. In demonstrating network potential to 
serve as a tunable drug releasing structures, a polymeric diffusional barrier was developed 
over the micelle-networks via an affinity based polymeric LBL deposition approach. The 
ability of those diffusional capping barriers to elicit a controlled drug release from 
networks, and its role in improving the network chemical stability was demonstrated. These 
biomimetic networks possess high relevance in developing in situ functional coats, and can 
be utilized for both localized and systemic delivery. The approach from this work can be 
extended to recreate variety of biomimetic functional structures at nano to mesoscale 
dimensions, on both regular/irregular surface topographies. Through careful selection of 
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building components and molecular driving forces, it is possible to recapitulate the 
biomimetic structural and functional behavior as those found in natural structures. This 
work apart from such biomimetic potential also possess wide applications in the field of 
regenerative medicine through its drug delivery potential.  
7-1. Future Perspective  
7-1.1. Modifying Structural and Chemical Characteristics of Synthetic Mucin-like 
Networks 
The goal of the current work was to demonstrate initially the ability to recreate the physical 
networks, without changing chemical properties. By keeping the surface chemistry 
constant, it was demonstrated that the changes in network properties can be achieved by 
simply adjusting the structure of the starting micelle, without requiring change in the 
micelle chemistry. However, the ability to include variations in the surface chemistry (e.g., 
charged groups, hydrogen bonding donors/acceptors, affinity groups) of the micelles and 
verify their impact on network properties is a potential future work.   
7-1.2. Transitioning Current Approach into In vivo Models  
In evaluating the practical feasibility as an oral topical application (e.g. buccal thin-film 
coat), the network formation approach can be investigated on a hamster model. 
Administering topical mouth rinses in hamsters are relatively more convenient than the rat 
models, due to the relatively high surface area availability from its buccal pouches (Figure 
7.1). Post oral thin-film development, studies investigating film stability or localized drug 
effect over mucosal injury sites can be potentially studied.  
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7-1.3. As a Permeable Biofunctional Coats for Implants (or Structures) 
The current approach for network formation were demonstrated on a regular flat 
polystyrene substrates via LBL addition/rinse off cycles. In developing biofunctional 
coatings over biomaterials or medical devices, a more conventional LBL dip coat approach 
can be adopted for formation over complex 3-dimensional structures or irregular 
morphologies. Unlike the traditional polyelectrolyte based multilayers, these structures are 
expected to be more readily self-organized due to combination of high affinity cross-linkers 
and structural characteristic of building blocks (e.g. micellar diameter, worm length), thus 
may require only fewer number of dipping cycles.  
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Figure 7.1.  Model showing synthetic mucin network development in invivo 
hamster buccal pouch  
a) Generalized scheme showing the progression of layer-by-layer (LBL) network growth 
from filamentous micellar structures.  b) Demonstrating the application procedure involved 
in forming layer-by-layer networks of filamentous micelles (FM-LBL) over animal 
models. The illustrative figure shows a single-layer deposition over hamster soft buccal 
cheek pouch from alternating streptavidin/Biotin-FM addition. This complementing 
addition cycles was repeated multiple times until desired number of layer additions 
(thickness) was achieved.  
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7-1.4. Developing Porous Scaffold Capable of Multiple Drug Delivery  
The current work demonstrated the ability of synthetic networks to function as drug 
releasing network. This approach can be extended in creating networks as a functional 
depot possessing multiple drug loadings (Figure 7.2). The capping layers formed from 
multilayer additions of biotinylated poly(acrylic acid)/streptavidin, as suggested in the 
current work, can be utilized for segregating the different drug payloads, creating drug 
compartments (zones) within the bulk porous structure.  
7-1.5. Developing Tunable Multi-Drug Release Systems by Controlling Barrier 
Functionality 
For developing tunable multi-drug release systems, the position of drug pay loads within 
the bulk network structure (top, middle or lower zones) can be altered. In combination to 
the drug payload position, the release kinetics can be modified by alerting the number of 
interlaying polymeric barriers and/or the capping layers (Figure 7.2). Here, polymeric 
barriers could likely segregate different drug payload zones, and its barrier thickness are 
easily controllable by varying the number of deposition cycles performed during the layer-
by-layer process. By incorporating such fundamental network modifications, desired 
release kinetics can be tailored for a specific biological need.  
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Figure 7.2. Prospective approach utilizing FM-LBL networks with polymeric 
cappings for multiple pay load release 
Model scheme suggesting multiple drug releasing FM network, which can be formed by 
deposition of FM possessing different formulated drug payloads within its micellar cores. 
In forming demarcation or barrier between different payloads, the capping barriers can be 
formed from biotin-poly(acrylic acid)/streptavidin multilayer LBL depositions. These 
networks was expected to be permeable, porous and hydrophilic in nature. Owing to its 
porous nature, it can serve as biofunctional scaffold, and its hydration property can inhibit 
protein opsonization which may be relevant in bioapplications such as implant coatings.  
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7-1.6. Gelation or Bulk Liquid Phase Cross-linking of Drug Encapsulated Polymeric 
Micelle  
In the current approach, the polymeric micellar structures were crosslinked at solid 
interfaces. However, the aggregation process can be extended or performed in the bulk-
liquid phase (Figure 7.3 and 7.4). Analogous to formation of fibrin clots, it was expected 
that with careful interplay between micellar particulate concentration in bulk liquid, 
stoichiometry of affinity cross-linkers (biotin to avidin ratio), and bulk liquid phase 
viscosity, the particulate gelation can be induced. This process can be potentially utilized 
in forming injectable in situ gels which can function as biodegradable scaffold for the open 
injured site, and was expected to serve as a wound protective barrier and concomitantly 
provide drug release. One potential barrier that needs to be overcome is to avoid 
sedimentation of crosslinked micellar structures in bulk liquid phase. To promote gelation 
and/or to keep the highly crosslinked micellar as a thixotropic mixture, a viscous polymeric 
additive can be introduced to the bulk liquid phase (e.g. high molecular weight 
poly(ethylene oxide) (PEO)), circumventing sedimentation issues. 
 
 
  
 
195 
 
 
 
 
 
 
 
 
 
 
Figure 7.3. Scheme suggesting cross-linking of filamentous nanocarriers in bulk-liquid phase using affinity based interactions, 
and its relevant cross-comparison with natural mucin multimers 
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Figure 7.4. Liquid-phase bulk aggregation of biotin functionalized spherical micelles 
The micellar aggregation process is not induced, without addition of affinity crosslinker streptavidin. However, with streptavidin 
addition, formation of micelle-aggregates was observed in the bulk liquid phase. The illustrative figure shows curcumin-loaded micellar 
aggregates visualized under epifluorescence microscopy (under FITC channel, 10x, 20x and 50x objectives). 
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APPENDIX 
 
A-1. Visualization of natural mucin depositions under bright field imaging 
 
 
 
 
 
 
 
Figure A-1.1. Visualization of natural mucin depositions under microscopy 
Mucin coat deposited (1% w/w) onto polystyrene substrate was visualized under bright 
field microscopy under various levels of magnification (10x, 20x and 50x magnification).  
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A-2. Formation of Layer-by-Layer Networks of Micelles using biotin-avidin 
affinity linkers 
In the previous studies, biotin-streptavidin cross-linkers were used to form networks. The 
protein streptavidin is usually derived from a bacterial source (e.g. Streptomyces avidinii). 
In our work, a recombinant streptavidin was used, which was produced in E. coli (Prospec-
Tany, NJ). As an alternative, avidin, which is derived from egg whites (hen eggs) can also 
be used to form a synthetic mucin network. Avidin possesses 4 biotin-binding sites which 
is similar in characteristics to streptavidin, thus it was expected to readily cross-link with 
biotin-micelles and form networks.  
Biotin functionalized spherical micelles (biotin-SM) with curcumin drug loading 
was formulated as described under Section 4-2.4. Biotin-streptavidin possess a dissociation 
constant (Kd) in the order of 4 x 10-14 M.234, 235 Although, avidin possess a much higher 
association for free biotin (Kd ~6 x 10-16 M),235, 236 its inherent binding potential decreases 
when biotin exists in conjugated form.237 Hence, in our work, streptavidin was preferred 
over avidin due to their higher specificity and binding potential for conjugated biotin. In 
an attempt to examine whether layer-by-layer networks of micelles can be formed using 
biotin-avidin affinity cross-linkers, the networks were grown on polystyrene substrate 
using the biotinylated spherical micelles (biotin-SM) and avidin additions, similar to the 
procedure adopted in Section 4-2.5. To demonstrate the micelle-LBL growth, networks 
with an increasing number of layers (NoL = 1, 3, 5, and 7) were developed. The formed 
networks were imaged using epifluorescence microscopy (Nikon Eclipse LV100, FITC 
filter, under 10x/20x objectives, NIS Elements). With increasing additions cycles, a 
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progressive growth in network formation was observed (Figure A-2.1). Visually, this 
network formation tendency appeared similar in structural characteristics (under 
fluorescence microscropy), as those cross-linked via streptavidin biolinkers. Thus, 
suggesting avidin cross-linkers can be used in forming micelle-LBL networks.  
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Figure A-2.1. Micelle-LBL networks formed from biotin-avidin affinity cross-linkers and its visualization under epifluorescence 
microscopy 
Fluorescence micrographs demonstrating formation of layer-by-layer networks of spherical micelles using biotin-avidin affinity 
interactions. Networks are formed from alternating additions of biotinylated-spherical micelle (Biotin-SM) and the protein avidin. SM-
LBL networks with increasing number of layers (1, 3, 5 and 7) are visualized at different levels of magnification (10x, 20x 
magnification). 
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A-3. Synthesizing Polymer-Drug Conjugate 
Loading small molecule curcumin drug in micellar cores of PEG-PLA based copolymers 
results in a diffusion based drug release. During these studies, nearly 99% drug release was 
achieved after ~24 hr time scale. By using polymer-drug conjugates such as curcumin-
poly(lactic acid) as an alternate for small molecule drug loading, it was expected that the 
drug release kinetics can be significantly altered. Such modification was expected to alter 
the distribution of drug loading in the micellar core. Since, by linking hydrophobic 
polymeric chains with drug molecule may facilitate better entanglement with micellar core 
(PLA chains). Thus, the encapsulation of drug-polymeric chains could possibly shift the 
drug release profile from being diffusional based to degradation induced release.  
A-3.1. Materials 
Poly(lactic acid), carboxylic acid terminated (MW ~7,200 Da) was purchased from 
Polysciences, Inc. (Warrington, PA) and was lyophilized prior to use. All other chemicals 
were used as purchased without any further purification unless stated. N, N’-
dicyclohexylcarbodiimide (DCC) and 4-dimethylaminopyridine (DMAP) were purchased 
from Acros Organics (Waltham, MA). Curcumin (from curcuma longa) was purchased 
from Sigma Aldrich (St.Louis, MO). Acetone was purchased from Pharmco-Aaper 
(Brookfield, CT).  
A-3.2. Synthesis of curcumin conjugated poly (lactic acid) (Curcumin-PLA) 
Curcumin was conjugated to poly(lactic acid) chains via steglich esterification chemistry 
(scheme shown in Figure A-3.1). The reactants curcumin and poly(lactic acid) was 
dissolved in anhydrous acetone and was nitrogen purged to remove oxygen. Here, the 
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curcumin was added in excess (curcumin: PLA ~6:1) to ensure that all carboxylic acid 
group in PLA chains were conjugated with curcumin molecule. To conjugate, DCC and 
DMAP was mixed in acetone and immediately added to the reactant mixture (syringe 
addition), under sealed conditions at room temperature. The reaction was allowed to 
proceed for ~48 hr.  
A-3.3. Purification of Curcumin-PLA 
Post reaction time (~2 days), the reaction mixture was subjected to primary purification 
using cold ether precipitation (atleast twice). During this process PLA-based chains (PLA 
or PLA-drug conjugate) separates out from excess or unreacted curcumin. To remove any 
possible trace of free curcumin from the product (curcumin-PLA), the precipitate was 
subjected to secondary purification using cold methanol. During this process, the polymeric 
chains were dissolved in chloroform and was added dropwise to cold methanol. Any trace 
amount of curcumin in the product dissolves in methanol (liquid phase), whereas relatively 
higher polymeric PLA chains forms a rubbery mass, which was isolated and dried off.  
A-3.4. Characterization of Curcumin-PLA 
The obtained product was characterized using gel permeation chromatography (GPC), 
which apart from the determining shifts in polymeric molecular weight upon curcumin 
conjugation was used in determining the presence of free curcumin. From results, a subtle 
increase in molecular weight after curcumin conjugation to poly(lactic acid) chains was 
observed, an indication of change in its molecular hydrodynamic radius (Figure A-3.2). 
These curcumin conjugated polymer (curcumin-PLA) can be detected under (free 
curcumin) wavelength λ=420 nm, which cannot be ascertained for free PLA chains, 
suggestive of formation of drug-polymer conjugate (Figure A-3.3). Further, the product 
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was also characterized using reverse-phase high pressure liquid chromatography (RP-
HPLC) and proton nuclear magnetic resonance spectroscopy (1HNMR).  
Polymer product was also subjected to reverse phase-HPLC analysis in 
substantiating drug-polymer conjugation. During RP-HPLC analysis, acetonitrile and 
water with 0.1% phosphoric acid (vol%) was used as the respective organic and polar 
phase. To facilitate for an easier separation of curcumin from curcumin-PLA conjugates, a 
gradient mode was used. In gradient HPLC mode, the organic solvent phase was increased 
from 50% to 100% (vol%) at a rate of 3.33 (vol%/min). From RP-HPLC analysis, a shift 
in column elution time was expected post-drug conjugation with polymeric chain. By 
conjugating a hydrophobic drug such as curcumin to PLA chains results in further increase 
in its overall hydrophobicity. In corroboration, the curcumin-PLA chains possessed a much 
higher affinity for C18-HPLC columns, and thereby eluted at a much higher time point in 
comparison to either curcumin or PLA chains (Figure A-3.5). The 1HNMR 
characterization also confirmed the presence of curcumin moieties in polymeric PLA 
chains (Figure A-3.4), where the proton contributions from both PLA peaks (-CH3 and –
CH peaks) and curcumin (-OCH3) peaks was observed in the product. It should be noted 
that the proton contributions from curcumin in curcumin-PLA conjugate is very subtle, this 
is due to the presence of overwhelming PLA protons in the conjugated product.  
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Figure A-3.1. Reaction scheme showing synthesis of curcumin conjugated poly(lactic 
acid) using a carbodiimide coupling chemistry 
Reaction scheme showing formation of curcumin-poly(lactic acid) conjugate by reacting 
carboxylic acid moieties in poly(lactic acid) with hydroxyl groups in curcumin, using N, 
N’-dicyclohexylcarbodiimide (DCC) as a coupling agent. The role of 4-
dimethylaminopyridine (DMAP) is to minimize the side reaction (reduce O-acryl 
intermediate to N-acyl urea conversion).  
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Figure A-3.2.  Molecular weight characterization using gel permeation 
chromatography on curcumin conjugated poly(lactic acid) 
GPC molecular weight characterization on curcumin-poly(lactic acid) conjugate and 
reactants (curcumin, poly(lactic acid)). Plot shows a subtle increase in molecular weight 
after curcumin conjugation in curcumin-PLA, this can be observed from cross-comparison 
with unconjugated polymer PLA. Also, absence of free curcumin (peak at t ~21.5 min) in 
curcumin-PLA suggests its product purity.   
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Figure A-3.3. Detecting the presence of conjugated curcumin in curcumin-PLA using 
gel permeation chromatography 
Using UV detection during GPC molecular weight characterization on curcumin-
poly(lactic acid) conjugate and reactants (curcumin, poly(lactic acid)). Optical absorbance 
of curcumin is at wavelength, λ= 420 nm. Using GPC (size based separation), it was 
observed that poly(lactic acid) chains contains curcumin optical signature (peak at retention 
time 14 to 17 min), suggesting conjugation of curcumin with polymeric chains (see inset). 
Free PLA chains (control) lacks this peak, due to absence of curcumin molecule. 
Expectedly, the free curcumin drug elutes at higher retention time (peak at ~21 min), due 
to its smaller molecular size and was observed readily at this wavelength.  
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Figure A-3.4. Proton-NMR characterization on curcumin-PLA conjugate 
1H-NMR characterization on curcumin-PLA conjugate verifies the conjugation of curcumin with polymeric PLA chains. This was 
substantiated from the presence of proton contributions from both PLA peaks (-CH3 and –CH peaks) and curcumin(-OCH3) peaks. The 
proton contributions from curcumin in curcumin-PLA conjugate is very subtle, due to the presence of overwhelming PLA protons in 
the conjugated product. 
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Figure A-3.5. Detecting the presence of free and conjugated curcumin in curcumin-
PLA using reverse phase-HPLC 
Using UV detection during reverse-phase HPLC characterization on product curcumin-
poly(lactic acid) conjugate, and free curcumin. Optical absorbance of curcumin is at 
wavelength, λ= 420 nm. During the affinity based chromatographic separation, curcumin 
elutes much quickly (retention time ~8 min), while curcumin-PLA conjugates which were 
comparatively more hydrophobic eluted at a much higher time scale (retention time 
~17min). Since the drug-polymer conjugate detection was carried out at a wavelength, 
λ=420 nm, which is specific only to free curcumin, it corroborates curcumin conjugation 
to the PLA chains.  
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LIST OF ABBREVIATIONS 
 
 
ACN      Acetonitrile 
AFM   Atomic force microscopy 
B-CDV  Biotinylated cyclodextran 
Biotin-FM  Biotinylated filomicelles 
Biotin-micelle  Biotinylated micelle 
Biotin-PAA  Biotinylated poly(acrylic acid) 
Biotin-PEG-NH2 Biotinylated poly(ethylene glycol)-amine 
Biotin-PEG-PLA Biotinylated poly(ethylene glycol)-block-poly(lactic acid) 
copolymer 
Biotin-SM  Biotinylated spherical micelles 
Biotin-0/PAA225k Non-biotinylated PAA  (MW ~225 kDa) 
Biotin-40/PAA225k Biotinylated PAA  (#40 Biotin molecule per PAA chain) 
BSA   Bovine serum albumin 
Capped FM  FM network with cappings 
C-CDV  Concanavalin A conjugated cyclodextran 
CFU   Cell forming units 
CLSM   Confocal laser scanning microscopy 
CMP   Cervical mucus plug 
CNT   Carbon nanotube 
CNW   Cellulose nanowhisker 
COPD   Chronic obstructive pulmonary disease 
CS    Chondroitin sulfate  
DA   Dopamine 
DAS   4,4’-diazido-2,2’-stilbenedisulfonic acid disodium 
DCC   N,N’-Dicyclohexylcarbodiimide 
DCM   Dichloromethane 
DCU   Dicyclohexylurea 
DDS   Drug delivery systems 
DMSO   Dimethyl sulfoxide 
DOPA   Dihydroxyphenylalanine 
DI   Deionized water 
ECM   Extracellular matrix 
EDC   1-ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride 
EO   Ethylene oxide 
FM   Filomicelles or Filamentous micelles 
FM-LBL  Layer-by-layer networks of filomicelles 
FTIR   Fourier transform infrared spectroscopy 
GI   Gastro-intestine  
GMB   Gastric mucosal barrier 
GPC   Gel permeation chromatography 
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HABA   4'-hydroxyazobenzene-2-carboxylic acid 
1H-NMR  Proton nuclear magnetic resonance 
HPMC   Hydroxypropylmethylcellulose 
LBL   Layer-by-layer 
MES   2-(N-morpholino)ethanesulfonic acid 
MIC   Minimum inhibitory concentration 
Micelle-LBL  Layer-by-layer network of micelles 
mPEG   Methoxy-poly(ethylene glycol) 
mPEG-PLA  Methoxy-poly(ethylene glycol)-block-poly(lactic acid) copolymer 
MW   Molecular weight 
NHS   N-hydroxysuccinimide 
NoL   Number of micelle addition cycles in micelle networks 
NoLcapping  Number of polymer addition cycles in capping layers 
NP   Nanoparticle 
OD   Optical density 
PAA   Poly(acrylic acid) 
PAH   Poly(allylamine hydrochloride) 
PC   Phosphorylcholine 
PE   Polyelectrolytes 
PEG   Poly(ethylene glycol) 
PEO-b-PCL  Poly(ethylene oxide)-block-poly(caprolactone) 
PEG-b-PLA  Poly(ethylene glycol)-block-poly(lactic acid)  
PEG-b-PLGA  Poly(ethylene glycol)-block-poly(D, L-lactic-co-glycolic acid) 
PEI   Poly(ethyleneimine) 
PEM   Polyelectrolyte Multilayers 
PLA   Poly(lactic acid) 
PLA-COOH  Acid-terminated poly(lactic acid) 
PLL   Poly(L-lysine) 
PS   Poly(styrene) 
PSS   Poly(sodium-p-styrene sulfonate) 
PTA   Phosphotungstic acid 
RFU   Relative fluorescence intensity 
ROP   Ring opening polymerization 
RP-HPLC  Reverse Phase- High Performance Liquid Chromatography 
SEM   Scanning electron microscopy 
SM   Spherical micelles 
SM-LBL  Layer-by-layer networks of spherical micelles 
TCA   Trichloroacetic acid 
TFA   Trifluoroacetic acid 
UF   Ultrafiltration 
125I-streptavidin   Radiolabeled streptavidin 
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